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A collection of twenty three selectively mono-protected di- and triamines, masked 
with the Boc, Fmoc or Ddiv protecting groups, were synthesised via continuous flow 
synthesis in a self-assembled meso-scale PTFE flow reactor. The continuous flow 
strategy offered direct access to the mono-protected compounds in good yields, 
especially in the case of the Fmoc carbamates which circumvented the use of another 
sacrificial protecting group. Two of the mono-Boc-protected carbamates were used as 
starting materials to generate N-alkylglycine monomers; synthesised via tandem 
mono-alkylation and Fmoc carbamation, linked by an in-line scavenging protocol 
using a silica-based trisamine scavenger resin. The final step of the monomer 
synthesis employed catalytic transfer hydrogenolysis using 20% Pd(OH)2/C and 1,4-
cyclohexadiene. The three-step flow procedure gave access to two monomers, with 
one of them being a novel N-alkylglycine unit bearing a triethylene glycol bridge. 
 
The monomers were used as building blocks to assemble new oligo-N-alkylglycines 
(peptoids) via microwave-assisted solid phase synthesis. Three different types of 
peptoids were synthesised: (i) oligo-N-(6-aminohexyl)glycines (“standard” peptoids), 
(ii) oligo-N-{2-[2-(2-aminoethoxy)ethoxy]ethyl}glycines (“triethylene glycol” [TEG] 
peptoids) and (iii) hetero-oligomers of alternating “standard” and “TEG” monomers 
(“hybrid” peptoids). The peptoids were evaluated for their cellular permeability and 
cytotoxicity with HeLa, HEK-293 and CHO cells. All the peptoids were shown to be 
non-cytotoxic at 10 µM based on cell proliferation assays. In general, it was found 
that the cellular uptake of the hybrid peptoids outperformed their standard and TEG 
analogues. Flow cytometry and confocal microscopy results revealed that the hybrid 
nonamer had the highest cellular uptake efficiency of all the peptoids synthesised. At 
a concentration of 1 µM, it outperformed the second best molecular transporter 




Chemical synthesis is broadly defined as the process of designing and constructing 
molecular structures. The conventional way of performing chemical synthesis relies 
heavily on traditional glassware set-ups that have remained relatively unchanged since 
the first lab reaction was performed in the 19th century. While round bottom flasks are 
cheap and easily replaceable, they are non-ideal in assisting reaction control due to 
their rigidity and size. An alternative technology in the form of tube-shaped plastic 
reactors, with shrunken dimensions (big enough to only fit a pinhead), has allowed 
chemists to manipulate chemical reactions in entirely different ways and this has led 
to the emergence of flow chemistry.  
 
This project has utilised flow chemistry to make peptoid monomers, the fundamental 
components of peptoids (a type of biologically active compounds), in a more efficient 
process. The monomers were built by linking a series of individual chemical reactions 
together in a flow reactor to increase productivity and minimise waste. They were 
then used as “building blocks”, much like the individual pieces in a Lego’s play kit, to 
assemble more complicated molecules (peptoids) for biological evaluation. The 
peptoids were tested for their efficiency in penetrating the plasma membrane of 
cancer cells, as well as their inherent potential to cause cell death. A chemical dye 
was attached to the peptoids to serve as a tracker to observe the movement of these 
compounds in cells. 
 
Peptoids that can cross the cellular barrier efficiently, without causing any significant 
cell mortality, can be used as delivery agents. Cargos such as drugs or genes (which 
would otherwise have problem penetrating the plasma membrane) can be transported 
into cells, for investigative or therapeutic purposes, by attaching them to peptoids. 
This research showed that peptoids that were built from two different types of 
monomers (hybrid peptoids) were much better transporters compared to those made 
entirely of a single monomer type (standard peptoids). The hybrid system possesses 
just the right balance of characteristics needed for membrane penetration. As a result, 
the hybrid peptoids have immense potential to be used as transporters in biochemical 
research. 
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CHAPTER 1  
INTRODUCTION 
 
1.1 Continuous Flow Synthesis – An Overview 
 
The concept of continuous flow processing has been used extensively in industrial 
manufacturing and processing activities, long before it was explored and adopted by 
bench chemists.1 Industrial scale processes such as the production of fine chemicals 
and petroleum refining inherently restrict the exclusive use of batch processing due to 
engineering issues as well as health and safety concerns.2 The continuous flow 
approach not only reduces the risks associated with scaled-up chemical processing, 
but also increases overall production capacity as a result of improved output generated 
by a “non-stop” feed stream of raw materials and reduces down-time of capital 
expensive plants.3,4 The potential of continuous flow processing caught the attention 
of research chemists working on laboratory scale syntheses and hence, the technology 
has been gradually developed and transferred to the bench over time.5-7  
The use of microreactors was heavily favoured when flow chemistry was first 
introduced, with these chip-based reactors fabricated using a diverse selection of 
materials (i.e. glass, elastomers, silicon, quartz, fluoropolymers, metals and 
ceramics).8-10 A wide range of organic synthetic transformations have been carried out 
in microreactors and extensive reviews have since been published which summarise 
the breadth of work performed by academic and industrial groups.11-13 While chip-
based reactors were immensely popular early on, technical issues such as irreversible 
channel blockage due to material precipitation and joint leakage seriously affected the 
reliability of microreactors. Over time, attention slowly shifted to other types of flow 
reactors with larger reaction chambers.14,15 The increased dimension of flow reactors 
from micro- to mesoscale not only improved plugging issues but also expanded the 
usability of the reactors. New generation flow reactors are commonly fitted with 
auxiliary components such as mixers, back pressure regulators and heat exchangers to 
enable a full range of chemically useful processing parameters.16-18 The reactor 
accessories, for example, promote enhanced solution mixing and enable super heating 
of solvents above their respective boiling points to allow a whole new level of 
reaction manipulation.19,20  
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“Shrinking” the reaction vessel’s volume provides access to vastly different 
physical properties, not normally seen at the macro level.21 As the internal volume of 
reaction is often kept to within a few millilitres, the reaction time of a chemical 
transformation is significantly shortened due to the marked improvement in heat 
transfer, mass transport and diffusional flux per unit volume / unit area.22 Precise 
control over the overall reaction time increases reaction selectivity, and the formation 
of side products is greatly reduced as a result of optimised contact time between 
substrates and reagents. Due to the small internal volume of flow reactors, rapid 
screening of chemical reactions can be achieved using only small quantities of 
reagents and catalysts.23 Hence, reaction optimisation can be economically 
accomplished with minimal generation of waste.24,25 Isothermal conditions are easily 
achieved due to the highly efficient heat exchange between a flow reactor and its 
surrounding environment.26 A narrow thermodynamic profile prevents the formation 
of hotspots which can lead to the initiation of unwanted side reactions and product 
decomposition.27 The continuous flow method thus serves as an excellent alternative 
to batch synthesis, which suffers from many physical drawbacks such as low reactor 
surface area to volume ratio and progressively declining rate of reaction as the 
concentration of reactants drop over time. As a consequence, chemical systems in 
batch reactors can experience poor heat transfer as well as inefficient mass transport 
which in turn can lead to poor reaction selectivity and product yields.  
 
1.2 Physical Characteristics of Flow Reactors 
 
Flow synthesis exploits the intrinsic properties of flow reactors which differ 
significantly from conventional macroscale organic laboratory synthetic apparatus.28 
Hollow channels, with well-defined internal diameter, are used as the physical 
reaction platform as opposed to ubiquitous round bottom flasks. In essence, a flow 
reactor is a modular, three dimensional reaction platform which enables spatial and 
temporal manipulation of mobile fluid streams (Figure 1.1). The inner dimension of a 
flow reactor typically exists in the range of 0.01 – 1.00 mm offering a very different 
physical environment in comparison to batch reactors. Starting materials are 
introduced separately via different inlets and converge at a mixing zone. From this 
point onwards, the mixture is fed into a common tubular space in which the chemical 




























Figure 1.1 An assortment of flow reactors made from different materials: AM Technology’s CoFlore 
disc reactor (A); Sigma-Aldrich’s glass microreactor (B); Thales Nano’s X-Cube stainless steel reactor 
(C); PTFE-based flow reactor (right) and a modified Thales Nano’s H-Cube (left) used for 
experimental work in this thesis (D).  
 
As the phrase ‘continuous flow’ itself suggests, substrates or reagents are 
continuously fed into the reactor to derive synthetically useful compounds. This is 
normally achieved via hydrodynamic pumping using standard high pressure liquid 
chromatography (HPLC) pumps. The reaction essentially begins at the point of 
mixing and ends upon exiting the reactor; effectively establishing a space-to-time 
relationship.21 In a flow reactor with fixed volume, the duration of the reaction is 
determined by the total flow rate of the reaction stream. The residence time (τ) of a 
reaction is defined as the total time spent within the flow reactor; as the reaction 
stream travels from the point of entry to the point of exit, and immediately quenched 
thereafter. This is represented by Equation 1:    
1−= VQτ    (1) 
where  τ = Residence time 
V = Internal volume of the flow reactor 




By keeping the internal volume of the flow reactor constant, the residence time can be 
controlled by adjusting the total flow rate of reaction. 
In addition, a continuous flow platform is often modular in nature and thus, 
has the flexibility to incorporate additional experimental set-ups to enable the 
comprehensive management of a chemical reaction. This build-as-you-go-to 
architecture works much like a Lego® play kit, giving users the ability to tailor their 
hardware according to different synthetic needs. As a result, individual stages of 
synthesis, reaction sampling, work-up and purification can be combined into a linear 
sequence to produce a seamless automated process.29-31 In contrast, conventional 
batch synthesis tends to be segmented with multiple sampling and intermediate 
purification steps involving manual processing.  
 
1.3 Challenges and Opportunities in Practical Flow Chemistry 
 
The use of flow chemistry as an alternative method to conventional batch synthesis 
presents vastly different challenges.32 In general, the continuous flow method has 
been lauded to deliver superior reaction selectivity. Better reaction selectivity leads to 
the minimisation of side product formation and thus, higher product yields. However, 
achieving significant reaction selectivity via the continuous flow route necessitates the 
use of specialised flow instruments which are not readily available to most chemists. 
While there are instrument manufacturers which specialise in the production of ready-
to-use continuous flow platforms (e.g. Syrris, Uniqsis and Vapourtec), these 
commercial systems can be cost prohibitive.  
In addition, most commercial flow systems are built for specific purposes and 
performing different chemical transformations requires switching of instruments. As a 
consequence, a substantial investment of hardware (i.e. mechanical pumps, reactors 
and accessories) has become a prerequisite prior to adopting the technology. 
Furthermore, each chemical reaction is typically assessed in batch mode before 
performing a continuous flow trial due to the significant risk of material 
incompatibility. Precipitation of reactants, products or side products during the course 
of synthesis will inevitably result in channel blockage and could damage the 
expensive flow reactors. Therefore, transferring a routinely performed synthesis from 
the round bottom flask to the continuous flow platform requires careful reaction 
scoping; taking into consideration solvent compatibility and reactant selection.  
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Despite the aforementioned challenges, flow chemistry does offer two key 
opportunities that are immensely attractive to research chemists.33 The promise of 
product scalability is rooted in the principle of ‘scaling out’ which replaces the 
conventional approach of batch ‘scale up’. Once an optimal reaction condition is 
identified, a continuous flow reaction is simply left to run for an extended duration to 
produce the desired quantity of product.34 This approach removes the process of re-
optimisation carried out in batch synthesis which is not only laborious but also 
introduces variability in product yield. Another option uses the ‘numbering up’ 
approach which promotes the use of parallelisation by splitting common feed streams 
into multiple flow reactors to achieve higher throughput.35,36  
Hence, it is possible to produce multi-gram quantities of target compounds 
using a relatively compact platform without the need to increase the foot print of the 
synthetic set-up. The same synthetic platform can be used for the initial reaction 
screening as well as the subsequent product scale out. In flow synthesis, the yield of a 
reaction can be conveniently transformed into a measurement of productivity.37 The 
second defining hallmark of the continuous flow method is the possibility of linking 
multiple synthetic steps into one linear process.38-40 With fewer intermediate 
purification steps, the duration of the overall synthesis could be shortened and product 
loss can be minimised to give higher product yield. Contrary to popular belief, multi-
step continuous flow synthesis does not necessarily entail the use of packed reagents, 
catalysts or scavengers.41-43 A target compound can be synthesised by linking several 
sequential reactions together without undergoing any intermediate purification as long 
as the chemical components within the reaction system are mutually compatible.44,45  
 
1.4 Analysis of Flow Literature  
 
An analysis of the flow literature from 2009 to 2013 revealed a growing trend of 
synthetic diversification which explores the many possibilities of utilising the 
continuous flow method to perform new synthetic endeavours. Due to the breadth of 
published work associated with flow chemistry, the term “continuous flow synthesis” 
was used as the key search phrase in identifying the most relevant publications in the 
literature pool. Using SciFinder, a topic query on the database of American Chemical 
Society’s Chemical Abstract Services returned a total of 121 publications. From 2009 
to 2013, there was an approximately four-fold increase in the number of papers 
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published, showing a growing influence of the continuous flow approach in different 





























Figure 1.2 The number of scientific publications directly associated with the term “continuous flow 
synthesis” based on the results returned by SciFinder on American Chemical Society’s Chemical 
Abstract Services (data as of March 2014).  
 
A further breakdown of the publication output reveals six main areas which 
have successfully adopted flow chemistry as shown in Figure 1.3. Using the 
continuous flow method to synthesise organic compounds is by far the most prevalent 
undertaking among research chemists in the past five years. This accounts for 40% of 
materials published in public domain, followed by nanoparticle synthesis (25%), 
continuous flow technology development (8%), catalysis (7%), polymer synthesis 
(5%), and the fabrication of organic electronic materials (4%). Specific to the 
synthesis of organic compounds, the target compounds synthesised has grown in 
complexity, combining multiple technologies to achieve a unique platform customised 
for each type of synthetic work. During the first half of the last decade, the focus of 
continuous flow organic synthesis was primarily on one-step transformations which 
are relatively straight forward, producing small organic molecules in high yields and 

























Figure 1.3 A total of 121 continuous flow synthesis publications, from 2009 to 2013, divided into six 
main research areas according to their respective frequencies. Notable examples of organic compounds 
which have been synthesised via flow chemistry are included.  
 
The first significant step towards fully unlocking the massive potential of the 
continuous flow method was made in 2006 when Baxendale et al. demonstrated the 
seven-step synthesis of a marine natural product – (±)-oxomaritidine, using 
immobilised reagents, catalysts and scavengers.46 This work led to more tandem 
transformations, connecting several steps into a sequence of multi-phase synthesis 
incorporating in-line analyses, work-up and purification.47-51 With regard to other 
more specialised work, nanoparticle and polymer syntheses benefit enormously from 
the narrow channels of flow reactors, providing a stringent control on particle size and 
molecular weight distribution which are often problematic in batch reactions.52,53 In 
addition, the development of the continuous flow method in recent years has also seen 
the inclusion of (i) microwave technology to promote process intensification and 
catalysis, as well as (ii) simulated moving-bed chromatography to link synthetic steps 
to the purification process.30,54 
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1.5 Overview of PhD  
 
The objectives of this PhD project were: (i) to build a self-assembled continuous flow 
platform capable of addressing the synthetic requirements of a research laboratory; 
(ii) to transfer an existing batch chemistry to the continuous flow mode via reaction 
screening, optimisation and scale out; and (iii) to apply the synthesised compounds as 
building blocks for chemical biology investigations. The project sought to explore the 
themes of reaction selectivity and product scalability in continuous flow chemistry by 
developing new synthetic methodologies that are both practical and accessible to 
research chemists. The work presented in this dissertation is divided into three main 
parts – Introduction (Chapter 1), Research Work (Chapter 2 – 4) and Experimental 
(Chapter 5). A brief overview of the research work is described in the following 
paragraph.  
Chapter 2 of this dissertation presents the selective mono-protection of di- and 
triamines as carbamates and enamines with three different types of protecting group. 
Twenty three compounds, with N-Boc, N-Fmoc and N-Ddiv protected amines of 
varying methylene spacer lengths, were synthesised via the continuous flow method. 
Moreover, six members of the library also contain ethylene glycol bridges separating 
the two terminal amino moieties. The stability of the N-Ddiv compounds to N→N’ 
migration were also investigated. Using two of the N-Boc-protected compounds as 
starting materials, Chapter 3 examines the multi-step continuous flow synthesis of N-
alkylglycine (peptoid) monomers, involving selective mono-alkylation, Fmoc 
carbamation and catalytic transfer hydrogenolysis. The first two steps were linked as a 
tandem sequence via the use of silica-based trisamine scavenger to remove excess 
alkylating agents in the reaction system. The last synthetic step was performed in a 
modified commercial hydrogenation platform (H-Cube). A transfer catalytic 
hydrogenolysis procedure was developed using 20% Pd(OH)2/C and 1,4-
cyclohexadiene as the catalyst and hydrogen donor pairing.  
Two different N-alkylglycine monomers were synthesised via the continuous 
flow method and used as the building blocks of oligo-N-alkylglycines. Chapter 4 
describes the microwave-assisted solid phase synthesis of oligo-N-alkylglycines and 
their biological evaluations. Nine different N-alkylglycine oligomers were assembled 
via solid phase synthesis and they were grouped into three categories, named 
Standard, Triethylene glycol (TEG) and Hybrid, according to their chemical 
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structures. The syntheses of the TEG and hybrid peptoids were aided by microwave 
irradiation. All the oligomers were evaluated for their cellular permeability and 
cytotoxicity in different cell lines. The significance of the biological results are 
highlighted at end of the chapter. In all three chapters, the synthetic protocols, along 
with the yield of each compound, are reported and discussed.  
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CHAPTER 2  
FLOW MEDIATED MONO PROTECTION OF DI- AND TRIAMINES 
 
2.1 Background: Selective Protection of Amines  
 
The use of different protecting groups to facilitate the construction of structurally 
complex compounds (e.g. peptides, oligosaccharides, glycolipids, etc.) has become a 
common strategy in the field of organic synthesis.55 While considerable efforts have 
been invested towards the development of novel protecting-group-free (PGF) 
synthesis, a large number of existing reactions are still overwhelmingly dependent on 
the use of protecting groups to mask competing reactivities of multi-functional 
molecules.56 Thus, the selective protection of functional groups is often regarded as a 
challenging aspect of synthetic work born out of sheer necessity. Mono-protected 
aliphatic compounds are especially important as they are commonly used as spacers, 
linkers or scaffolds in larger molecular assemblies.57-59 
It is widely known that the selective mono-protection of a multi-functional 
molecule with two or more chemically identical moieties is difficult to achieve due to 
competing active sites between the unprotected substrate and the mono-protected 
product. Conventional synthetic practice of using one-to-one equivalent of reagent to 
substrate in generating the desired mono-protected compound often results in poor 
product yield due to the formation of the di-protected side product.60,61 In overcoming 
this, different strategies have been introduced to achieve a high degree of selectivity.62 
The reactivity of protecting group precursors plays an important role in inducing 
reaction mono-selectivity. Pittelkow et al. demonstrated the use of tert-butyl phenyl 
carbonate to generate N-tert-butyloxycarbonyl protected diamines in decent yields.63 
However, the reduced reactivity of the phenyl carbonate based precursor necessitates 
aggressive reaction conditions to promote the carbamation reaction. 
An alternative method to promote reaction selectivity was reported by Pringle 
via the concept of “ionic immobilisation” utilising strong cation exchange (SCX) 
chromatography.64 This was preceded by the work of Das et al. who employed 
sulfonic acid functionalised silica as a heterogeneous “catalyst” to attain 
chemoselective protection of various amino compounds.65 In addition, mono-
acylation of cyclic diamines on solid phase has also been investigated.66 Subsequent 
cleavage from the solid support leads to the formation of the mono-protected products 
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in good yields. However, this approach falls short in term of synthetic efficiency due 
to the additional synthetic steps involved (i.e. resin binding and cleavage) which 
limits the step economy of the reaction (Scheme 2.1).67 The use of chemical 
auxiliaries such as MgCl2 or AlCl3, Cu(BF4)2.nH2O, 9-borabicyclo[3.3.1]nonane (9-
BBN), and HCl to  induce selectivity have also been reported.68-71 While these 








































P.G. = Protecting GroupSi
 
Scheme 2.1 Selective protection of amines via different strategies as reported in the literature.64-66  
 
  A more common solution employed in the literature involves the use of a 
large excess of the reaction substrates (diamines) against the limiting reagent 
(protecting group precursor).72 Even though satisfactory yields (with respect to the PG 
precursor) of the reaction are obtained from such approach, the method itself is less 
than ideal due to a gross violation of atom economy.73 Besides being economically 
wasteful, using a large excess of starting materials is not only environmentally 
unsustainable but also leads to isolation and purification challenges during final work-
up. Presented with the problem of reaction selectivity in the macroscale batch 
environment, the selective mono-protection of di- and triamines using three different 
protecting groups tert-butyloxycarbonyl (Boc), 9-fluorenylmethyloxycarbonyl (Fmoc) 
Ionic Immobilisation 
Heterogeneous “Catalysis” 
Solid Phase Functionalisation 
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and 1-(4,4-dimethyl-2,6-dioxocyclohexylidene)isovaleryl (Ddiv) via continuous flow 
synthesis was investigated.  
The Boc and Fmoc groups are popular masking moieties used in organic 
synthesis. The Boc group can be removed by acid-catalysed hydrolysis whereas the 
Fmoc group is removed by base-catalysed β-elimination.74 On the contrary, the Ddiv 
group is a relatively recent invention which can withstand acidic and basic conditions 
but is readily removed via nucleophilic substitution.75 This chapter discusses the 
selective continuous flow mono-protection of aliphatic acyclic di- and triamines via 
two different types of reaction – (i) N-carbamation of primary amines using Boc and 
Fmoc protecting groups, and (ii) enamination of primary amines with the Ddiv 
protecting group (Scheme 2.2). Di-tert-butyl-dicarbonate (Boc2O) and N-(9-
flourenylmethoxycarbonyloxy)succinimide (Fmoc-OSu) which are commercially 
available were chosen as the protecting group precursors to derive the series of N-
carbamates (-NHCO2R) whereas 2-(1-hydroxy-3-methylbutylidene)-5,5-
dimethylcyclohexane-1,3-dione (DdivOH) was used to generate the enamine 
derivatives (-NHCR1=CR2). These reactions require markedly distinct reaction 





















Scheme 2.2 Formation of primary amine-based N-carbamates and enamine.  
 
2.2 Continuous Flow Set-Up 
 
The reaction set-up for the continuous flow synthesis of mono-protected di- and 
triamines was divided into two stages (Figure 2.1). In the first stage (pre-
conditioning), the reactants were brought to optimum temperature prior to mixing. 
During the pre-conditioning step, the two reactants (amines and protecting group 
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precursors) were pumped through two separate PTFE capillary tubing (0.50 mm I.D.) 










Figure 2.1 Reaction set-up for the continuous flow synthesis of mono-protected di- and triamines. 
 
This was achieved by physically immersing the tubing in a bath set to the 
desired working temperature of the reaction, thus allowing starting materials to be 
pre-conditioned before mixing in the T-mixer. This pre-conditioning reduces the time 
required for the reactants to reach thermal equilibrium within the flow reactor as soon 
as mixing begins and promotes reproducibility. In the second stage (post mixing), the 
reaction proceeded along a PTFE-based flow reactor (0.50 mm I.D., 2.00 mL internal 
volume, 10.16 m total length). Upon exiting the flow reactor, the reaction stream was 
immediately quenched.  
 
2.3 Mono-Boc Carbamation  
 
The first point of investigation was the selective introduction of a Boc group onto a 
symmetrical molecule bearing a pair of terminal amino moieties using Boc2O as the 
protecting group precursor. In continuous flow experiments, yields of reaction are 
controlled via the manipulation of (i) reaction stoichiometry, (ii) reaction temperature 
and (iii) residence time. Solvent screening was initially performed to determine the 
best solvent system for the reaction studied. This was to ensure full physical 
compatibility of the reaction mixture within the flow reactor.  
Precipitation of materials was observed with the use of dichloromethane and 
1,4-dioxane during batch synthesis, hence these solvents were deemed incompatible 














with the flow set-up. Methanol proved to be the ideal solvent as it afforded complete 
solubility of all reactants and product mixtures. 1,6-Diaminohexane 1a was used as 
the arbitrary test substrate during preliminary screenings. In order to minimise the 
formation of side products, reaction screenings were performed at 0°C while the 
residence time was fixed at 1 min. The reaction was quenched by dropping the crude 
stream into a collection vial filled with cold MeOH containing an excess of silica-
based trisamine scavenger. This ensured no further reaction occurred between the 
reactants beyond the stipulated residence time in the flow reactor.   
 
2.3.1 Reaction Stoichiometry, Temperature and Residence Time  
 
With an initial concentration of 0.10 M for both the diamine and Boc2O, the optimal 
reaction stoichiometry was determined. As the stoichiometric excess of the diamine 
was raised from 1.0 to 3.0 equivalents, the corresponding yield of product formation 
increased accordingly (entries a – j, Table 2.1). At 2.5 equivalents of diamine, a 
maximum yield of 70% N-Boc-1,6-diaminohexane 2 was found with no further 
improvement as more diamine was used. Furthermore, the formation of the di-
protected side product 3 was noticeably suppressed (i.e. a decrease of almost six 
times) at higher diamine concentrations (entries a vs. j, Table 2.1). It was evident that 
the mono-protected species predominates when an excess of diamine was used in the 
reaction and the results confirmed previous published reports concerning the positive 
effect of stoichiometric excess of diamine on the selectivity of the reaction.72  
Increasing the reaction temperature from 0 to 25°C had a detrimental effect on 
product yield with more side products formed (entries f – i, Table 2.1). A lower 
reaction temperature proved to be advantageous in slowing down the second 
nucleophilic attack. Thus, using 1.0 to 2.0 equivalents of Boc2O to diamine, a good 
balance between starting material consumption (61% conversion based on diamine) 
and product yield (64%) was achieved (entry f, Table 2.1). Halving the residence time 
from 1.0 to 0.5 min had no appreciable influence on the product output (entries f vs. k, 
Table 2.1), while the yield dropped from 64 to 53% with an extra minute of dwell 
time (entries f vs. l, Table 2.1). Prolonging the residence time undoubtedly increases 
the probability of molecular interaction between the product and the unreacted Boc 
group precursor within the flow reactor. Therefore, the residence time for the reaction 
was kept at 1.0 min.  
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Table 2.1 Formation of mono-Boc-protected diamines 2, 4 and 6 as a function of reaction 


















∆ Residence time, Temperature 
& Reactor I.D.
 









a 1a 1.0 0.5 0 1.0 42 (1 : 0.56)i 
b 1a 1.2 0.5 0 1.0 48 (1 : 0.40) 
c 1a 1.4 0.5 0 1.0 54 (1 : 0.36) 
d 1a 1.6 0.5 0 1.0 52 (1 : 0.34) 
e 1a 1.8 0.5 0 1.0 57 (1 : 0.26) 
f 1a 2.0 0.5 0 1.0 64 (1 : 0.19) 
g 1a 2.0 0.5 25 1.0 53 (1 : 0.22) 
h 1a 2.5 0.5 0 1.0 70 (1 : 0.18) 
i 1a 2.5 0.5 25 1.0 62 (1 : 0.23) 
j 1a 3.0 0.5 0 1.0 67 (1 : 0.10) 
k 1a 2.0 0.5 0 0.5 63 (1 : 0.12) 
l 1a 2.0 0.5 0 2.0 53 (1 : 0.13) 
m 1a 2.0 1.0 0 1.0 53 (1 : 0.23) 
n 1a 2.0 1.6 0 1.0 51 (1 : 0.24) 
o 1b 2.0 0.5 0 1.0 64 (1 : 0.24) 
p 1b 2.0 1.0 0 1.0 60 (1 : 0.15) 
q 1b 2.0 1.6 0 1.0 50 (1 : 0.36) 
r 1c 2.0 0.5 0 1.0 65 (1 : 0.21) 
s 1c 2.0 1.0 0 1.0 66 (1 : 0.13) 
t 1c 2.0 1.6 0 1.0 59 (1 : 0.38) 
i The molar ratio of mono-Boc product to di-Boc side product.  
ii  Conditions: 0.10 M Boc2O as the limiting reagent. MeOH as solvent.  
 16 
2.3.2 Flow Reactor’s Internal Diameter  
 
The role of flow reactor’s internal diameter as a distinct feature of the continuous flow 
process was also examined. While previous published work have utilised 
microreactors and micromixers to achieve selective mono-acylation and alkylation 
respectively, none has specifically studied the relationship between flow reactor’s 
internal diameter and the selectivity profile of a consecutive competitive reaction 
within the meso-scale range.76 Hence, a comparison of product selectivity was derived 
by performing the mono-protection reaction in separate tubular flow reactors of 
different internal diameters (i.e. 0.5, 1.0 and 1.6 mm respectively). Employing test 
substrate 1a, the product yield fell by as much as 11% when the internal diameter 
increased from 0.5 to 1.0 mm. A further increase of 0.6 mm in the cavity size of the 
tubing had little consequence on the isolated yield (entries f, m & n, Table 2.1).  
In order to generate additional evidence, the experiments were repeated with 
1,2-diaminoethane 1b and 1,4-diaminobutane 1c. Based on the results obtained with 
the diamino compounds having shorter alkyl chain length, both the 0.5 and the 1.0 
mm I.D. flow reactors produced comparable product yields in the region of 60 – 66%. 
Interestingly, better mono-selectivity was observed with the use a larger internal 
diameter (i.e. 1.0 mm I.D.) for both compounds 1b and 1c (entries o, p, r & s, Table 
2.1). However, lower yields were obtained with a 1.6 mm I.D. flow reactor and the 
product to side product ratios were conspicuously in favour of the di-protected species 












Figure 2.2 Reactor’s internal diameter vs. product yield of N-Boc-diamines. Conditions: 2.0 equiv 





















I.D. = 0.5 1.0 1.6
- c- i i t i i - - i i
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In general, there was a positive enhancement on the preferential formation of 
the mono-protected product when reactions were performed in flow reactors with 
smaller internal diameters. The mass transfer mechanism in the continuous flow 
system is governed primarily by molecular diffusion.77 This is determined by the fluid 
flow behaviour within the tubular reactor as indicated by the Reynolds number (Re).22 
An Re value below 2300 represents a general laminar flow regime in which viscous 
forces predominate over inertial forces. Using Equation 2: 
 
      Re 
µ
υρ D..
=      (2) 
where ρMeOH at 0°C = 0.81 x 10
3 kgm-3        
υ = 2.00 x 10-3 Lmin-1 
µMeOH at 0°C = 8.17 x 10
-4 Pa.s 
 
The individual Re corresponding to the 0.5, 1.0 and 1.6 mm I.D. flow reactors are 
84.16, 42.08 and 26.30 respectively.  
The calculated values confirmed that non-turbulent flow prevails in all three 
systems but the smallest internal diameter of 0.5 mm produces a disturbed laminar 
flow (i.e. small vortical irregularities occurring at curved fluid path) which has a 
direct effect on the mixing efficiency within the flow reactor. As the starting materials 
converge into a single stream, a smaller internal diameter provides a shorter path of 
diffusion for the reacting molecules to traverse through; hence speeding up the overall 
mixing process which ultimately determines the homogeneity of the solution. 
Achieving a homogenous environment early in the reaction is essential in reducing the 
occurrence of side-reaction as a result of competing cascading reactions among all the 
reacting species. 
As shown in Figure 2.3, the diamine (represented by the blue spheres) must 
effectively diffuse through the product layer (green spheres) as the reaction 
progresses, in order to react with the protecting group agent (yellow spheres). A 
slower rate of mixing, relative to the rate of side product formation, impedes the 
chemical selectivity of the reaction system. When compared to a batch environment, 
inefficient mechanical stirring often leads to poor solution mixing and creates 
localised concentration hotspots of starting materials. System inhomogeneity 
inevitably causes statistically biased distribution of reacting molecules at the expense 




Figure 2.3 Consecutive reactions of (i) product formation (between blue and yellow spheres) and (ii) a 
competitive subsequent transformation of product to side product (between green and yellow spheres).  
 
2.3.3 Synthetic Scope  
 
Based on the optimal reaction parameters established using the test substrates 
aforementioned (entries f, o & r, Table 2.1), the scope of the continuous flow mono-
Boc carbamation reaction was examined with a series of aliphatic acyclic di- and 
triamines of varying alkyl chain length and bridge motifs (Table 2.2). 
For the α, ω-alkanediamines, the yields of the mono-protected species were 
found to be the range of 59 – 77%; demonstrating good overall selectivity but with no 
distinct correlation between product exclusivity and the length of the alkane chain 
(entries a – e, Table 2.2). In addition, a similar level of selectivity was also observed 
with the ethylene glycol-diamines showing a lack of influence of the ethylene glycol 
(EG) moiety on the behaviour of the diamino molecule (entries f & g, Table 2.2). 
When the continuous flow method was used to synthesise mono-Boc protected 
triamines, a higher yield was obtained with diethylenetriamine in comparison to 
4,7,10-trioxatridecan-1,13-diamine (entries h vs. i, Table 2.2). In both cases, side 
products in the form of di- and tri-Boc-protected species were isolated via flash 
column chromatography. The presence of extra methylene groups appears to reduce 
the reaction selectivity as the formation of N,N,N-Boc-protected 4,7,10-trioxatridecan-




Table 2.2 Mono-Boc carbamation of di- and triamines via continuous flow synthesis. 




m = 1, n = 2, o = 1

















m = 2, n = 2








Flow conditions: 1.0 min, 0 oC
H2N NHBoc
n
n = 2 - 6
2.0 equiv
 
Entry Amine Product 
Isolated Yieldi 
(%) 
a H2N NH22  
H2N NHBoc2  
64 
b H2N NH23  
H2N NHBoc3  
77 
c H2N NH24  
H2N NHBoc4  
65 
d H2N NH25  
H2N NHBoc5  
59 
e H2N NH26  


































i Average isolated yield of three separate experiments per entry.  
ii  Conditions: Boc2O (5.0 mmol) : Amine (2.00 equiv) at 0°C and 1.0 min residence time. MeOH 






















2.4 Mono-Fmoc Carbamation 
 
In general, batch synthesis of N-Fmoc diamino compounds has proven to be 
remarkably problematic and there is a lack of preceding literatures on the direct 
synthetic access of the Fmoc-appended target molecules. The prevalent method of 
using a large excess of diamine over the protecting group precursor to gain mono-
selectivity is not suited for mono-Fmoc protection since the Fmoc moiety is easily 
cleaved by free amines (i.e. working as a base in a β-elimination reaction) upon pro-
longed exposure in the solution.  
The most commonly used strategy thus far involves the mono-Boc protection 
of the diamine, followed by an Fmoc protection of the remaining free amino moiety 
and finally, the Boc group cleavage to give the compound of interest.78 The three-step 
procedure is uneconomical and has poor atom economy due to the introduction and 
subsequent removal of a sacrificial protecting group.73 This provides an excellent 
opportunity to demonstrate the flexibility of the continuous flow platform as it would 
offer superb control of reaction time in a meso-scale reaction setting.  
 
2.4.1 Solvent and Concentration  
 
Having established the optimal conditions for the mono-Boc carbamation of diamines, 
an attempt to use the same set of parameters to synthesise an analogous series of 
mono-protected carbamates using Fmoc as the protecting group of interest was made. 
Initial experiments were unsuccessful due to system blockage as a result of material 
precipitation within the flow reactor. The mono- and di-Fmoc-protected compounds 
were found to be insoluble in MeOH and instantly precipitate upon formation.  
Furthermore, the protecting group precursor Fmoc-OSu is rapidly hydrolysed in 
MeOH due to the nucleophilic nature of the solvent. Consequently, solvent screening 
was performed to find a suitable replacement for MeOH.  
Among the polar aprotic (i.e. acetonitrile, ethyl acetate, dichloromethane, 
dimethylformamide and tetrahydrofuran) and non-polar (i.e. 1,4-dioxane and diethyl 
ether) solvents tested, only dimethylformamide afforded acceptable solubility for both 
the starting materials and the resulting Fmoc-protected compounds. Nonetheless, it 
has been observed that the solubility of diamines in DMF decreases with longer alkyl 
chain length and in general, a concentration of 0.10 M provided the optimal 
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compound solubility for all of the diamines used. As a result, the starting 
concentration of Fmoc-OSu was reduced to 0.05 M to retain the same stoichiometric 
excess of diamines to the protecting group precursor (1.0 to 2.0 equivalents). 
Moreover, the residence time was shortened from 1.0 to 0.5 min whilst maintaining 
the reaction temperature at 0°C. The reaction was quenched by dropping the crude 
stream into a collection vial filled with cold methanolic hydrochloric acid (– 20 oC, 
pH 2 – 3) [Details are illustrated in the Experimental Section as Figure 5.2a & b; page 
85]. The free amino moiety was instantly protonated in the acidic solution thus 
preventing further reaction between the reactants. 
 
2.4.2 Synthetic Scope 
 
Based on the new reaction conditions, a series of mono-Fmoc protected compounds 
were synthesised (Table 2.3). In general, good yields ranging from 51 – 63% were 
obtained with the α, ω-alkanediamines with no discernible association between alkyl 
chain length and product mono-selectivity (entries a – d, Table 2.3). However, the use 
of 1,6-diaminohexane 1a only gave a mediocre 45% yield which is lower than a 
statistically favourable outcome (entry e, Table 2.3). This could indicate a limitation 
of the method to effectively derive mono-Fmoc-alkanediamines beyond members 
bearing alkyl backbone longer than five methylene groups. With regard to mono-
Fmoc-EG-diamines, a good selectivity was observed with a 10% yield difference 
between compounds bearing two and three repeating EG units (entries f vs. g, Table 
2.3). Interestingly, substituting Fmoc-OSu with 9-flourenylmethoxycarbonyl chloride 
(Fmoc-Cl) as the protecting group precursor led to significantly lower yields (i.e. 25 – 




Table 2.3 Mono-Fmoc carbamation of diamines via continuous flow synthesis. 




m = 1, n = 2, o = 1












Flow conditions: 0.5 min, 0 oC
H2N NHFmoc
n





Entry Amine Producti 
Isolated Yieldii 
(%) 
a H2N NH22   
HCl.H2N NHFmoc2  
63 
b H2N NH23  
HCl.H2N NHFmoc3  
59 
c H2N NH24  
HCl.H2N NHFmoc4  
51 
d H2N NH25  
HCl.H2N NHFmoc5  
62 
e H2N NH26  
















HCl.H2N O NHFmoc3  
51 
i  Product exists as a hydrochloride salt due to acid quenching. 
ii  Average isolated yield of three separate experiments per entry.  
iii  Conditions: Fmoc-OSu (2.5 mmol) : Amine (2.00 equiv) at 0°C and 0.5 min residence time. 
DMF was used as the solvent. 
 
2.5 Mono Enamination with the Ddiv Group 
 
Whilst numerous publications have reported the selective carbamation of amines, 
limited progress has been made on the non-carbamate based protection route via the 
formation of enamine derivatives using the 1-(4,4-dimethyl-2,6-
dioxocyclohexylidene)ethylene (Dde) protecting group.79 Reactive amines that are 
masked as enamines are typically stable to both acidic and basic conditions, thus 















achieved via nucleophilic substitution) when used in combination with either Boc or 
Fmoc protecting groups.80  
Preliminary work carried out using 1,6-diaminohexane 1a and 2-
acetyldimedone (DdeOH) produced an unstable product which rapidly rearranges 
after chromatographic separation.57 Detailed investigations revealed the inherent 
instability of the mono-Dde protected compound as the Dde group was susceptible to 
nucleophilic removal of the free terminal primary amine upon product isolation. As a 
consequence, the Dde group freely migrates from one molecule to another resulting in 




MeOH H2N NHDden + DdeHN NHDden
Product Side Product
Migration of the Dde group  
Scheme 2.3 Mono-Dde protection of diamines and the resulting Dde group migration.  
 
In addressing the product stability issue, the protecting group precursor 
DdeOH was subsequently replaced with DdivOH which introduces the isovaleryl 










DdeOH DdivOH  
Figure 2.4 Structural difference of the Dde/Ddiv protecting group precursors.  
 
Being a variant of the original Dde group, the Ddiv protecting group offers enhanced 
product stability owing to steric hindrance afforded by the isovaleryl handle. The 
structural modification significantly slows down the rate of protecting group 
migration by limiting the access of any free nucleophiles to the electrophilic β-carbon. 
The desired protecting group precursor was easily synthesised by reacting dimedone 
with pre-activated isovaleric acid to yield DdivOH.75  
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2.5.1 Temperature and Reaction Stoichiometry  
 
Using MeOH as the reaction solvent, the best conditions for the enamination reaction 
were established via continuous flow screening. Taking advantage of the 
chromophore of the Ddiv group, HPLC was used as a tool to rapidly establish the 
favoured reaction parameters (i.e. methyl benzoate was used as an internal standard to 
standardise all HPLC results). The reaction was quenched by dropping the crude 
stream into a collection vial containing cold MeOH (–20 oC).  
 Among the key parameters studied, temperature was found to play the most 
significant role in promoting the enamination reaction. No product formation was 
observed below 90°C with a residence time window of two minutes. Hence, the 
reaction temperature was gradually increased until the mono-Ddiv test compound 30 
was detected by HPLC analysis. When compared with the same residence time, 
raising the reaction temperature from 120 to 130°C consistently gave higher product 
yields. However, product mono-selectivity was adversely affected when the reactants 
were subjected to prolonged heating. At 130°C, a substantial drop in product yield 
was observed when the residence time was extended from one to two minutes (entries 
k vs. l, Table 2.4).  
Hence, the exposure of reactants to elevated temperatures must be carefully 
controlled to avoid feeding excessive energy into the reaction system which promotes 
the formation of unwanted side products. With regard to reaction stoichiometry, it was 
shown that increasing the stoichiometric excess of the diamine from 1.2 to 2.0 
equivalents improved the product mono-selectivity from 57 to 81% (entries c vs. k, 
Table 2.4). This demonstrates a strong positive influence of substrate concentration on 
the corresponding yield of the mono-Ddiv compound; similar to the preferential 
formation of mono-carbamates as discussed in earlier sections. 
 25 
Table 2.4 Formation of N-Ddiv-1,6-diaminohexane 21 as a function of reaction stoichiometry, 










∆ Residence time & Temperature
 








a 1.2 120 1.0  53 (1 : 0.30)iii 
b 1.2 120 2.0 44 (1 : 0.39) 
c 1.2 130 1.0 57 (1 : 0.29) 
d 1.2 130 2.0 53 (1 : 0.43) 
e 1.5 120 1.0 65 (1 : 0.30) 
f 1.5 120 2.0 66 (1 : 0.50) 
g 1.5 130 1.0 71 (1 : 0.40) 
h 1.5 130 2.0 65 (1 : 0.33) 
i 2.0 120 1.0 75 (1 : 0.28) 
j 2.0 120 2.0 64 (1 : 0.30) 
k 2.0 130 1.0 81 (1 : 0.24) 
l 2.0 130 2.0 29 (1 : 2.48) 
i System was pressurised to 5 bar. 
ii Methyl benzoate was used as an internal standard . HPLC wavelength – 254 nm.  
iii  The integrated peak ratio of product 21 to side product 22. 
iv  Conditions: 0.10 M DdivOH as the limiting reagent. MeOH as solvent. 
 
2.5.2 Synthetic Scope 
 
A series of mono-Ddiv protected compounds were synthesised employing the most 
favourable conditions found during the reaction screening stage (Table 2.5). Excellent 
yields (i.e. 91 & 80% respectively) were obtained with shorter members of the α, ω-
alkanediamine family (entries a & b, Table 2.5). This suggests the tangible influence 
of a steric field exerted by the Ddiv group within its vicinity; thus restricting the 
access of the remaining free terminal amine to another DdivOH molecule. 
As the backbone length increases, less of the spatial hindrance effect is 
transferred across the alkyl bridge resulting in a steady decline of product mono-
selectivity (entries c – e, Table 2.5). Nonetheless, the inference excludes EG-diamines 
as a higher product yield (i.e. 71%) was obtained with a diamine molecule bearing 
three repeating EG units vis-à-vis its shorter analogue (entries f vs. g, Table 2.5). In 
order to determine the stability of the mono-Ddiv compounds, their half lives were 
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measured via HPLC analysis. With initial concentrations of 1.1 – 2.2 mM, pure 
mono-Ddiv compounds were heated to 80°C for 16.5 h. Based on the calibration 
curves of product concentration against time, the corresponding half lives for the 
compounds studied were between 8.4 and 25.4 h at 80oC (Table 2.6). 
 
Table 2.5 Mono-Ddiv enamination of diamines via continuous flow synthesis. 




m = 1, n = 2, o = 1












Flow conditions: 0.5 min, 0 oC
H2N NHDdiv
n
n = 2 - 6
2.0 equiv
 
Entry Amine Product 
Isolated Yieldi 
(%) 
a H2N NH22   
H2N NHDdiv2  
91 
b H2N NH23  
H2N NHDdiv3  
80 
c H2N NH24  
H2N NHDdiv4  
72 
d H2N NH25  
H2N NHDdiv5  
72 
e H2N NH26  
















H2N O NHDdiv3  
71 
i Average isolated yield of three separate experiments per entry.  
ii  Conditions: DdivOH (5.0 mmol) : Amine (2.00 equiv) at 130°C and 1.0 min residence time. 






















oC   
(h) 
a 
H2N NHDdiv2  
1.6 8.4 
b H2N NHDdiv3  
2.2 8.4 
c H2N NHDdiv4  
1.6 12.0 
d H2N NHDdiv5  
1.5 15.1 







g H2N O NHDdiv3  
1.1 12.1 
i Compounds were dissolved in MeOH. 
 
2.6  Summary 
 
A composite library of twenty three selectively mono-protected aliphatic acyclic di- 
and triamines was synthesised via continuous flow (Table 2.7). Members of the 
library, bearing three different orthogonally compatible protecting groups – Boc, 
Fmoc and Ddiv, were generated in good to excellent yields (i.e. 45 – 91%) using a 
meso-scale continuous flow reactor. As a result of enhanced mixing and efficient 
physical transport within a meso-scale environment, the continuous flow method 
demonstrates a high level of reaction selectivity control through a combination of 
spatial and temporal manipulation as opposed to conventional applications of catalysts 
or chemical auxiliaries. Using protecting group precursors which are commercially 
available (Boc2O and Fmoc-OSu) as well as easily accessible synthetically (DdivOH), 
the newly developed procedure provides an economical alternative to existing 
synthetic routes which are costly and restrictive in scale.  
Owing to the flexibility of the continuous flow system, optimal reaction 
conditions for a specific reaction can be easily adjusted as a function of fluid flow rate 
and bath temperature. In general, short residence time and low reaction temperature 
(i.e. 1 min at 0°C) favour the carbamation reaction whereas enamination of the 









130°C). As DdivOH is sterically hindered, a significantly higher reaction temperature 
is required to increase the rate of effective molecular collisions to facilitate the 
enamination reaction. With the continuous flow method, the reaction can be easily 
scaled out by increasing the length of experimental output without any further 
optimisation once the ideal conditions have been identified. This was successfully 
demonstrated on a 20.0 g scale continuous flow synthesis of N-Boc-1,6-
diaminohexane 2 using the same experimental set-up and reaction parameters as 
described in Section 2.3.  
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Table 2.7 Continuous flow synthesis of mono-protected di- and tri-amines. P.G. denotes protecting 
group. 
∆ τ & T 































(Boc2O, Fmoc-OSu or DdivOH)
 
Isolated Yield (%)i 
Entry Amines 
P.G. = Bocii P.G. = Fmociii P.G. = Ddiviv 
a H2N NH22  
64 63 91 
b H2N NH23  
77 59 80 
c H2N NH24  
65 51 72 
d H2N NH25  
59 62 72 
e H2N NH26  

















55 - - 
i H2N NH
NH2
 40 - - 
i Average isolated yield of three separate experiments per entry.  
ii  Conditions: Boc2O (5.0 mmol) : Amine (2.00 equiv) at 0°C and 1.0 min residence time. MeOH was 
used as the solvent. 
iii Conditions: Fmoc-OSu (2.5 mmol) : Amine (2.00 equiv) at 0°C and 0.5 min residence time. DMF 
was used as the solvent. 
iv Conditions: DdivOH (5.0 mmol) : Amine (2.00 equiv) at 130°C and 1.0 min residence time. MeOH 




MULTI-STEP CONTINUOUS FLOW SYNTHESIS OF MONOMERS  
FOR PEPTOID SYNTHESIS 
 
3.1 Background: Peptidomimetics 
 
Peptides are superb ligands for proteins and they have immense potential as tools and 
agents for biological investigations.82 Unfortunately, they can have limited in vivo 
application due to poor pharmacokinetic properties and susceptibility to proteolytic 
degradation.83 As a consequence, the discovery of compounds mimicking the 
functions of conventional peptides but with better metabolic stability has led to the 
development of peptidomimetics.84 The term peptoid was originally introduced by 
Farmer and Ariëns in 1982 to describe a broad class of peptidomimetics which exhibit 
the biological functionality of peptides but are structurally distinct from α-peptides.85 
































Figure 3.1 Generic structures of a conventional α-peptide compared to an oligo-N-substituted glycine 
or peptoid (R1-4 represent side chains).  
 
3.1.1 Peptoids as Molecular Transporters  
 
Cellular delivery of biologically relevant cargos (e.g. genes, proteins, drugs and 
imaging probes) via complexation or conjugation with a transporter is of tremendous 
importance in cell biology.87-91 It has great potential in medicinal applications 
involving the assisted delivery of synthetic probes and therapeutic agents into target 
cells. As a result, the development of molecular transporters that provide the highest 
level of cellular uptake for a broad selection of synthetic- and bio-cargos has attracted 
considerable attention. The role of peptoids in facilitating cellular uptake and delivery 
is well known and it is discussed in this section.   
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A breakthrough was made in the late 1980s when researchers correlated the 
presence of the trans-activator of transcription (Tat) protein to increased viral 
transcription and replication activities in HIV-infected cells.92 Subsequent work led to 
the isolation of a short sequence of polypeptide, RKKRRQRRR (residues 49 to 57), 
identified as the primary region responsible for the translocation of the Tat protein 
across the plasma membrane, an amphiphilic lipid bilayer which limits the movement 
of molecules between the intercellular space and the cell cytoplasm.93 The hydrophilic 
head group bears a negatively charged phosphate moiety whereas fatty acids make up 
the hydrophobic tails of the plasma membrane. In order for molecular transporters to 
effectively penetrate the cell membrane, they must interact with both the hydrophilic 
and the hydrophobic segments of the lipid bilayer.  
The aforementioned sequence of basic amino acids comprising of arginines 
(R), lycines (K) and glutamine (Q) became the first generation of transporters known 
as cell penetrating peptides (CPPs).94 They are essentially short chain peptides 
capable of translocating the cell membrane with remarkable efficiency. In most cases, 
highly permeable CPPs contain more hydrophilic residues than hydrophobic ones.95 
Peptides with side chains bearing amino or guanidinium moieties generally 
demonstrate high cellular internalisation even though the uptake efficiency and 
organelle specificity are markedly influenced by the amino acid residues involved. In 
intercellular environments, the peripheral amines are protonated and this promotes the 
interaction between the cationic side chains and the hydrophilic head groups of the 
cell membrane. This initial electrostatic interface eventually leads to the encapsulation 
of the transporters. The actual mechanism of uptake remains unclear even though 
recent reviews have proposed a dual pathway mechanism involving both endocytosis 
(active transport) and direct translocation (passive diffusion).96,97  
Although the use of CPPs as molecular vehicles has attracted a substantial 
following, they are susceptible to enzymatic degradation which compromises their use 
as ideal transporters. As such, re-engineered analogues of CPPs which remove the 
proteolytic vulnerability of α-peptides but retain their cell penetrating properties have 
been introduced. The relocation of side chain from the α-carbon to the α-amino group 
prevents enzymatic recognition of the resulting N-alkylglycine oligomers and greatly 
improves their bioavailability. While stereocentres are clearly absent in peptoids, 
chirality is unnecessary for cellular uptake as confirmed through CPP models and 
studies.98,99 It has been reported that peptoids can exhibit a three- to thirty-fold 
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increase in permeability compared to their peptide analogues.95 Multiple publications 
have elucidated the structural characteristics of cell penetrating peptoids (CPPos) that 
are responsible for their impressive cell penetrating abilities.59,95,100-102  
In general, a high density of positive charge on the side chains is identified as 
the hallmark of efficient molecular transporters. Nevertheless, it is not the sole 
determining feature as ensuing investigations have revealed other factors influencing 
the rate of transporter uptake. When analysing their performance, four key 
physicochemical properties should be taken into consideration. These include (i) 
lipophilicity, (ii) polar surface area (i.e. the sum of Van der Waals surface area of 
oxygen and nitrogen atoms, including the attached hydrogens), (iii) hydrogen bonding 
capacity (i.e. sum of hydrogen bond acceptors and donors), as well as (iv) side chain 
composition.95  Based on the work of Kodadek et al., the tertiary amides of the 
oligomer backbone has been attributed as the primary reason for the enhanced cellular 
penetration ability of peptoids. The absence of the highly polar amide hydrogens on 
the backbone results in lower polar surface area (PSA) in peptoids (Figure 3.2). 
Decreased polarity benefits cellular internalisation as formation of a hydration shell 















Figure 3.2 Peptoids have lower solvent accessible surface areas of heteroatoms due to the lack of 
amide hydrogens on their backbone.  
 
It is hypothesised that oligo-N-alkyl glycines require lower desolvation energy 
to move from an aqueous environment (the interstitial compartment) to the fatty 
interior of the plasma membrane. The lower number of available hydrogen bond 
donors is also important as this reduces the hydrogen bond donor-acceptor 
interactions between the peptoid backbone and the hydrophilic head groups of the 
lipid bilayer. With regard to side chain composition, Wender et al. deduced that non-
rigid and unhindered straight chain methylene spacers (between the head group and 
the peptoid backbone) play a decisive role in promoting translocation activity.98 
Increasing the distance between the peripheral head group and the oligomer backbone 
resulted in the enhancement of transporter uptake. Interestingly, peptoids bearing side 
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chains with guanidinium head group provided better penetration results in comparison 
to other types of cationic moieties but they are generally more toxic.101,102 In addition 
to the preceding discussion, molecular size, volume and rigidity of peptoid structures 
also have minor influence on the efficacy of their cellular translocation.  
Based on existing literature, there is a general consensus that amphiphilicity 
(i.e. the hydrophilic and hydrophobic properties of a molecule) of molecular 
transporters dictate their overall cell permeability. Cationic systems are fundamentally 
the architectural starting point in the process of designing optimum transporters. The 
performance of these cationic oligomers can be improved by fine tuning their 
amphiphatic characteristics via the incorporation of different side chain motifs.103 In 
most cases, CPPos possess a homogeneous sequence of alkyl or aryl side chains even 
though oligomers with an alternating sequence of alkyl-aryl side chains have also 
been reported.59,88 However, a conspicuous absence among the commonly used side 
chain motifs is the ethylene glycol (EG) moiety. The inclusion of polyethylene glycol 
(PEG) into dendrimeric systems has been shown to decrease the cytotoxicity of gene 
delivery vehicles.104,105 Furthermore, PEGylation of dendritic polymers enhances their 
solubility and prolongs their circulation time in the bloodstream.106 This provided the 
motivation to incorporate ethylene glycol-based side chains into peptoid transporters 
as these structures could potentially provide enhanced cellular penetration ability.  
 
3.2 Background: Peptoid Monomers 
 
In essence, peptoids are synthetically engineered polymers made of repeating N-
substituted glycine units. Peptoids are typically synthesised via solid phase peptide 
synthesis (SPPS) involving the stepwise addition of the desired monomers.86,107  The 
SPPS method is well suited to laboratory scale synthesis and has good synthetic 
efficiency up to approximately 50 residues.108 The SPPS strategy has been widely 
adopted by many research laboratories.59,98,109 Moreover, a high level of purity of the 
target peptoids can be obtained using an optimised synthetic route which negates 
further downstream purification.110  
Gaining access to structurally creative peptoids necessitates the availability of 
N-substituted glycine monomers. These structurally diverse monomers are responsible 
for the unique properties observed on peptoids and the structure-activity relationship 
of peptoids has been well elucidated by several different research groups.87,88,95,111 
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Published work has described a diverse range of monomers over the years; consisting 
of alkyl or aryl side chains with acidic, basic or neutral moieties. The architecture of 
these monomers can generally be simplified into two main parts – the glycine core 
and the chemically decorated side chain which is connected to the glycine amine 















Figure 3.3 Glycine core of a peptoid monomer (in red) and selected examples of side chains, R (in 
blue), as reported in the literature.88 
 
The first method involves constructing the monomer through a series of 
sequential steps employing solution phase chemistry to give the desired monomeric 
building block (Figure 3.4a).110,112 The end product is then used in solid phase 
analogous to the role of amino acids in solid phase peptide synthesis. The alternative 
strategy uses a “sub-monomer” method which directly builds the monomer, unit by 
unit, on solid phase through a repetitive cycle of amide coupling and nucleophilic 
substitution utilising submonomers (Figure 3.4b).113 The availability of a vast library 
of commercially available reagents highlights the unique advantage of the sub-
monomer approach. Furthermore, it circumvents the need for a main chain protecting 
group as haloacetic acid (BrCH2CO2H) directly couples to the amine after pre-
activation with a carbodiimide.  
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(b) Sub-monomer method (Two halves make a whole)
P.G. (P.G. = protecting group)
 
Figure 3.4 Comparison of the monomer vs. sub-monomer methods.112,113 
 
Subsequently, the second half of the sub-monomer is introduced via a 
nucleophilic substitution reaction with a primary amine displacing the halogen and 
generating a new secondary amine which allows the propagation of the target 
compound. Both strategies were introduced by Zuckerman et al. and have since been 
extensively adapted by other research groups.114 The sub-monomer method negates 
the need for pre-made monomers and is intuitively easier to apply. However, side 
reactions could lead to poor yields and low purity of the target compound.  
On the contrary, the use of peptoid monomers during SPPS involves the 
iterative cycle of main chain protecting group cleavage and amide coupling. Each 
monomer is fundamentally a protected N−substituted glycine unit which proliferates 
the peptoid chain. Prior to the invention of the sub-monomer method, Zuckerman et 
al. synthesised multiple monomers to be used in peptoid assembly. However, the 
productivity of their synthetic endeavours was the rate limiting factor in generating 
enough compounds to be used for subsequent downstream processes.114 As a 
consequence, the development of an alternative synthetic method which could address 
the shortcomings of existing solution phase chemistry would undoubtedly provide a 
much needed answer to rapidly produce motif-specific monomers in high yields.  
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3.3 Background: Batch Synthesis of Peptoid Monomers  
 
The optimisation work presented in this chapter discusses the synthesis of the N-
Fmoc-(6-Boc-aminohexyl)glycine monomer. Bradley et al. developed a four-step 
route which begins with the mono-Boc protection of 1,6-diaminohexane (Scheme 
3.1).115 The N-Boc-protected compound was then mono-alkylated with ethyl 
bromoacetate, followed by saponification to liberate the acid moiety. The last step 
involves an Fmoc carbamation of the secondary amine using Fmoc-OSu which gives 
the desired compound. The Boc and Fmoc protecting groups are appended to the 
monomer to facilitate peptoid chain assembly on solid support using an Fmoc-SPPS 
strategy, with the Boc group removed in the final step. The procedure suffered from a 
relatively moderate yielding alkylation reaction (55%) and a low yield for the ester 





























Scheme 3.1 A sequential synthesis of the N-Fmoc-(6-Boc-aminohexyl)glycine monomer.115 
 
The aforementioned synthetic route was later re-optimised by substituting 
ethyl 2-bromoacetate with benzyl 2-bromoacetate to allow replacement of the 
saponification step with a hydrogenation procedure (Scheme 3.2).112 While the first 
two steps remain unchanged, the Fmoc carbamation is performed immediately after 
the alkylation reaction in the new sequence. The liberation of the acid functionality is 
achieved by palladium-catalysed hydrogenolysis to remove the benzyl protecting 
group, thus giving the target monomer. The mono-protection step was carried out with 
a large excess of the diamine substrate over the protecting group pre-cursor. Although 
the procedure is well established and gives seemingly good results, it is synthetically 
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inefficient (i.e. 6 equivalents of diamines to the limiting reagent). Chapter 2 of this 



































Scheme 3.2 An alternative route leading to the N-Fmoc-(6-Boc-aminohexyl)glycine monomer.112  
 
 In the original route, an inorganic base was added to hydrolyse the ester but 
careful control of the succeeding reaction condition was necessary to prevent the 
formation of an anhydride between the Fmoc protecting group precursor and the free 
acid (Scheme 3.1, step [iii]). The modified strategy introduced the use of benzyl 2-
bromoacetate as the alkylating agent of choice as the benzyl (–CH2Ph) protecting 
group can be easily removed by a catalytic hydrogenolysis process. This eliminated 
the saponification reaction which then allowed the base labile protecting group to be 
introduced following the mono-alkylation of the free primary amine. Changing the 
reaction sequence proved to be highly beneficial as the Fmoc carbamation step 
demonstrated improved reaction yields. However, the final step of Pd-catalysed batch 
hydrogenolysis proved to be challenging due to several reasons.  
The Fmoc group can be susceptible to hydrogenolytic cleavage upon pro-
longed exposure to palladium and hydrogen.74 In a batch environment, the contact 
time between substrate, reagent and catalyst is immensely difficult to control. 
Furthermore, there are inherent safety concerns when scaling up the reaction due to 
the reactivity of hydrogen in the presence of the palladium catalyst. As a consequence 
of the drawbacks highlighted, developing a more refined method of sequential 
synthesis is highly attractive in lieu of the continued use of batch chemistry. The 
continuous flow method provides an ideal platform in offering new opportunities to 
improve the overall efficiency of the peptoid monomer synthesis.  
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3.3.1 Pre-Flow Model Reaction 
 
A direct transfer of reaction conditions from batch mode to the flow platform is 
typically not possible due to the risk of solvent incompatibility, among other things, 
which promotes material precipitation during the reaction.32 Hence, reaction screening 
was initially performed in batch to observe the behaviour of each transformation in 
the three-step sequence (Scheme 3.3). The monomer synthesis begins with N-Boc-
1,6-diaminohexane 2 which serves as the Nω-protected side chain of the monomer 
unit. Using benzyl 2-bromoacetate as the alkylating agent and triethylamine as the 
base, spontaneous material precipitation (i.e. TEA-bromide salt) was observed in 
single- or mixed-solvent systems of 1,4-dioxane, DCM and THF. Acetonitrile 
provided complete solubility of the reaction mixture and gave the mono-alkylated 


































Scheme 3.3 Batch synthesis of monomer 31. Reagents and conditions: (a) benzyl 2-bromoacetate (1 
equiv), TEA (3 equiv), MeCN, 18 h, 59%; (b) Fmoc-OSu (1 equiv), MeCN, 18 h, 98%; (c) NH4HCO2 
(2.5 equiv), 10% Pd/C (8.0 mol%), EtOH, 19 min, 54%. 
 
Subsequently, the mono-alkylated compound was reacted with Fmoc-OSu to 
give the Fmoc-protected benzyl acetate 30. Even though material solubility ceased to 
be a problem at this stage, performing the reaction in DCM gave 78% yield whereas 
the use of MeCN gave close to quantitative yield post chromatographic purification. 
The final step of benzyl group removal utilising heterogeneous Pd-catalysed transfer 
hydrogenolysis was performed in ethanol; employing ammonium formate and 10% 
Pd/C as the hydrogen donor / catalyst pairing.116 At a catalyst loading value of 8.0 
mol%, the reaction was complete within 19 min (based on HPLC analysis) and gave 
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the monomer 31 in a final purified yield of 54%. In-house experiments also confirmed 
published reports of the lability of the Fmoc group under hydrogenolysis 
conditions.117,118 Hence, the delicate control of reaction time is a prerequisite in 
preventing the unwanted removal of the Fmoc protecting group from the monomer.  
 
3.4 Selective Alkylation in Flow 
 
The following section focuses on the continuous flow synthesis of benzyl 2-(6-Boc-
hexylamino)acetate 29a (Scheme 3.4). In general, the alkylation reaction in batch 
produces inconsistent results as a consequence of over-alkylation. Due to an inductive 
effect, the secondary amine product is innately more nucleophilic compared to its pre-
cursor. Upon formation of the mono-alkylated compound, a consecutive competitive 
reaction takes place leading to the generation of the di-alkylated species. Hence, the 
explicit goal of the alkylation reaction in flow was to achieve a high degree of mono-
alkylation and minimising excessive di-alkylation. In the following discussion, the 
progress of the alkylation reaction was monitored via HPLC and the best parameters 



















Scheme 3.4 Alkylation of N-Boc-1,6-diaminohexane 2 leads to the formation of the product 29a and a 




As the nucleophilic attack occurs on the halogen-bearing carbon, a bromide anion is 
liberated and it readily abstracts a proton from the quaternary nitrogen centre. Thus, a 
mole of hydrogen bromide is generated and serves as a source of acid in the reaction 
mixture. In order to prevent the protonation of the nucleophile, an organic base is 
typically used to neutralise the acidic species. As a result, the base-halide salt 
spontaneously crashes out in non-compatible solvent systems as described in Section 
3.3.1. Performing the alkylation reaction in the continuous flow set-up necessitates the 
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use of a polar medium and four different organic solvents – DCM, DMF and MeCN 
(polar aprotic) as well as MeOH (polar protic), were tested.  
Material precipitation was only observed in DCM while the rest afforded 
complete solubility due to their increased polarity. Using three equivalents of DIPEA 
and a substrate concentration of 40 mM, MeCN gave a higher product yield compared 
to DMF (i.e. 85 vs. 69% based on HPLC analysis) when the reaction was carried out 
under flow conditions (τ – 3 min and T – 100°C). In addition, MeCN also produced a 
better ratio of product to side product relative to the values obtained in DMF (Entries 
b vs. c, Table 3.1). Unsurprisingly, MeOH gave a dismal 14% yield using the same 
reaction conditions (Entry a, Table 3.1). The nucleophilic solvent is unsuited for the 
reaction as it reacts readily with the alkylating agent leading to a loss of reactant. 
 
3.4.2 Residence Time and Temperature 
 
The residence time was initially set at 3 min as very low starting material conversion 
was observed below this duration. A window of reaction temperatures between 80 to 
130°C were tested and the maximum yield was observed between 100 and 110°C 
(Figure 3.5). Using MeCN as the solvent, the working pressure of the system 
exceeded 2 bar at 107°C and increasing the temperature beyond 110°C had a 
detrimental effect on the yield of the reaction. The alkylation step did not benefit from 
a pro-longed exposure to high reaction temperature as increasing the residence time 
by an extra two minutes at 90°C led to a drop in reaction yield. This observation was 
later confirmed with other elevated temperature set points. Thus, an obvious trend 
emerged from this study correlating shorter residence time at higher temperature with 














Figure 3.5 Continuous flow alkylation of N-Boc-1,6-diaminohexane 2 with a 3 vs. 5 min residence 
time.  
 
3.4.3 Base and Substrate Concentration 
 
Having established the optimal residence time and reaction temperature, other 
reaction parameters were evaluated. In the alkylation reaction, an excess of organic 
base was used to prevent deactivation of the nucleophile. Three equivalents of 
selected organic bases were tested for their effectiveness in the reaction. Both 1,8-
diazabicycloundec-7-ene (DBU) and piperidine gave very low yields in the alkylation 
reaction (Entries d & e, Table 3.1). A highly probable cause is the reaction between 
the alkylating agent and the organic bases which occurs preferentially over the 
nucleophilic attack of the primary amine substrate. While piperidine is a known 
nucleophile, an amidine base such as DBU is typically classified as non-nucleophilic. 
However, in-house experiments confirmed published findings with regard to the less 
conspicuous nucleophilic nature of DBU.119 As such, two tertiary amine bases (TEA 
and DIPEA) which are sterically hindered, were chosen for further testing. 
Interestingly, DIPEA afforded a better yield compared to TEA (i.e. 85 vs. 69%) using 
the same reaction conditions (Entries c vs. f, Table 3.1).  
As the productivity of a flow reaction is correlated to the substrate 
concentration, the molarity of N-Boc-1,6-diaminohexane 2 was increased from 40 to 
100 mM in anticipation of retaining the high mono-alkylated yield. Unfortunately, the 
reaction yield dropped by 15% with only a slight change in the product to side 
product ratio in favour of the di-alkylated species (Entry h, Table 3.1). The results 
indicated that the conversion of starting material to product was less effective at 



















3 min 5 min
Working pressure, P ≥ 2 bar
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compound, an optimised flow reaction should simply be allowed to run longer with 
minimal adjustment to its substrate concentration. When seen from a method design 
perspective, it was interesting to note that a lower product yield was observed when 
both reagent and substrate were not subjected to the pre-heating treatment described 
in Section 2.2 of Chapter 2 (Entry g, Table 3.1).  
 
3.4.4 Flow versus Batch and Microwave Methods 
 
A series of comparison was made between the continuous flow experiments and 
several variations of the alkylation reaction in batch mode. Firstly, the alkylation 
reaction was subjected to microwave irradiation to mimic the high thermal transfer 
efficiency of a flow set-up. At 68% yield, rapid heating to the desired working 
temperature using microwave irradiation appeared to favour the formation of the 
mono-alkylated product over the side product (Entry i, Table 3.1). It is postulated that 
the rapid heating afforded by microwave irradiation generates a uniform thermal 
profile within the reaction system as opposed to the formation of localised hot spots 
when the reaction system was subjected to a normal heating process.120 
This was supported by the evidence obtained from another set of experiment 
which employed conventional heating using a standard laboratory oil bath. In addition 
to a less favourable product to side product ratio, the product yield was 8% lower 
compared to the microwave irradiated reaction (Entry j, Table 3.1). Further 
investigations revealed that in a room temperature reaction that was left to stir for 24 
h, the side product formation was almost two and half times more than that observed 
in the microwave reaction. However, prolonging the reaction at room temperature did 
increase the product yield by as much as 12% as the extended time drives the reaction 
to completion (Entry k, Table 3.1).  
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Entry Method Solvent Base 
Conditionsi  
([Substrate] / Heating mode) 
HPLC Yield 29aii 
(%) 
a Flow MeOH DIPEA [40 mM], reactor in oil bath 14 
b Flow DMF DIPEA [40 mM], reactor in oil bath  69 (1 : 0.16)iii 
c Flow MeCN DIPEA [40 mM], reactor in oil bath 85 (1 : 0.10) 
d Flow MeCN Piperidine [40 mM], reactor in oil bath 6  
e Flow MeCN DBU [40 mM], reactor in oil bath 10  
f Flow MeCN TEA [40 mM], reactor in oil bath 69 (1: 0.06) 
g Flow MeCN DIPEA [40 mM], no pre-heating 69 (1 : 0.08) 
h Flow MeCN DIPEA [100 mM], reactor in oil bath 70 (1 : 0.11) 
i Batch MeCN DIPEA [40 mM], µwave irradiation 68 (1 : 0.05) 
j Batch MeCN DIPEA [40 mM], tube in oil bath 60 (1 : 0.09) 
k Batch MeCN DIPEA [40 mM], 24 h at r.t. 80 (1 : 0.12) 
i  Scale of each experiment – 20 µmol. Conditions: τ − 3 min, T – 100°C, Flow reactor volume – 2 mL 
ii  Methyl benzoate was used as an internal standard. HPLC wavelength – 254 nm.  
iii  The integrated peak ratio of product 29a to side product 29b. 
 
Based on the results presented, the continuous flow method provided the 
optimum solution in deriving the mono-alkylated compound with good yield as well 
as superior speed of access. Hence, using the optimised conditions, the reaction was 
scaled out with a 4 mL flow reactor to produce ~ 1.00 g of the mono-alkylated 
compound 29a at 67% isolated yield in approximately five hours (Scheme 3.5). An 
analogue of the compound, bearing a triethylene glycol (TEG) bridge between two 







Scheme 3.5 Single step flow alkylation of N-Boc-diamino compounds 2 or 10 to give the mono-
alkylated products 29a or 32. 
 
3.5 In-Line Scavenging of Excess Alkylating Agent  
 
The continuous flow alkylation reaction was performed in a single step. It was vital to 
quench the reaction stream, post flow reactor, in order to remove the excess alkylating 
reagent. The crude solution was collected into a flask containing scavenging resin 
which captures the unreacted alkylating agent prior to reaction work-up.  The crude 
mixture was purified by flash column chromatography to give the isolated product. 
While this approach is useful in a single step transformation, a sequential continuous 
flow reaction requires an in-line scavenging procedure which could scavenge the 
alkylating agent from the first exiting stream before being fed into the next 
reaction.121 This would remove the need for an intermediate process of column 
purification after the first reaction stage and allow the integration of two cascading 
steps (alkylation and Fmoc carbamation). 
Two different silica-based scavengers, Si-Thiol (loading value: 1.43 mmolg-1) 
and Si-Trisamine (loading value: 1.58 mmolg-1), were chosen as potential candidates 
due to the silica core’s inert stability and non-swelling properties in organic solvents 
(Figure 3.6). Both scavengers were packed into their respective columns and tested 
for their scavenging efficiency. In a typical set-up, an exiting stream from the 





40 mM in MeCN
4 mL reactor
+ DIPEA (3 equiv)

























τ = 3.0 min, T = 100°C, 
Q = 1.33 mLmin-1


















scavenging column (Scheme 3.6). The efficiency of each scavenger species was then 











Figure 3.6 (Left) Silica-based thiol (Silicycle’s Siliabond) and tris-amine (Biotage’s ISOLUTE) 
scavengers; (Right) Columns packed with scavenger resin (diameter x length: 0.5 x 5.0 / 6.0 cm). 
 
Based on qualitative analysis, the Si-Trisamine scavengers were more 
effective in removing the excess alkylating agent relative to the mercaptan particles 
under the same reaction conditions. This could be a consequence of the deactivated 
sulfhydryl moiety which slowly undergoes oxidation at ambient conditions. As a 
result, Si-Trisamine was chosen as the in-line scavenger for the two-step 
transformation process. For an alkylation reaction at 4.9 mmol scale, a column 
measuring 0.5 x 6.0 cm (diameter x length) packed with 0.62 g of Si-Trisamine 
scavengers was used to remove unreacted alkylating agent from the exiting reaction 
stream. Hence, roughly 0.60 g of trisamine scavengers is consumed for every gram of 


















Scheme 3.6 In-line scavenging protocol of unreacted alkylating reagent.  
 
3.6 Fmoc Carbamation in Flow 
 
Prior to performing the two-step sequential transformation (linking alkylation to Fmoc 
carbamation directly), the one step synthesis of the Fmoc-protected compound 30 was 
attempted in flow (Scheme 3.7). In a direct adaption of the reagent used in batch 
synthesis, Fmoc-OSu was used as the protecting group precursor to introduce the 
Fmoc synthon and the reaction was performed at room temperature in MeCN. With a 
substrate concentration of 20 mM and one equivalent of Fmoc-OSu, a minimum of 3 
min was required to facilitate the complete conversion of the mono-alkylated 
compound 29a to its Fmoc-protected analogue 30. After reaction work-up, the Fmoc-
protected compound was obtained in excellent yield at 98%. Changing the solvent 
system proved to be detrimental to the product yield as DCM only gave 78% yield 
whereas an equal mixture of 1,4-dioxane and DCM led to a further 16% slide in the 
purified yield. Likewise, the TEG analogue 33 also gave close to quantitative yield 
when synthesised via the continuous flow method.  
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Scheme 3.7 Single step flow carbamation of Nα-alkyl-Nω-Boc-diamines 29a and 32 to give the Fmoc-
protected compounds 30 and 33. 
 
3.7 Tandem Alkylation and Fmoc Carbamation in Flow 
 
The goal of the sequential continuous flow reaction was to remove the intermediate 
purification step which is both labour intensive and time consuming. The ability to 
link two cascading reactions into a single transformation sequence is highly appealing 
as it increases the synthetic efficiency of the overall transformation. The removal of 
the flash chromatography procedure has the distinct advantage of reduced material 
consumption. Nonetheless, in order to merge two different synthetic transformations 
into a single sequence, the exiting stream of the first reaction must be fully compatible 
with the reaction conditions of the subsequent conversion. As such, the overall 
conversion must be viewed as a continuous process which demands complete reagent 
solubility and minimal occurrence of unwanted side reactions.  
In reviewing the two-step transformation of the N-Boc-protected diamines to 
their Fmoc-protected alkyl analogues, the requirement of chromatographic 
purification between the first and the second stage was addressed by introducing a 
silica-based trisamine scavenging column to remove the excess alkylating agent 
(Section 3.5). However, the use of DIPEA during the alkylation step carries the risk of 
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result, the original design of a seemingly straight forward synthetic route had to be 
revised accordingly. A decision was made to switch the Fmoc precursor to FmocCl. 
The nucleophilic attack on the protecting group precursor would liberate a chloride 
anion which forms an equivalent of hydrochloric acid. Under normal conditions, the 
acid would protonate the secondary amine and thus, deactivates the nucleophile. 
However, as the first reaction stream contains an excess of DIPEA, the base would 
neutralise the acid readily and protects the nucleophile from in situ passivation.  
Armed with the modified sequence, the two-step transformation was carried 
out as depicted in Scheme 3.8. It is important to note that a cooling process (using 
water bath) was introduced after the scavenging protocol to cool down the first 
reaction stream prior to the second stage mixing (Details are illustrated in the 
Experimental Section as Figure 5.8; page 112). With an equal residence time of 3.0 
min for both the alkylation and Fmoc carbamation steps, respectively; the syntheses 
of 30 and its TEG analogue 33 gave 69 and 62% yields over two steps. In a scale-out 
reaction spanning slightly over six hours, 1.4 g of the Fmoc-protected benzyl acetate 
30 was produced from 4.9 mmol of N-Boc-1,6-diaminohexane 2. The experiment was 
also successfully repeated on a similar scale using N-Boc-1,8-diaminotriethylene 



















Scheme 3.8 Tandem alkylation and Fmoc carbamation as a continuous sequence. 
 
3.8 Catalytic Hydrogenolysis in Flow 
 
The last stage of the monomer synthesis involves the catalytic hydrogenolysis of the 
Fmoc-protected benzyl acetate compound 30 to derive its debenzylated analogue 31. 
The heterogeneous catalysis reaction typically uses a solid supported transition metal 
as the catalyst and a source of molecular hydrogen is required to facilitate the 
chemical transformation.122 The versatility of the palladium metal is well described in 
the literature and it remains as the one of the most popular transition metals in 
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promoting a wide range of chemical reactions.123,124 Specific to the hydrogenolysis 
reaction, an interesting side reaction has been detected during the batch synthesis of 
























Scheme 3.9 Palladium-catalysed debenzylation and its side reaction. 
 
It has been found that the Fmoc protecting group is labile towards palladium-
catalysed hydrogenolysis. While the removal of the benzyl group remains as the 
primary effect of the reaction, the Fmoc group is unwittingly cleaved depending on 
the reactivity of the catalyst, the duration of reaction and the substrate concentration. 
Similar observations have been reported in the literature and the side reaction affects 
both the conventional method of performing hydrogenolysis (i.e. hydrogen gas with 
catalyst) as well as catalytic transfer hydrogenation (i.e. the generation of molecular 
hydrogen in situ via a hydrogen donor).118,125 In order for hydrogenolytic cleavage to 
take place, a suitable leaving group (e.g. carboxylate anions) must be present and the 
resulting carbenium ion must also be sufficiently stabilised.126  
The preferential cleavage of the benzyl group over the Fmoc group could 
occur as a result of steric limitation exerted by the large fluorenyl ring. As the 
catalytic cycle takes place on the palladium metal, the substrate must be correctly 
aligned to the catalyst surface in order for the hydrogen transfer process to occur.127 
As the fluorenyl moiety is more bulky relative to the benzyl group, achieving the 
correct molecular orientation would be mechanistically harder. As a result, a 
particular interest in performing the catalytic flow hydrogenolysis is to generate a 
high degree of selectivity during the reaction sans Fmoc group removal. It was 
hypothesised that facile manipulation of contact time between the catalyst and the 
substrate could be exploited to promote a high level of reaction selectivity during the 
transformation process.  
In addition, other types of transition metal catalysts which have been reported 
to be effective in encouraging selective hydrogenolysis were also tested for their 
efficacy in promoting the debenzylation reaction.128 A decision was made to develop 
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transfer hydrogenation in flow due the practical aspects of instrumentation. 
Microwave-assisted catalytic hydrogenolysis was also attempted in order to derive a 
comparison between flow transfer hydrogenolysis and the microwave method.  
 
3.8.1 Continuous Flow Transfer Hydrogenolysis 
 
The continuous flow transfer hydrogenolysis reaction was performed using 
ThalesNano’s CatCart catalysts. Each cartridge measures 30 mm in length with a 
diameter of 4 mm and has an average weight loading of 150 mg (i.e. mass of solid 
supported catalyst).129 It is conveniently inserted into a hollow aluminium chamber 
which can be digitally heated to the desired working temperature (Figure 3.8). 
Specific to the hydrogenolysis reaction, an ethanolic stream of reactants containing 
the substrate and hydrogen donor was passed through the CatCart to effect chemical 
transformation. Several hydrogen donor and catalyst pairings were investigated for 
their efficacy in facilitating the reaction. Cost friendly hydrogen donor sources such 
as ammonium formate and 1,4-cyclohexadiene were the main candidates tested during 













Figure 3.8 (Left) Aluminium heating chamber and the unidirectional flow stream; (Right) CatCart’s 
packed catalyst.  
 
 Initially, ammonium formate and 10% Pd/C were chosen as the hydrogen 
donor and catalyst pairing to mirror the catalytic system used in the analogous batch 
reaction described in Section 3.3.1. Unfortunately, a serious fluctuation in system 
pressure was detected when ammonium formate was used as the hydrogen donor. It 
has been established that the crystalline compound spontaneously decomposes into 
ammonia, carbon dioxide and hydrogen gas when exposed to palladium metal.132 The 
evolution of gaseous by-products proved to be detrimental as the reaction stream’s 
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flow rate was adversely affected leading to pump failure during reaction. 
Furthermore, the presence of ammonia increases the risk of side product formation as 
the Fmoc group is susceptible to basic cleavage.133 As a consequence, the hydrogen 
donor was replaced with 1,4-cyclohexadiene which gives a mole of H2 per donor 
molecule as well as benzene, an inert by-product.134  
Using 30 as the test substrate and 2.5 equivalents of 1,4-cyclohexadiene as the 
hydrogen donor, a series of experiments was performed employing two separate 
catalyst systems – 10% Pd/C and 20% Pd(OH)2/C (Pearlman’s catalyst).
135 Palladium 
metal actively promotes hydrogenolysis whilst discouraging aromatic ring’s saturation 
and carbon supported catalysts are reportedly more reactive as a result of increased 
active surface area.126,136 Three different substrate concentrations (i.e. 15, 30 and 50 
mM) were prepared and each was tested with 10% Pd/C as the catalyst. An 
experiment performed at room temperature with 15 mM of substrate concentration 
and 1.00 mLmin-1 flow rate gave a poor 23% product yield based on HPLC analysis 
(Entry a, Table 3.2).  
 
Table 3.2 The efficiency of Pd-catalysed flow transfer hydrogenolysis as a function of catalyst system 





















HPLC Yield 31aii 
(%) 
a 10% Pd/C 15  23iii 
b 10% Pd/C 15  78 (1 : 0.25)iv 
c 10% Pd/C 30 69 (1 : 0.15) 
d 10% Pd/C 50 54 (1 : 0.10) 
e 20% Pd(OH)2/C 15 96 (1 : 0.00) 
f 20% Pd(OH)2/C 30 82 (1 : 0.08) 
g 20% Pd(OH)2/C 50 70 (1 : 0.10) 
  i Conditions: H2 donor – 2.5 equiv of 1,4-cyclohexadiene; Solvent – EtOH;  
   Q – 1.00 mLmin-1; T - 40°C; Scale – 7.5 µmol. 
ii  Aniline was used as internal standard. HPLC wavelength – 254 nm. 
 iii  T - 25°C 
 iv  The integrated peak ratio of product 31a to side product 31b. 
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Increasing the temperature by 15°C significantly enhanced the rate of reaction 
as 78% of product 31a was detected. However, an unwanted side reaction was also 
observed as one fifth of the converted starting material underwent Fmoc cleavage to 
give the side product 31b (Entry b, Table 3.2). At higher substrate concentrations, 
starting material conversion became less effective despite seeing a reduced formation 
of side product (Entries c & d, Table 3.2). Even though the catalyst gave decent yields 
across the range of concentrations studied, an attempt to scale out the reaction 
exposed a serious underlying problem of material retention. In a scale out experiment, 
saturation of the catalyst system was observed after 20 min (i.e. ~ 14% of total 
reaction progress) as only starting material was detected in the exiting stream. 
Interestingly, a sample collected from the post-run flushing stream with pure 
hydrogen donor solution revealed the presence of the product, mixed with starting 
material.  
Performing a pro-longed flushing protocol did little to remove the starting 
material as it was strongly adsorbed on the packed catalyst. Continuous flushing of 
the cartridge with copious amount of solvent was tremendously wasteful and time 
consuming. Furthermore, it was shown that using the 10% Pd/C packed cartridge 
resulted in elevated system pressure; fluctuating between 9 to 11 bar during the 
reaction. Hence, it is highly probable that the unknown degree of matrix porosity 
within each type of CatCart catalyst plays a significant role in the retention of 
substrate and product. In addressing the material retention issue, the packed cartridge 
was subsequently replaced with CatCart’s version of Pearlman’s catalyst. When 
performing experiments using the 20% Pd(OH)2/C catalyst, it was immediately 
evident that the system pressure generated by the reaction stream was noticeably 
lower (i.e. 1 bar consistently) compared to the previous catalyst used. This suggests a 
much higher matrix porosity within the CatCart and thus, could potentially reduce the 
retention of materials in the packed cartridge. On a side note, Pd metal leaching was 
not investigated in this study.  
Similarly, 1,4-cyclohexadiene was used as the hydrogen donor and the 
reaction stream flow rate was kept unchanged at 1.00 mLmin-1. It was evident that the 
overall results were much better with Pearlman’s catalyst compared to 10% Pd/C. At 
15 mM of substrate concentration, 96% of product formation was measured by HPLC. 
More importantly, no side product was seen within the limit of detection (Entry e, 
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Table 3.2). Even though product yield was negatively affected by increasing the 
substrate concentration, an impressive 70% yield was still recorded at a concentration 
of 50 mM (Entry g, Table 3.2). More importantly, the product to side product ratios at 
lower substrate concentrations were better than their corresponding values using 10% 
Pd/C as the catalyst (Entries e & f vs. 2 & 3, Table 3.2). Using the optimised 
conditions, ~ 1.00 g of the debenzylated product 31a and its TEG analogue 34 were 
scaled out at 70 and 68% isolated yields, respectively, in slightly more than three 
















Scheme 3.10 Continuous flow transfer hydrogenolysis.  
 
Based on the results obtained, it can be concluded that the efficiency of flow 
transfer hydrogenolysis is highly dependent on the temperature of the reaction as well 
as the substrate concentration (Figure 3.9). While a fair comparison of synthetic 
efficiency between catalytic transfer hydrogenolysis carried out in batch versus the 
flow method is not entirely possible due to the vastly different mode of reaction, it is 
speculated that the increased efficiency witnessed in flow catalysis is greatly 
facilitated by a pseudo-stoichiometric effect. This is due to the availability of an 
overwhelming excess of catalyst when a unidirectional stream of reactants flows 
through the packed cartridge. Nonetheless, without the right catalyst system, 
consistency is difficult to achieve in flow transfer hydrogenolysis as a consequence of 
material retention which affects the steady state flow of a reaction stream. As a side 
note, CatCart’s 5% Pt/C and 5% Ru/Al2O3 failed to derive the desired product despite 
claims of their ability to promote the debenzylation process in batch chemistry.128  
15 mM in EtOH
20% Pd(OH)2/C
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Figure 3.9 Efficacy of catalysts is dependent on substrate concentration. 
 
3.8.2 Microwave-Assisted Catalytic Hydrogenolysis  
 
Several publications have advocated the use of microwave instruments to achieve 
high synthetic productivity with improved speed and efficiency.137-139 A series of 
experiments were conducted to compare the results obtained from the catalytic flow 
method against the microwave approach. The experiments were performed using a 
CEM Discover SP microwave unit coupled to a Parker’s hydrogen generator (Figure 
3.10). The hydrogen gas was channelled into the microwave module via a gas 
addition unit which regulates the amount of hydrogen gas available for reaction. 
Based on the manufacturer’s recommendation, the substrate 30 was prepared at a 
concentration of 0.25 M and 10% Pd/C was used as the catalyst.  
 
 
Figure 3.10 (From left to right) CEM Discover SP microwave unit coupled to a gas addition unit and a 
hydrogen gas generator.  
 56 
 Using 4.5 mol% of catalyst loading, the reaction gave a limited 26% yield of 
the debenzylated product 31a when irradiated under microwave conditions for 2 min 
(Entry a, Table 3.3). When the reaction time was extended to 10 min at 80°C, the yield 
increased substantially to 87%; accompanied by the occurrence of Fmoc cleavage. 
Subjecting the same reaction to a further 3 min irradiation time caused a 12% decline 
in product yield as more of the side product was produced (Entries b & c, Table 3.3). 
When the scale of the experiment was increased by two and a half times, the reaction 
which was microwave irradiated for 12 min at 80°C gave only 41% of product yield 
(Entry d, Table 3.3). Prolonging the reaction time by an extra 8 min, in addition to 
increasing the hydrogen gas pressure to 60 psi, produced a much better result at 60% 
yield after chromatographic purification (Entry e, Table 3.3).  
 

















30 31a 31b  
Entry 
Scale of 30 
(mmol) 
Conditionsi 
HPLC Yield 31aii 
(%) 
a 0.48 2 min, 55°C, 50 psi 26 
b 0.48 10 min, 80°C, 50 psi 87 (1 : 0.15)iii 
c 0.48 13 min, 80°C, 50 psi 75 (1 : 0.33) 
d 1.20 12 min, 80°C, 50 psi 41 (1 : 0.02) 
e 1.20 20 min, 80°C, 60 psi 87 (1 : 0.18) 
60
iv  
     i  Conditions: Catalyst – 10% Pd/C (4.5 mol%); Solvent – EtOH 
     ii Aniline was used as internal standard. HPLC wavelength – 254 nm. 
    iii The integrated peak ratio of product 31a to side product 31b.  
    iv Isolated yield. 
 
 Despite its proven functionality in assisting the hydrogenolysis reaction, the 
microwave method suffers from common limitations associated with batch chemistry. 
At comparable substrate concentrations, the formation of side product is 
conspicuously more prominent in reactions which had undergone microwave 
irradiation. This could be attributed to the excessive contact time between the active 
palladium catalysts and the starting material which is tremendously difficult to control 
in a batch environment. Besides, the productivity of synthesis is also limited by the 
maximum volume of reactants that can be accommodated by the reaction vessel 
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during each cycle of microwave irradiation. Hence, scaling up an optimised reaction 
would be impractical as it involves reiterative irradiation of individual vessels serially. 
In comparison, the scaling out strategy in flow offers a continuous mode of processing 
which sidesteps the use of expensive instrumentations. As such, adapting the flow 
strategy could greatly benefit synthetic laboratories seeking a systematic process of 
rapidly screening, optimising and scaling out target compounds, all on the same 
platform.  
 
3.9 Summary  
 
In conclusion, the multi-step synthesis of peptoid monomers has been successfully 
achieved via the continuous flow method (Figure 3.15). In addition to synthesising the 
N-Fmoc-(6-Boc-aminohexyl)glycine monomer 31a, a novel analogue of the monomer 
bearing a triethylene glycol bridge motif, N-Fmoc-((2-(2-Boc-
aminoethoxy)ethoxy)ethyl)glycine 34 was also synthesised via the same optimised 
route. Even though direct optimisation of reaction conditions is not always possible 
due to physical incompatibility of materials in the flow reactor, the flow method 
demonstrated great flexibility in providing quick access to valuable synthetic 
compounds. Based on the work discussed in this chapter, the peptoid monomers were 
synthesised in three steps; starting from the selective alkylation of N-Boc protected 
diamines, followed by an Fmoc carbamation reaction and lastly, Pd-catalysed 
hydrogenolysis. The first two steps were successfully linked as a tandem reaction 
which gave yields exceeding 60%.  
 The sequential reaction removed an intermediate purification requirement by 
introducing an in-line scavenging protocol. Silica-based trisamine scavengers were 
used to remove unreacted alkylating agent from the first reaction stream before being 
fed into the second reaction. The scavengers exhibited excellent durability and 
approximately 0.60 g of scavengers is consumed for every gram of mono-alkylated 
compound produced. Lastly, transfer hydrogenolysis was performed using 20% 
Pd(OH)2/C and 1,4-cyclohexadiene as the catalyst and hydrogen donor pairing. Good 
yields (68 – 70%) were obtained for the monomer 31a and its ethylene glycol 
analogue 34. Even though Fmoc cleavage was still observed in flow transfer 
hydrogenolysis, its occurrence was greatly reduced compared to batch chemistry as a 
























Scheme 3.11 Multi-step continuous flow synthesis of the N-Fmoc-(6-Boc-aminohexyl)glycine 
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MICROWAVE-ASSISTED SOLID PHASE SYNTHESIS OF PEPTOIDS  
AND THEIR BIOLOGICAL EVALUATION 
 
4.1 Solid Phase Synthesis of Peptoids 
 
This chapter examines the assembly of three different types of peptoids via solid 
phase peptide synthesis (SPPS). They include (i) oligo-N-(6-aminohexyl)glycines 
(hereafter known as standard peptoids), (ii) oligo-N-((2-(2-
aminoethoxy)ethoxy)ethyl)glycines (triethylene glycol [TEG] peptoids), and (iii) 
oligomers of alternating standard and TEG monomers (hybrid peptoids) (Figure 4.1). 
The solid phase method uses polymeric resins as the solid support on which the target 
compounds were constructed. The resins were functionalised with an appropriate 
linker prior to the synthesis of the oligo-N-alkylglycines. The work presented in this 
chapter used an Fmoc strategy to assemble the desired peptoids. The monomers N-
Fmoc-(6-Boc-aminohexyl)glycine 31a and N-Fmoc-((2-(2-Boc-
aminoethoxy)ethoxy)ethyl)glycine 34, were synthesised with fully orthogonal 
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Figure 4.1 N-alkylglycine monomers 31a and 34 were used to construct the standard, Triethylene 
Glycol (TEG) and hybrid peptoids via Fmoc-based SPPS.  
 
In order to study the comparative cellular uptake efficiency of these molecular 
transporters, a nine-member collection of fluorescently labelled peptoids with varying 
backbone lengths (i.e. penta-, hepta- and nona-mers) and side chain compositions (i.e. 
homogeneous single-type residue vs. alternating dual-type residues) were synthesised. 
The peptoids share a generic template consisting of a fluorescent dye (5(6)-
carboxyfluorescein) and the peptoid, linked by the 6-aminohexanoic acid (Ahx) 
spacer. The cytotoxicity and cell permeability of these oligomers were evaluated on 
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three different cell lines – human embryonic kidney (HEK293), human cervical 
carcinoma (HeLa) and Chinese hamster ovary (CHO) cells. The cytotoxicity assay, 
flow cytometry and confocal microscopy results of the peptoids are discussed in 
Section 4.2. 
 
4.1.1 Rink Amide Functionalisation of Aminomethyl Polystyrene Resins 
 
The construction of oligo-N-alkylglycines began with the selection of an appropriate 
solid support. Aminomethyl polystyrene (PS) resins were chosen due to their 
popularity in SPPS. Robust PS resins are commercially available and have good 
swelling properties and compatibility with the organic solvents used during SPPS 
synthesis (i.e. DCM, DMF and MeOH). 
 A Rink amide linker was coupled to the solid support as a prelude to the 
assembly of the peptoids, with the acid labile linker giving a primary amide at the C-
terminal position following acid cleavage. At a concentration of 0.37 M, three 
equivalents of the Rink amide linker, ethyl 2-cyano-2-(hydroxyimino)acetate 
(Oxyma) and N,N-diisopropylcarbodiimide (DIC) were dissolved in DMF and added 
to the aminomethyl PS resins (loading value: 1.23 mmolg-1) (Scheme 4.1). Oxyma 
was used as an additive to give an active ester.140 It is an alternative to the 
traditionally used hydroxybenzotriazole (HOBt) which has recently caused some 
























Scheme 4.1 Functionalisation of aminomethyl PS resins with the acid labile Rink amide linker. (a) DIC 
(3 equiv), Oxyma (3 equiv), 0.37 M in DMF, 1.5 h.  
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4.1.2 Solid Phase Synthesis of Standard Peptoids 
 
Three “standard” peptoids of five, seven and nine residues (S5, S7 and S9) were 
synthesised using established SPPS procedures (Scheme 4.2). The linker’s Fmoc 
protecting group was removed to liberate the primary amine functionality using 20% 
piperidine in DMF. Subsequently, monomer 31a was coupled using Oxyma and DIC 
(0.15 M). The progress of reaction was monitored by a qualitative ninhydrin test.  
 Upon confirming the first residue had been successfully attached, a reiterative 
cycle of Fmoc-deprotection and amide coupling was performed until the desired 
backbone length was achieved. Due to the unmasked amine being a secondary amine, 
the deprotection and coupling steps were monitored with chloranil tests. When the 
main chain length reached > 5 residues, the reactions were heated to 60oC for 15 min, 
followed by an extended 15 min of mechanical agitation at room temperature to 
enhance the coupling efficiency of those residues which were otherwise severely 
affected by steric hindrance. 
 Once the desired length was achieved, an Ahx spacer was conjugated to the 
final residue and then capped with 5(6)-carboxyfluorescein to produce the final dye-
labelled oligo-N-alkylglycine. The spacer was incorporated as a bridge between the 
fluorescein dye and the naked peptoid to prevent possible interference of fluorophore 
activity by the oligomer. The final compound was cleaved from the linker using a 
cleavage cocktail of 95% trifluoroacetic acid (TFA) : 2.5% triisopropylsilane (TIS) : 
2.5% H2O. TIS and water are commonly added into the mixture as scavengers to 
“mop-up” reactive electrophiles that are generated during the acidic cleavage. Post 
cleavage work-up led to the isolation of the target compounds. All three peptoids were 
successfully synthesised in good yields and their identities confirmed by MALDI-












































n = 5      S5  
   = 7      S7
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n
Scheme 4.2 Synthesis of fluorescein-labelled standard peptoids S5, S7 and S9. (a) 20% piperidine in 
DMF (2 x 15 min); (b) monomer 31a (2 equiv), DIC (2 equiv), Oxyma (2 equiv), 0.15 M in DMF, 30 
min (S5) and 60oC, 15 min, followed by r.t. for 15 min (S7 and S9); (c) N-Fmoc-6-aminohexanoic acid 
(2 equiv), reagents and conditions as in (b); (d) 5(6)-carboxyfluorescein (2 equiv), reagents and 
conditions as in (b); (e) TFA, 2.5% TIS, 2.5% H2O, 3 h.  
 
4.1.3 Microwave-Assisted Solid Phase Synthesis of TEG Peptoids 
 
The standard pentamer peptoid S5 was conveniently synthesised through SPPS 
performed at ambient conditions whereas the syntheses of heptamer S7 and nonamer 
S9 required additional heating. However, constructing oligomers bearing the TEG 
motif necessitated the use of microwave heating to assemble the desired target 
compounds. Initial attempts to synthesise the TEG peptoids using monomer 34 under 
the conditions reported in Section 4.1.2 proved futile and no product was isolated. 
Multiple attempts to remove the Fmoc group on the fifth coupled residue, 
employing standard Fmoc cleavage protocol, were unsuccessful. The use of elevated 
reaction temperature and extended incubation time (i.e. 60oC for 30 min) were equally 
disappointing. In addition, the use of a stronger cleavage cocktail (i.e. 2% DBU : 2% 
piperidine in DMF) under various physical conditions also gave no visible signs of 
Fmoc removal. Aggregation of the peptoid structure was suspected to be the main 
reason behind the failure of the Fmoc deprotection step. This could be attributed to 
the increased bulkiness of the overall structure as a result of multiple ethylene glycol 
units on the side chains. Hence, a more effective method of Nα-Fmoc deprotection was 
needed. In addressing this issue, the synthesis of the TEG peptoids was attempted in a 
 64 
microwave synthesiser (Scheme 4.3). The coupling mixture was prepared at 0.14 M 
with a 3 : 1 ratio of DMF : DCM as the solvent system of choice. The addition of 25% 
DCM facilitated solid support swelling, decreasing steric crowding on the resin. 
Starting with the first residue, the Fmoc group deprotection was accomplished 
via microwave irradiation (60oC for 10 min) using 20% piperidine in DMF. The 
procedure was performed twice during each stage of deprotection. Subsequently, the 
amide coupling reaction was microwave irradiated for 25 min at 70oC. During the 
propagation of the oligomer’s backbone, the reiterative cycles of Fmoc-deprotection 
and amide coupling were all carried out under microwave conditions. This included 
the conjugation of the Ahx spacer as well as attachment of fluorescein. The TEG 
peptoids T5, T7 and T9 were isolated successfully following acidic cleavage in 
moderate yields. This was a major breakthrough as each step of synthesis proceeded 
smoothly as confirmed by qualitative chloranil tests. It was clear that the Nα-Fmoc 
deprotection step benefited tremendously from the microwave-assisted heating. The 
unique interaction between the electromagnetic field and the solvent molecules in a 
microwave reaction system effectively produces a narrow thermal distribution not 
seen in conductive heating. This uniform thermal profile is believed to significantly 







































(TEG = Triethylene glycol)
n = 5      T5  
   = 7      T7
   = 9      T9
n
34
Scheme 4.3 Synthesis of fluorescein-labelled TEG peptoids T5, T7 and T9. (a) 20% piperidine in 
DMF (2 x 60oC, 10 min, µwave); (b) monomer 34 (2 equiv), DIC (2 equiv), Oxyma (2 equiv), 0.14 M 
in 3 : 1 of DMF : DCM, µwave, 70oC, 25 min; (c) N-Fmoc-6-aminohexanoic acid (2 equiv), reagents 
and conditions as in (b); (d) 5(6)-carboxyfluorescein (2 equiv), reagents and conditions as in (b); (e) 
TFA, 2.5% TIS, 2.5% H2O, 3 h.  
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4.1.4 Microwave-Assisted Solid Phase Synthesis of Hybrid Peptoids 
 
The synthesis of peptoids with an alternating sequence of different monomers has 
been attempted previously but an oligomer featuring the combination of N-(6-
aminohexyl)glycine 31a and N-((2-(2-aminoethoxy)ethoxy)ethyl)glycine 34 is 
unreported. A structure bearing alternating side chains of hexyl- (i.e. six methylene 
units) and TEG-spacers represents a new hybrid system. The physicochemical 
properties of the hybrid oligomers are expected to be considerably different from 
either the standard or the TEG peptoids. In an effort to correlate the cellular 
penetration efficiency of molecular transporters with their structural amphiphilicity, 
these hybrid systems appear to be the ideal synthetic model for such evaluation.  
 Using the same microwave-assisted synthesis protocol described in Section 
4.1.3, the hybrid peptoids H5, H7 and H9 were synthesised accordingly (5 – 12 
yields) [Scheme 4.4]. Monomer 31a was attached to the Rink linker, serving as a 
reference point for the propagation of the peptoid backbone. The pentamer H5 was 
relatively accessible in comparison to the heptamer H7 and the nonamer H9, as 
despite the use of microwave irradiation, the cleavage of the Nα-Fmoc group was 
severely problematic once the backbone length of the oligomer ≥ 8 coupled residues. 
It was found that the deprotection of the Fmoc group belonging to (i) the Ahx spacer 
on the heptamer (Fmoc-Ahx-[Hex7TEG6Hex5TEG4Hex3TEG2Hex1]-PS) and (ii) the 
last TEG residue on the octamer (Fmoc-TEG8-
[Hex7TEG6Hex5TEG4Hex3TEG2Hex1]-PS) was unsuccessful even under forceful 
microwave heating. 
While the exact reason for the failure of the Fmoc deprotection step remains 
unknown, oligomer aggregation was believed to be responsible for the experimental 
observation. The combination of hexyl and TEG side chains could produce multiple 
intra- and intermolecular interactions involving the solid-supported constituents. In 
addition, the ethylene glycol moieties are expected to interact with solvent molecules 
within their vicinity, thus forming a “solvation shell” around the peptoid. As a result, 
aggregation of the oligomer (which could potentially generate secondary structures), 
as well as the solvent shell effect, effectively limit the access of piperidine to the 
Fmoc cleavage site. Hence, the cleavage solution was changed from 20% piperidine 
in DMF to a more potent mixture of 2% DBU : 2% piperidine in DMF.  
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The DBU / piperidine pairing has been advocated as the Fmoc cleavage 
cocktail of choice when working with difficult peptide sequences. The addition of 
piperidine is necessary to enable the scavenging of the dibenzofulvene by-product. 
The mixture was added to the resins and microwave irradiated at 60oC for 10 min. 
The solution was then drained and a fresh portion of the cleavage mixture was added 
to the resin. In order to drive the deprotection reaction to completion, the 
concentration of the mixture was increased to 4% DBU : 4% piperidine in DMF and 
microwave irradiated for a second time. The modified deprotection step gave 
encouraging results as qualitative tests indicated the successful removal of the Fmoc 
protecting group. While all three hybrid peptoids were successfully isolated post 
cleavage work up, the final yields of the heptamer H7 and nonamer H9 were 
disappointingly low. Nonetheless, the microwave-assisted protocol could be 
optimised for future synthesis of the hybrid oligomers and serious consideration 
























































n = 2      H5  
   = 3      H7
   = 4      H9
Scheme 4.4 Synthesis of fluorescein-labelled hybrid peptoids H5, H7 and H9. (a) 20% piperidine in 
DMF (2 x 60oC, 10 min, µwave) (up to heptamer) & 2% DBU : 2% piperidine in DMF in DMF (60oC, 
10 min, µwave) followed by 4% DBU : 4% piperidine in DMF (60oC, 10 min, µwave) (octamer and 
beyond); (b) monomers 31a and 34 in a successive manner (2 equiv), DIC (2 equiv), Oxyma (2 equiv), 
0.14 M in 3 : 1 of DMF : DCM, µwave, 70oC, 25 min; (c) N-Fmoc-6-aminohexanoic acid (2 equiv), 
reagents and conditions as in (b); (d) 5(6)-carboxyfluorescein (2 equiv), reagents and conditions as in 
(b); (e) TFA, 2.5% TIS, 2.5% H2O, 3 h.  
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4.2 Biological Evaluation of Peptoid Transporters 
 
4.2.1 Purification of the Peptoids 
 
After the post cleavage work-up, the peptoids were purified via semi-preparative 
HPLC prior to biological evaluations. The attachment of 5(6)-carboxyfluorescein 
enables the flow cytometry and confocal microscopy investigations of the peptoids 
with cells.143 Based on the best peak separation of the crude peptoid as identified by 
analytical HPLC, a corresponding semi-preparative method was created for the 
purpose of compound purification; with the compound analysed via LC-MS and 
MALDI-TOF MS (Figure 4.2). The isolated fractions of the target compound were 
combined and lyophilised to give a solid for S5, S7 and S9; and a viscous oil for T5, 




Figure 4.2 Chromatographic separation of the crude peptoid S5 (tR: 2.1 – 2.3 min) via analytical 
HPLC. The chromatography process was carried out using Dionex’s Acclaim 120 column (C18, 5 µm, 
120  Å, 4.6 x 150.0 mm) in a 30 minute gradient from 5 to 95% MeCN  (with 0.1% HCO2H in H2O) at 
a flow rate of 1.0 mLmin-1. The circled double peaks represent isomers of 5(6)-carboxyfluorescein-
peptoid conjugate. HPLC wavelength: 254 nm (A) and 495 nm (B).  












4.2.2 Cytotoxicity  
 
Each compound was dissolved in water and its concentration determined using UV 
/Vis spectroscopy based on the extinction coefficient of 5(6)-carboxyfluorescein (i.e. 
2.9 x 104) at 475 nm.144 The biological assays were performed by Dr. Ana Maria 
Perez-Lopez and the results are reported and discussed in this thesis.    
The cytotoxicity of the standard, TEG and hybrid peptoids was evaluated with 
two different colorimetric agents, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) and propidium iodide (PI) (Figure 4.3).145,146 The 
tests are complementary as the formazan-based assay measures the enzymatic activity 
of viable cells whereas the PI assay only stains the DNA of membrane-damaged cells. 
Hence, the different mechanisms of action involved for each dye can be used to 























Figure 4.3 Chemical structures of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) (λabs: 570 nm) and the corresponding formazan (a); and propidium iodide (λmax excitation: 535 
nm & λmax emission: 617 nm) (b) used for cytotoxicity assays. 
 
 For the cytotoxicity assays, the concentration of the peptoids was set at 10 µM 
and were added to HeLa cells; and incubated for 24 hours. The assay showed that all 
the peptoids were non-cytotoxic with cell viability measurements ≥  80% (Figure 4.4). 
The increasing backbone length of the oligomers did not appear to cause any 
significant cell death, confirming previous reports on the non-cytotoxicity of standard 
peptoids and generating new information regarding the newly synthesised TEG and 
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hybrid oligomers.112 The PI assay was performed via flow cytometry and it also 
showed excellent cell proliferation after 24 hours with measurements showing ≥ 90% 
cell viability (Figure 4.5). As both the MTT and PI assays were carried out 
independently of each other, it was reasonable to conclude that all the oligomers were 
non-toxic to HeLa cells at the concentration tested.  
 
 
Figure 4.4 MTT cell proliferation assay of standard, TEG and hybrid peptoids on HeLa cells. 1 x 104 
cells per well (in 96-well plate) were treated with 10 µM of each peptoid for 24 h at 37oC (n = 3). 




Figure 4.5 PI cell viability assay of standard, TEG and hybrid peptoids on HeLa cells. 3 x 104 cells per 
well (in 48-well plate) were treated with 10 µM of each peptoid for 24 h at 37oC (n = 2). Fluorescence 




4.2.3 Cellular Uptake Efficiency  
 
The cellular uptake analysis was performed via flow cytometry. When the 
fluorescein-conjugated peptoids are internalised by cultured cells, the cells are 
distinctively labelled and their unique fluorescence signal can be tracked.147-149 In 
general, the cellular uptake efficiency was tested on three different cell lines: 
HEK293, HeLa and CHO cells (in triplicate).  
At each sampling point, the cells were washed and re-suspended in phosphate 
buffered saline (PBS) solution and analysed via flow cytometry. Trypan blue was 
added to the suspension to quench any extracellular or membrane-associated 
fluorescence.150 The fluorescence characteristic of each cell sample was measured, 
quantified and ultimately converted into a measurement of relative fluorescence 
intensity (RFI), which is a function of the mean fluorescence of labelled-cells relative 
to a population of untreated cells.  
 
4.2.3.1 Oligomer Length  
 
Based on previous research, homo-oligomers of N-(6-aminohexyl)glycines were 
shown to be capable of effecting cellular internalisation.112 A nonamer peptoid, being 
the largest member amongst the reported collection, was the most efficient molecular 
transporter. It was established that the longest oligomer backbone correlates with the 
best cellular uptake of peptoids. As such, the total number of positively charged 
moieties (i.e. protonated side chain amines) on the peptoid strongly influences the 
internalisation of the molecule.  
In this study, all the standard peptoids S5, S7 and S9 were internalised by the 
different cell types tested at a concentration of 10 µM. With HeLa, HEK293 and CHO 
cells, the nonamer S9 was approximately five times more efficient than the pentamer 
S5 (Figure 4.6, A – C). More specifically, signal saturation was observed in HeLa and 
CHO cells after 5 hours. The results obtained from this investigation confirmed 
previous studies which highlighted the cellular penetration efficacy of S9 as the most 
effective transporter. Therefore, this was used as a positive control to provide a basis 
of comparison when discussing the cellular uptake efficiency of the TEG and hybrid 





































Figure 4.6 Cellular uptake assays of standard (A – C) and TEG (D – F) peptoids in HeLa, HEK293 and 
CHO cells. 3 x 104 cells per well (in 48-well plate) were treated with 10 µM of each peptoid for 2, 5 
and 24 h at 37oC (n = 6). Fluorescence was measured via flow cytometry at an excitation wavelength of 
488 nm, and emission monitored with a 530 / 30 band-pass filter. 
 
 The TEG peptoids T5, T7 and T9 are inherently more hydrophilic compared 
to the standard homo-oligomers due to the presence of multiple ethylene glycol units 
on the side chains. The oxygen atoms are hydrogen bond acceptors which increase the 
degree of solvation of the transporter. It was hypothesised that (i) a longer oligomer 
backbone would produce a higher rate of cellular uptake, thus corroborating 
observations seen in standard peptoids; and (ii) the enhancement of molecular 











solubility could lead to an increased translocation of the TEG peptoids, therefore 
surpassing the performance of the standard homo-oligomers (Note: This point is 
discussed in Section 4.2.3.2 – Side Chain Motif). Interestingly, both hypotheses were 
proven inaccurate as the experimental findings revealed unusual characteristics of the 
TEG peptoids. In HeLa cells, the nonamer T9 was indeed the most efficient 
transporter, registering almost twice the fluorescence intensity of the shortest peptoid 
(T9 > T7 > T5) (Figure 4.6, D). However, there was no discernible difference in term 
of uptake efficiency of the TEG peptoids in HEK293 cells when experimental error 
was taken into consideration (Figure 4.6, E).  
In CHO cells, the cellular uptake efficiency of the heptamer T7 was higher 
than the nonamer T9, breaking the general presumption that links longer peptoid 
backbone with increased cellular internalisation (T7 > T9 > T5) (Figure 4.6, F). 
Repeated experiments produced similar results and thus, implied specific transporter 
affinity towards different types of cell lines. A decrease in the fluorescence signals of 
T5, T7 and T9 was observed after 24 hours and it was highly probable that the 
fluorescein-conjugated peptoids were leaking from the labelled cells.151 Prolonged 
incubation of cultured cells with the TEG peptoids could cause supersaturation of 
cells, leading to an efflux of the peptoid from the interior of the cells. Based on these 
findings, the cellular penetration efficacy of the TEG homo-oligomers is intrinsically 








































Figure 4.7 Cellular uptake assays of hybrid peptoids at 10 µM (G – I) and 1 µM (J - L) in HeLa, 
HEK293 and CHO cells. 3 x 104 cells per well (in 48-well plate) were treated with the specified 
concentration of each peptoid for a pre-determined duration at 37oC (n = 6). Fluorescence was 
measured via flow cytometry at an excitation wavelength of 488 nm, and emission monitored with a 
530 / 30 band-pass filter. 
 
Compared to the TEG peptoids, the cellular uptake efficiency of the hybrid 
hetero-oligomers H5, H7 and H9 was clearly dependent on their backbone length.  
Comparing all three hybrid peptoids, the heptamer H7 was better than H5 in 












translocating the cellular membrane but the nonamer H9 displayed truly remarkable 
penetration efficiency as a transporter. Across different cell types, it registered an 
average fluorescence intensity of almost seven times to that of the pentamer H5 after 
5 hours of incubation at 10 µM (H9 > H7 > H5) (Figure 4.7, G – I).  
Specific to HeLa cells, a reduction in the fluorescence intensity of the 
nonamer H9 was recorded after 24 hours (Figure 4.7, G). The internalised transporter 
molecules could escape from within the cells as a result of overloading and the 
phenomenon was postulated to be concentration dependent. Consequently, the 
concentration of the peptoid medium was decreased by ten-fold to 1 µM in 
subsequent experiments. At 1 µM, no fluorescence decrease was detected in any of 
the experiments. In HeLa cells, the uptake of H9 was approximately thirty times 
better than H5 after 3 hours (Figure 4.7, J). The excellent performance of the hybrid 
nonamer H9 was also reproduced in both HEK293 and CHO cells (Figure 4.7, K & 
L).  
 
4.2.3.2 Side Chain Motif 
 
Based on the results presented in the previous section, it was evident that the 
nonamers S9, T9 and H9 were the best transporters from each category of peptoid 
synthesised. A direct comparison of all three nonamers was made to evaluate the 
relationship between the side chain motif and the cellular internalisation efficiency of 
these transporters.  
At a concentration of 10 µM, the penetration efficiency of H9 was 
approximately four times better than the standard peptoid S9 after 2 hours of 
incubation in HEK293 cells. Meanwhile, the TEG nonamer T9 was the least effective 
agent as its measured fluorescence intensity was eleven times less than H9 under 
similar conditions (Figure 4.8, M). When the starting concentration was reduced by 
ten-fold to 1 µM, the efficacy of H9 in translocating the cellular membrane was even 
more remarkable as the hetero-oligomer was sixteen times more permeable than S9 at 
a similar concentration.  
In HeLa cells, the fluorescence intensity of the hybrid peptoid H9 (i.e. at 10 
µM) was about thrice of the standard homo-oligomer S9. Unsurprisingly, the TEG 
nonamer T9 lagged behind H9 by a factor of five, indicating poor transporter 
efficiency in the cervical carcinoma cells (Figure 4.8, N). More importantly, the 
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permeability of H9 at 1 µM (i.e. in both HEK293 and HeLa cells) was comparable to 
the performance of S9 at 10 µM (within experimental error). According to confocal 
microscope analysis, H9 was approximately seven-fold more permeable than S9 
based on the intensity measured from a sample cell at 1 µM (Figure 4.9). Such high 
level of cellular permeability at low transporter concentration has not been previously 
reported.  
Results obtained from CHO cells were also consistent with the aforementioned 
findings confirming the exceptional performance of H9. On average, H9 was twice as 
permeable as S9 and thrice as good as T9 in CHO cells (Figure 4.8, O). However, the 
efficacy of the hybrid peptoid in these cells was less pronounced at the lower end of 
the tested concentrations. In general, the hybrid nonamer H9 was undisputedly the 
most efficient peptoid; with all cells 100% labelled within 2 hours of incubation at 
































Figure 4.8 A comparison of cellular uptake efficiency of nonamer peptoids S9, T9 and H9 with 
different side chain motifs in HEK293, HeLa and CHO cells. 3 x 104 cells per well (in 48-well 
plate) were treated with the specified concentration of each peptoid for 2 h at 37oC (n = 6). 
Fluorescence was measured via flow cytometry at an excitation wavelength of 488 nm, and 











Figure 4.9 Confocal microscope analysis of HeLa cells. 4 x 105 were seeded onto glass cover slip (6-
well plate) and incubated with S7, S9, H7 and H9 at 1 µM for 12 h at 37oC (n = 6). Cells were fixed 
with paraformaldehyde (4% w/v in PBS), treated with Hoechst 33342 (1% w/v in PBS) and imaged at 
λex: 407 nm and 488 nm respectively. MFI denotes mean fluorescence intensity and the captured image 
was analysed with Leica’s LAS AF software. 
 
An analysis of the chemical structure of the modified peptoids provides 
important clues regarding the role of the added ethylene glycol units. On the TEG 
nonamer T9, there are a total of nine side chain units on each transporter molecule. 
Each side chain carries two ether groups, all of which can serve as hydrogen bond 
acceptors. This is expected to increase the solubility of the TEG peptoid significantly 
due to improved interaction between the transporter and its aqueous environment. 
While enhanced solubility was expected to increase the cell permeability of the 
transporter, experimental results revealed that the presence of excessive hydrogen 
bond acceptors negatively affected the cell permeability of the TEG peptoid. 
Furthermore, T9 being the largest member in the collection (i.e. with a molecular 
weight of 2182.51 Da) could slow down the internalisation process due to its 
molecular size.  
It was obvious that the standard nonamer S9 outperformed the TEG nonamer 
T9 in all three cell types tested. A plausible explanation lies in the dynamic 
interaction between the peptoid and the lipid bilayer cell membrane. The initial ionic 
interaction between the TEG peptoid’s cationic side chains and the negatively charged 
head groups of the plasma membrane could be reduced by a “water shell” surrounding 
the triethylene glycol side chains. It is also possible that the process of internalisation 
is disrupted once the transporter reaches the lipophilic inner fold of the cell 
membrane. The highly hydrophilic side chains of the transporter might be 
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incompatible with the hydrophobic tails of the lipid bilayer, thus impeding the 
penetration of the transporter molecules.  
In contrast, the hybrid peptoid H9 displayed excellent cell penetrating 
behaviour relative to both the standard and TEG oligomers. This infers that achieving 
a delicate balance between molecular solubility and lipophilicity is essential in 
improving the cellular uptake efficiency of peptoid transporters. With a 4 : 5 ratio of 
N-((2-(2-aminoethoxy)ethoxy)ethyl) to N-(6-aminohexyl) side chains, the hybrid 
nonamer could possess an ideal proportion of structural amphiphilicity. The hybrid 
transporter is expected to be more soluble than standard peptoids but retains sufficient 
lipophilic characteristics to aid the mechanism of internalisation. Nonetheless, other 
factors contributing to the enhanced performance of the hybrid transporter could not 
be ascertained based on current data.  
It has been reported that a six-residue peptoid (i.e. a shorter analogue of the 
nonamer peptoid S9) with N-(4-aminobutyl) side chains adopts a pseudo-helical 
structure in water with an all-cis amide conformation and such structural 
conformation is functionally important for certain CPPs to translocate the cell 
membrane.152,153 Therefore, there is a possibility that the hybrid nonamer espoused a 
unique structural conformation which facilitates the process of internalisation. In-
depth structural investigations are required to elaborate the intricacies the hybrid 
transporter.  
 The locality of the hybrid peptoids, once internalised, was of special interest 
due to their distinct amphiphilic characteristics. Thus, confocal microscopy was used 
to image the internalised transporters. Figure 4.10 shows a series of images taken 
from HeLa cells after incubation with hybrid heptamer H7 at 1 µM for 12 hours 
(Figure 4.10, P). Based on the images, the peptoid could be seen in vesicular pockets 
(i.e. peripheral bright fluorescence clusters) surrounding the cell nuclei (Figure 4.10, 
R). The cytosol of cells was also clearly stained with green fluorescence implying a 
release of the transporter from the endosomes over time. The nucleus (stained with the 
blue bis-benzimide dye) showed no indication of peptoid internalisation (Figure 4.10, 
Q). The locality of the internalised hybrid transporter is consistent with previously 
observed confocal images of standard peptoids.112 In general, no extraordinary 












Figure 4.10 Confocal microscope image of HeLa cells. 4 x 105 were seeded onto glass cover slip (6-
well plate) and incubated with hybrid peptoid H7 at 1 µM for 12 h at 37oC (n = 6). Cells were fixed 
with paraformaldehyde (4% w/v in PBS), treated with Hoechst 33342 (1% w/v in PBS) and imaged at 
λex: 407 nm (Q) and 488 nm (R), respectively. (P) represents a transposition of images from the 




A total of nine peptoids, from three different structural categories, were synthesised 
via solid phase synthesis. These include the homo-oligomers of (i) N-(6-
aminohexyl)glycines (standard peptoids) and (ii) N-((2-(2-
aminoethoxy)ethoxy)ethyl)glycines (TEG peptoids), as well as the hetero-oligomer of 
alternating standard and TEG residues (hybrid peptoids). 5(6)-carboxyfluorescein was 
used as a fluorescence tracker in monitoring the cellular activity of the peptoids via 
flow cytometry. Under normal synthetic conditions, it was discovered that the Nα-
Fmoc group deprotection of the TEG and hybrid peptoids was problematic when the 
length of the oligomer backbone was ≥ five monomer units. Therefore, the TEG and 
hybrid peptoids were assembled using microwave-assisted SPPS which provided 
access to the novel architectures. Three members of each peptoid category – 
pentamer, heptamer and nonamer, were synthesised for biological evaluations. 
 The peptoids were evaluated for their cytotoxicity and cellular uptake 
efficiency in three different cell lines (HEK293, HeLa and CHO). Based on the results 
of MTT and PI assays, all the peptoids were observed to be non-cytotoxic at a 
concentration of 10 µM as evidenced by the relatively high HeLa cell viability. In 
general, the standard and hybrid peptoids demonstrated positive correlation between 
translocation efficiency and the length of oligomer backbone (nonamer > heptamer > 
pentamer). However, the TEG peptoids were more cell specific; displaying markedly 
different permeability in the different cells tested. While all nine peptoids showed 
P Q R 
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cellular internalisation, the hybrid nonamer was the best transporter. Experimental 
findings showed that HEK293 and HeLa cells were successfully labelled by the 
hybrid nonamer H9 after 2 hours of incubation at a concentration of 1 µM; 
demonstrating comparable internalisation efficiency to the standard nonamer S9 at a 
much higher concentration (i.e. 10 µM). The superior performance of the hybrid 
peptoid is believed to stem from its amphiphilic characteristics, achieving a good 
balance between enhanced solubility through the addition of multiple ethylene glycol 
units and retaining sufficient lipophilic characteristic via the six methylene spacer-











All solvents, reagents, catalysts and resins were obtained from commercial suppliers 
and used without purification, unless otherwise stated.  
 
5.1.2 Instruments  
 
1H and 13C NMR spectra were recorded on an automated Bruker AVA 500 (500 and 
125 MHz, respectively) in the indicated solvents at 298 K. Chemical shifts (δ) are 
quoted in parts per million (ppm) relative to the residual solvent and all coupling 
constants (J) were measured in Hertz (Hz). 
Electrospray mass spectrometry analysis was performed on an Agilent 1100 
series LC-MS system. Mass spectra were acquired via a VG Platform Single 
Quadrupole Electrospray Ionisation (ESI) mass spectrometer. High Resolution Mass 
Spectrometry (HR-MS) was performed using Bruker 3.0 T Apex II 
spectrometer.           
Analytical HPLC was conducted on an Agilent 1100 series HPLC system 
coupled to a Polymer Lab PL-ELS 1000 Evaporative Light Scattering (ELS) detector 
with UV detection at 220, 254, 260, 282 and 495 nm. Supelco’s Discovery® C18 (50 
mm x 2.1 mm x 5 µm) column was used. Elution was performed with Solvent A 
(0.1% formic acid in HPLC-grade deionised water) and Solvent B (0.1% formic acid 
in HPLC-grade MeOH / MeCN) at 1 mLmin-1 with a gradient of 5 to 95% B over 3 
min, followed by 2 min isocratic at 95% B and ending with a gradient of 95 to 5% B 
over 1 min. 
Infrared (IR) spectra were recorded on a Fourier Transform IR Bruker Tensor 
27 spectrometer. All samples were run neat and frequencies were reported in cm-1. 
Only frequencies corresponding to significant functional groups are reported. 
Microwave reaction was carried out by irradiating the reaction mixture in a 
Biotage Initiator Microwave Synthesiser at 2.45 GHz.  
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Live cells were monitored using a Leica fluorescence microscope (20x) under 
bright light and 488 nm excitation. Flow cytometry analysis was carried out on a 
Becton Dickinson (BD) FACS Aria® cytometer using FACSDiva® or FlowJo 
software. The absorbance of 96-well plates was read on a Benchmark Bio-Rad 
microplate reader at 570 nm using the Microplate Manager 4.0 software. Confocal 
images were taken on a Leica SP5 confocal microscope and Zeiss 510 Meta software 
was used for digital acquisition. Deconvolution was carried out using AutoQuant X 
software. 
 
5.2 Flow Instrumentation 
 
The flow experiments were performed on a self-assembled continuous flow set-up. 



















Figure 5.1 General schematic of the continuous flow set-up. 
 
 Two or more HPLC pumps were used to deliver the reactants continuously 
into the flow reactor. Each pump was equipped with a pressure transducer to monitor 
the pressure of the flow system during reactions. Material precipitation within the 
flow reactor could easily be detected when the pressure of the system suddenly 
increases at a constant total flow rate. A simple T-mixer (commercially available) 
with an internal bore of 0.80 mm was used to mix two separate feed streams and the 
mixture was channelled into the flow reactor.   
Inlet 1 Inlet 2 
Product Collection 




Back Pressure Regulator 
(when necessary) 
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The coil reactor was made of PTFE tubing (0.50 mm I.D.) with an internal 
volume of 2.00, 4.00 or 8.00 mL. PTFE tubing was chosen as it is chemically inert, 
corrosion resistant towards a broad range of solvents, acids and bases as well as being 
highly lubricious (with a low coefficient of friction). In order to perform reactions at 
elevated temperatures, an adjustable back pressure regulator (BPR) was installed to 
pressurise the flow system. Standard HPLC fittings were used to connect each 
individual component to create a fully functional reaction platform. Detailed 
specifications of the system are listed in Table 5.1.  
 
Table 5.1 System specifications of the continuous flow set-up. 
Component Specification 
HPLC Pump Pump: Knauer Smartline Pump 100 
Pumphead: 10 mL with ceramic inlays (with pressure 
transducer) 
Flow range: 0.001 – 10.000 mLmin-1 
Delivery system: Double-piston pump with main and auxiliary 
piston 
Dimension: 110 x 130 x 250 mm (W x H x D) 
Flow accuracy: < 1.0% at 1 mLmin-1, 12 MPa 
Flow precision: < 0.5% at 1 mLmin-1, 12 MPa 
Reagent Inlet Material: PTFE tubing (1.00 mm I.D.) 
Mixer Configuration: T-Mixer 
Material: PEEK 
Bore size: 0.80 mm 
Flow Reactor Material: PTFE tubings (0.50 mm I.D.) 
Operating Temperature: -270 to 260oC 
Back Pressure 
Regulator 
Diaphragm: Spring-loaded FFKM (perfluorinated rubber) 
Housing: PEEK 
Membrane: Polyimide 
Operating Pressure: 1 – 20 bar 
Product Outlet Material: PTFE tubing (0.50 mm I.D.) 
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5.3 Experimental for Chapter 2 
 


































Figure 5.2b Flow reaction stream from point of entry A to point of exit C, and the subsequent 
quenching. Residence time is calculated based on the total time spent from A to C at a constant 2.0 mL 
reactor volume. 
 
Flow Screening Procedure: 
 
Diamines 1a, 1b or 1c (0.10 M, 10 mL) and Boc2O (0.10 M, 10 mL) in MeOH were 
fed continuously into a PTFE reactor (0.50, 1.00 or 1.50 mm I.D., 2.00 mL total 
volume) immersed in a water bath set to the desired working temperature (0 or 25oC). 
The reactants were introduced via two separate pre-conditioning segments of PTFE 




Crude collection into cold MeOH 
with excess silica-based Trisamine 
scavenger.  
Diamine / MeOH, 10.0 mmol, 0.20 M 
Q = 1.00 mLmin-1 
 
PTFE Reactor 
0.5 mm I.D., 2.00 mL 
PTFE tubing, 1.0 / 1.5 mm I.D. 
0.58 mL  
PTFE tubing, 0.5 mm I.D. 
0.18 mL; Immersed in ice 
bath at 0oC 
τ = 1.0 min, T = 0oC 
Q = 2.00 mLmin-1 
Boc2O / MeOH, 5.0 mmol, 0.10 M 




Total length = 10.16 m (2.0 mL internal volume) 
Point of entry A 
(post T-mixer) 
Immersed in water bath set at 0 oC 
No ext ra  tubing is 
connected to the outlet 
o f  C .  Q u e n c h i n g 
occurs immediately in 
the collection flask. 
Note: 
5 cm of tubing (from B to C) 
is part of the flow reactor.  
B C 
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tubing (0.5 mm I.D., 0.18 mL volume) immersed in a temperature adjusted bath. The 
reactants converged in the T-mixer and the stoichiometry as well as residence time of 
the reaction were determined by adjusting the individual flow rates of the HPLC 
pumps.  The reaction stream (20 mL) was collected at steady state after 1.5 reactor 
volume, into a flask filled with cold MeOH (80 mL, – 20oC) containing an excess of 
trisamine scavenger (0.63 g, 1.0 mmol; assuming 50% mono-Boc carbamation 
efficiency). The solution was filtered and the filtrate concentrated in vacuo. The crude 
mixture was purified via flash column chromatography (silica gel, 90:10 DCM / 
MeOH with 0.1% TEA) and the product yields reported accordingly.  
 
General Scale-Out Procedure: 
 
Diamines and triamines 1a – 1i (0.10 M, 50 mL) and Boc2O (0.20 M, 50 mL) in 
MeOH were fed continuously into a PTFE reactor (0.50 mm I.D., 2.00 mL total 
volume) immersed in an ice bath (0oC). The reactants were introduced via two 
separate pre-conditioning segments (temperature set at 0oC) of PTFE tubing (0.5 mm 
I.D., 0.18 mL volume). The reactants converged in the T-mixer and the total flow rate 
of reaction stream was fixed at 2.00 mLmin-1 to give a residence time of 1.0 min. The 
reaction stream (100 mL) was collected at steady state after 1.5 reactor volume, into a 
flask filled with cold MeOH (200 mL, –20oC) containing an excess of trisamine 
scavenger (3.00 g, 4.7 mmol; assuming 50% mono-Boc carbamation efficiency) under 
rigorous stirring. The solution was filtered and the filtrate concentrated in vacuo. The 
crude mixture was purified via flash column chromatography (silica gel, 90:10 DCM / 
MeOH with 0.1% TEA) to give: 
 









Yield: 0.51g (64%); yellow oil 
 
IR (neat): ν (cm-1) = 3294, 2976, 1687, 1519; 1H NMR (500 MHz, CDCl3): δ [ppm] = 
1.43 [s, 9H, (CH3)3], 2.04 (s, 2H, NH2), 2.81 (t, J = 5.9 Hz, 2H, NH2CH2), 3.20 (q, J 
= 5.6 Hz, 2H, CH2NH), 4.99 (br s, 1H, NH); 
13C NMR (125 MHz, CDCl3): δ [ppm] = 
28.40 [(CH3)3], 40.37 (NH2CH2), 41.63 (CH2NH), 79.07 [OC(CH3)3], 156.02 
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(NHCO2C); LC-MS (ESI
+): m/z (%) =161.2 (100) [M+H]+ ; HR-MS (C7H16N2O2): 
calc: 160.1206; found: 160.1202. Spectral data are consistent with the literature.
I 
 









Yield: 0.67 g (77%); yellow oil  
 
IR (neat): ν (cm-1) = 3383, 2967, 2918, 1687, 1518, 1163; 1H NMR (500 MHz, 
CDCl3): δ [ppm] = 1.43 [s, 9H, (CH3)3], 1.60 – 1.64 (m, 2H, NH2CH2CH2CH2NH), 
2.16 (s, 2H, NH2), 2.76 (t, J = 6.6 Hz, 2H, NH2CH2), 3.19 – 3.23 (m, 2H, CH2NH), 
4.90 (br s, 1H, NH); 13C NMR (125 MHz, CDCl3): δ [ppm] = 28.40 [(CH3)3], 33.26 
(NH2CH2CH2CH2NH), 38.39 (CH2NH), 39.61 (NH2CH2), 79.09 [OC(CH3)3], 156.15 
(NHCO2C); LC-MS (ESI
+): m/z (%) = 175.2 (100) [M+H]+; HR-MS (C8H18N2O2): 
calc: 174.1363; found: 174.1361. Spectral data are consistent with the literature.I 
 









Yield: 0.61 g (65%); yellow oil 
 
IR (neat): ν (cm-1) = 3363, 2975, 2929, 1526, 1171; 1H NMR (500 MHz, CDCl3): δ 
[ppm] = 1.43 [s, 9H, (CH3)3], 1.45 – 1.53 [m, 4H, NH2CH2(CH2)2CH2NH], 1.80 (s, 
2H, NH2), 2.71 (t, J = 6.7 Hz, 2H, NH2CH2), 3.10 – 3.12 (m, 2H, CH2NH), 4.69 (br s, 
1H, NH); 13C NMR (125 MHz, CDCl3): δ [ppm] = 27.43 (CH2CH2NH), 28.40 
[(CH3)3], 30.56 (NH2CH2 CH2), 40.38 (CH2NH), 41.65 (NH2CH2), 79.06 
[OC(CH3)3], 156.01 (NHCO2C); LC-MS (ESI
+): m/z (%) = 189.2 (100) [M+H]+; 
211.2 (6) [M+Na]+; HR-MS (C9H20N2O2): calc: 188.1519; found: 188.1520. Spectral 
data are consistent with the literature.I 
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Yield: 0.60 g (59%); yellow oil 
 
IR (neat): ν (cm-1) = 3331, 2974, 2931, 1521, 1170; 1H NMR (500 MHz, CDCl3): δ 
[ppm] = 1.33 – 1.38 [m, 2H, NH2(CH2)2CH2(CH2)2NH], 1.43 [s, 9H, (CH3)3], 1.46 – 
1.52 (m, 4H, NH2CH2CH2CH2CH2CH2NH), 1.91 (br s, 2H, NH2), 2.70 (t, J = 7.0 Hz, 
2H, NH2CH2), 3.09 – 3.13 (m, 2H, CH2NH), 4.56 (br s, 1H, NH); 
13C NMR (125 
MHz, CDCl3): δ [ppm] = 24.01 [NH2(CH2)2CH2(CH2)2NH], 28.40 [(CH3)3], 29.86 
(CH2CH2NH), 32.95 (NH2CH2CH2), 40.46 (CH2NH), 41.88 (NH2CH2), 79.04 
[OC(CH3)3], 155.98 (NHCO2C); LC-MS (ESI
+): m/z (%) = 203.2 (100) [M+H]+; HR-
MS (C10H22N2O2): calc: 202.1676; found: 202.1670. Spectral data are consistent with 
the literature.I 
 









Yield: 0.66 g (61%); yellow oil 
 
IR (neat): ν (cm-1) = 3367, 1683, 1519; 1H NMR (400 MHz, CDCl3): δ [ppm] = 1.31 – 
1.34 [m, 4H, NH2(CH2)2(CH2)2(CH2)2NH], 1.43 – 1.50 [m, 13H, 
NH2CH2CH2(CH2)2CH2CH2NH, C(CH3)3], 1.89 (s, 2H, NH2), 2.68 (t, J = 7.0 Hz, 2H, 
NH2CH2), 3.08 – 3.10 (m, 2H, CH2NH), 4.54 (br s, 1H, NH); 
13C NMR (100 MHz, 
CDCl3): δ [ppm] = 26.47 [NH2(CH2)2CH2CH2(CH2)2NH], 26.57 
[NH2(CH2)2CH2CH2(CH2)2NH], 28.40 [(CH3)3], 30.01 (CH2CH2NH), 33.35 
(NH2CH2CH2), 40.47 (CH2NH), 41.95 (NH2CH2), 79.01 [OC(CH3)3], 155.98 
(NHCO2C); LC-MS (ESI
+): m/z (%) = 217.2 (100) [M+H]+; HR-MS (C11H24N2O2): 
calc: 216.1832; found: 216.1835. Spectral data are consistent with the literature.I 
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Yield: 0.81 g (65%); yellow oil 
 
IR (neat): ν (cm-1) = 3367, 1685; 1H NMR (400 MHz, CDCl3): δ [ppm] = 1.44 [s, 9H, 
C(CH3)3]; 1.73 (s, 2H, NH2), 2.88 (t, J = 5.2 Hz, 2H, CH2NH2), 3.31 – 3.32 (m, 2H, 
CH2NH), 3.51 – 3.55 [m, 4H, CH2O(CH2)2OCH2], 3.61 [br s, 4H, 
NHCH2CH2O(CH2)2OCH2CH2NH2] 5.18 (br s, 1H, NH); 
13C NMR (100 MHz, 
CDCl3): δ [ppm] = 28.40 [(CH3)3], 40.33 (CH2NH), 41.65 (NH2CH2), 70.18 
[NH2(CH2)2O(CH2)2O], 70.21 (OCH2CH2NH), 73.25 (NH2CH2CH2), 79.18 
[OC(CH3)3], 156.02 (NHCO2C); LC-MS (ESI
+): m/z (%) = 249.2 (100) [M+H]+; 
271.2 (14) [M+Na]+; HR-MS (C11H24N2O4): calc: 248.1731; found: 248.1729. 
Spectral data are consistent with the literature.II 
 











Yield: 1.07 g (67%); yellow oil 
 
IR (neat): ν (cm-1) = 3348, 2866, 1692, 1521, 1109; 1H NMR (500 MHz, CDCl3): δ 
[ppm] = 1.42 [s, 9H, (CH3)3], 1.75 [quin., J = 6.4 Hz, 4H, 
NH2CH2CH2(CH2OCH2)3CH2], 2.08 (s, 2H, NH2), 2.83 (t, J = 6.6 Hz, 2H, NH2CH2), 
3.20 – 3.22 (m, 2H, CH2NH), 3.53 [t, J = 6.0 Hz, 2H, NH2(CH2)2CH2O], 3.55 – 3.60 
[m, 6H, NH2(CH2)3O(CH2)2O(CH2)2OCH2], 3.62 – 3.64 [m, 4H, 
NH2(CH2)3O(CH2)2O(CH2)2O], 5.1 (br s, 1H, NH); 
13C NMR (125 MHz, CDCl3): δ 
[ppm] = 28.43 [(CH3)3], 29.63 (CH2CH2NH), 32.57 (NH2CH2CH2), 38.41 (NH2CH2), 
39.61 (CH2CH2NH), 69.44 [NH2(CH2)2CH2O], 69.55 [OCH2(CH2)2NH], 70.12 
[NH2(CH2)3OCH2], 70.16 [NH2(CH2)3OCH2CH2], 70.49 [NH2(CH2)3O(CH2)2OCH2], 
70.53 [NH2(CH2)3O(CH2)2OCH2CH2], 78.91 [OC(CH3)3], 156.13 (NHCO2C);  LC-
MS (ESI+): m/z (%) = 321.2 (100) [M+H]+; 343.2 (5) [M+Na]+; HR-MS 
(C15H32N2O5): calc: 320.2306; found: 320.2307. Spectral data are consistent with the 
literature.III 
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Yield: 0.56 g (55%); yellow oil 
 
IR (neat): ν (cm-1) = 3296, 2974, 2931, 1686, 1517, 1166; 1H NMR (500 MHz, 
CDCl3): δ [ppm] = 1.43 [s, 9H, (CH3)3], 2.07 (s, 2H, NH2), 2.67 (t, J = 5.8 Hz, 2H, 
NH2CH2), 2.72 (t, J = 5.8 Hz, 2H, NH2CH2CH2), 2.80 (t, J = 5.8 Hz, 2H, 
NHCH2CH2NH), 3.21 – 3.22 (m, 2H, CH2CH2NH), 5.06 (br s, 1H, NHCO2C);  
13C 
NMR (125 MHz, CDCl3): δ [ppm] = 28.38 [(CH3)3], 40.24 (NH2CH2), 41.46 
(CH2NHCO), 48.94 (NHCH2CH2NH), 51.63 (NH2CH2CH2NH), 79.15 [OC(CH3)3], 
156.15 (NHCO2C); LC-MS (ESI
+): m/z (%) = 204.1 (38) [M+H]+. Spectral data are 
consistent with the literature.IV 
 











Yield: 0.46 g (40%); yellow oil 
 
IR (neat): ν (cm-1) = 3353, 2982, 2865, 1682, 1519; 1H NMR (500 MHz, CDCl3): δ 
[ppm] = 1.43 [s, 9H, (CH3)3], 1.65 (sex, J = 6.6 Hz, 4H, 
NH2CH2CH2CH2NHCH2CH2), 1.84 (s, 2H, NH2), 2.68 (t, J = 6.4 Hz, 4H, 
CH2NHCH2), 2.79 (t, J = 6.7 Hz, 2H, NH2CH2), 3.19 – 3.20 (m, 2H, CH2NH), 5.19 
(br s, 1H, NHCO2C); 
13C NMR (125 MHz, CDCl3): δ [ppm] = 28.41 [(CH3)3], 29.66 
(NHCH2CH2CH2NH), 33.07 (NH2CH2CH2CH2), 39.07 (CH2NHCO), 40.45 
(NH2CH2), 47.63 [NHCH2(CH2)2NH], 47.84 [NH2(CH2)2CH2NH], 79.00 
[OC(CH3)3], 156.14 (NHCO2C); LC-MS (ESI
+): m/z (%) =  232.3 (100) [M+H]+; 
254.2 (8) [M+Na]+. Spectral data are consistent with the literature.IV 
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Figure 5.3 Mono-Fmoc carbamation via continuous flow synthesis. 
 
General Scale-Out Procedure:  
 
Diamines 1a – 1g (0.05 M, 50 mL) and Fmoc-OSu (0.10 M, 50 mL) in DMF were fed 
continuously into a PTFE reactor (0.50 mm I.D., 2.00 mL total volume) immersed in 
an ice bath (0oC). The reactants were introduced via two separate pre-conditioning 
segments (temperature set at 0oC) of PTFE tubing (0.5 mm I.D., 0.18 mL volume). 
The reactants converged in the T-mixer and the total flow rate of reaction stream was 
fixed at 4.00 mLmin-1 to give a residence time of 0.5 min. The reaction stream (100 
mL) was collected at steady state after 1.5 reactor volume, into a flask filled with cold 
methanolic HCl (50 mL, –20oC, pH 2 – 3) under rigorous stirring. The solution was 
concentrated in vacuo and distilled water (50 mL) was added into the crude mixture to 
precipitate the insoluble side product. The white solid was filtered off and the aqueous 
solution was washed with EtOAc (2 x 50 mL). Subsequently, the aqueous layer was 
adjusted to pH 8 by adding saturated NaHCO3 solution (30 mL) and extracted with 
DCM (2 x 100 mL). The organic layer was washed with brine (2 x 100 mL) and dried 
over NaSO4. The drying agent was filtered off and the filtrate was acidified to pH 3 






Pump 1 Pump 2 
T-Mixer 
Fmoc-OSu / DMF, 2.5 mmol, 0.05 M 
Q = 2.00 mLmin-1 
 
Crude collection into cold 
methanolic HCl (~ pH 2 – 3).  
Diamine / DMF, 5.0 mmol, 0.10 M 
Q = 2.00 mLmin-1 
 
PTFE Reactor 
0.5 mm I.D., 2.00 mL 
PTFE tubing, 1.0 / 1.5 mm I.D. 
0.58 mL  
PTFE tubing, 0.5 mm I.D. 
0.18 mL; Immersed in ice 
bath at 0oC 
τ = 0.5 min, T = 0oC 
Q = 4.00 mLmin-1 
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Yield: 0.44 g (63%); off-white solid  
 
M.p. 115 – 117oC; IR (neat): ν (cm-1) = 3287, 2948, 2837, 1647, 1407, 1015; 1H NMR 
(500 MHz, MeOD): δ [ppm] = 3.04 – 3.05 (m, 2H, HCl.NH2CH2), 3.39 (t, J = 5.4 Hz, 
2H, CH2NHCO), 4.23 (t, J = 6.5 Hz, 1H, CH-9), 4.42 (d, J = 6.6 Hz, 2H, 
CO2CH2CH-9), 7.32 (t, J = 7.4 Hz, 2H, CH-2 and -7), 7.40 (t, J = 7.4 Hz, 2H, CH-3 
and -6), 7.66 (d, J = 7.4 Hz, 2H, CH-1 and -8), 7.81 (d, J = 7.5 Hz, 2H, CH-4 and -5); 
13C NMR (125 MHz, MeOD): δ [ppm] = 39.50 (HCl.NH2CH2), 41.20 (CH2NHCO), 
68.05 (CO2CH2CH-9), 121.01 (CH-3 and -6), 126.44 (CH-2 and -7), 128.19 (CH-4 
and -5), 128.87 (CH-1 and -8), 142.70 (CH-4a and -4b), 145.30 (CH-8a and -9a), 
159.42 (NHCO2); LC-MS (ESI
+): m/z (%) = 283.2 (90) [M+H]+; 305.2 (10) 
[M+Na]+; HR-MS (C17H18N2O2): calc: 282.1363; found: 282.1359. Spectral data are 
consistent with the literature.V 
 









Yield: 0.44 g (59%); off-white solid 
 
M.p. 127 – 129oC; IR (neat): ν (cm-1) = 3331, 2945, 2833, 1645, 1448, 1320, 1110; 
1H NMR (500 MHz, MeOD): δ [ppm] = 1.77 – 1.85 (m, 2H, 
HCl.NH2CH2CH2CH2NH), 2.91 (t, J = 7.3 Hz, 2H, HCl.NH2CH2), 3.21 (t, J = 6.5 Hz, 
2H, CH2NHCO), 4.21 (t, J = 6.5 Hz, 1H, CH-9), 4.42 (d, J = 6.6 Hz, 2H, 
CO2CH2CH-9), 7.32 (t, J = 7.4 Hz, 2H, CH-2 and -7), 7.40 (t, J = 7.4 Hz, 2H, CH-3 
and -6), 7.64 (d, J = 7.5 Hz, 2H, CH-1 and -8), 7.80 (d, J = 7.5 Hz, 2H, CH-4 and -5); 
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13C NMR (125 MHz, MeOD): δ [ppm] = 29.26 (HCl.NH2CH2CH2CH2NH), 38.32 
(HCl.NH2CH2), 43.64 (CH2NHCO), 54.85 (CH-9), 67.73 (CO2CH2CH-9), 121.06 
(CH-3 and -6), 126.11 (CH-2 and -7), 128.18 (CH-4 and -5), 128.86 (CH-1 and -8), 
142.72 (CH-4a and -4b), 145.31 (CH-8a and -9a), 159.43 (NHCO2); LC-MS (ESI
+): 
m/z (%) = 297.2 (87) [M+H]+; HR-MS (C18H20N2O2): calc: 296.1519; found: 
296.1519. Spectral data are consistent with the literature.VI 
 









Yield: 0.40 g (51%); off-white solid 
 
M.p. 110 – 112oC; IR (neat): ν (cm-1) = 3304, 2943, 2831, 1449, 1024; 1H NMR (500 
MHz, MeOD): δ [ppm] = 1.55 – 1.60 (m, 2H, HCl.NH2CH2CH2), 1.64 – 1.70 (m, 2H, 
CH2CH2NHCO), 2.94 (t, J = 7.3 Hz, 2H, CH2NHCO), 3.15 (t, J = 6.6 Hz, 2H, 
HCl.NH2CH2), 4.20 (t, J = 6.7 Hz, 1H, CH-9), 4.37 (d, J = 6.7 Hz, 2H, CO2CH2CH-
9), 7.31 (t, J = 7.4 Hz, 2H, CH-2 and -7), 7.40 (t, J = 7.4 Hz, 2H, CH-3 and -6), 7.65 
(d, J = 7.4 Hz, 2H, CH-1 and -8), 7.80 (d, J = 7.5 Hz, 2H, CH-4 and -5); 13C NMR 
(125 MHz, MeOD): δ [ppm] = 25.79 (HCl.NH2CH2CH2), 27.90 
[HCl.NH2(CH2)2CH2], 40.45 (HCl.NH2CH2), 40.92 (CH2NHCO), 67.69 
(CO2CH2CH-9), 120.99 (CH-3 and -6), 126.14 (CH-2 and -7), 128.17 (CH-4 and -5), 
128.83 (CH-1 and -8), 142.68 (CH-4a and -4b), 145.36 (CH-8a and -9a), 159.08 
(NHCO2); LC-MS (ESI
+): m/z (%) = 311.2 (100) [M+H]+; 333.2 (7) [M+Na]+; HR-
MS (C19H22N2O2): calc: 310.1676; found: 310.1675. Spectral data are consistent with 
the literature.VII 
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Yield: 0.50 g (62%); off-white solid 
 
M.p. 94 – 96oC; IR (neat): ν (cm-1) = 3333, 2943, 2831, 1566, 1450, 1106; 1H NMR 
(500 MHz, MeOD): δ [ppm] = 1.35 – 1.43 (m, 2H, HCl.NH2(CH2)2CH2), 1.51 – 1.57 
(m, 2H, CH2CH2NHCO), 1.64 – 1.70 (m, 2H, HCl.NH2CH2CH2), 2.91 (t, J = 7.6 Hz, 
2H, CH2NHCO), 3.12 (t, J = 6.9 Hz, 2H, HCl.NH2CH2), 4.20 (t, J = 6.7 Hz, 1H, CH-
9), 4.37 (d, J = 6.7 Hz, 2H, CO2CH2CH-9), 7.31 (t, J = 7.5 Hz, 2H, CH-2 and -7), 
7.40 (t, J = 7.4 Hz, 2H, CH-3 and -6), 7.64 (d, J = 7.5 Hz, 2H, CH-1 and -8), 7.80 (d, 
J = 7.5 Hz, 2H, CH-4 and -5); 13C NMR (125 MHz, MeOD): δ [ppm] = 24.55 
[HCl.NH2(CH2)2CH2], 28.20 (HCl.NH2CH2CH2), 30.41 (CH2CH2NHCO), 40.70 
(HCl.NH2CH2), 41.28 (CH2NHCO), 43.56 (CH-9), 67.59 (CO2CH2CH-9), 120.99 
(CH-3 and -6), 126.14 (CH-2 and -7), 128.16 (CH-4 and -5), 128.82 (CH-1 and -8), 
142.68 (CH-4a and -4b), 145.38 (CH-8a and -9a), 159.05 (NHCO2); LC-MS (ESI
+): 
m/z (%) = 325.2 (74) [M+H]+; HR-MS (C20H24N2O2): calc: 324.1832; found: 
324.1827. Spectral data are consistent with the literature.VII 
 









Yield: 0.38 g (45%); off-white solid 
 
M.p. 99 – 101oC; IR (neat): ν (cm-1) = 2955, 2867, 1637, 1569, 1466, 1321, 1097; 1H 
NMR (500 MHz, MeOD): δ [ppm] = 1.37 – 1.44 [m, 4H, HCl.NH2(CH2)2(CH2)2], 
1.52 (quin., J = 6.9 Hz, 2H, CH2CH2NHCO), 1.66 (quin., J = 7.4 Hz, 2H, 
HCl.NH2CH2CH2), 2.91 (t, J = 7.5 Hz, 2H, CH2NHCO), 3.11 (t, J = 6.9 Hz, 2H, 
 93 
HCl.NH2CH2), 4.20 (t, J = 6.8 Hz, 1H, CH-9), 4.36 (d, J = 6.8 Hz, 2H, CO2CH2CH-
9), 7.31 (t, J = 7.4 Hz, 2H, CH-2 and -7), 7.40 (t, J = 7.5 Hz, 2H, CH-3 and -6), 7.65 
(d, J = 7.5 Hz, 2H, CH-1 and -8), 7.81 (d, J = 7.6 Hz, 2H, CH-4 and -5); 13C NMR 
(125 MHz, MeOD): δ [ppm] = 27.20 [HCl.NH2(CH2)3CH2], 28.54 
[HCl.NH2(CH2)2CH2], 30.70 (HCl.NH2CH2CH2), 35.43 (CH2CH2NHCO), 40.72 
(HCl.NH2CH2), 41.46 (CH2NHCO), 67.61 (CO2CH2CH-9), 120.99 (CH-3 and -6), 
126.17 (CH-2 and -7), 128.17 (CH-4 and -5), 128.82 (CH-1 and -8), 142.68 (CH-4a 
and -4b), 145.40 (CH-8a and -9a), 159.03 (NHCO2); LC-MS (ESI
+): m/z (%) = 339.2 
(87) [M+H]+; 361.2 (8) [M+Na]+; HR-MS (C21H26N2O2): calc: 338.1989; found: 














Yield: 0.56 g (61%); off-white solid 
 
M.p. 113 – 115oC; IR (neat): ν (cm-1) = 3313, 2942, 2830, 1449, 1114; 1H NMR (500 
MHz, MeOD): δ [ppm] = 3.06 (t, J = 5.0 Hz, 2H, CH2NHCO), 3.28 – 3.29 (m, 2H, 
HCl.NH2CH2), 3.53 [t, J = 5.6 Hz, 2H, OCH2CH2NH), 3.60 – 3.67 [m, 6H, 
HCl.NH2CH2CH2O(CH2)2O], 4.20 (t, J = 6.7 Hz, 1H, CH-9), 4.35 (d, J = 6.7 Hz, 2H, 
CO2CH2CH-9), 7.30 (t, J = 7.4 Hz, 2H, CH-2 and -7), 7.38 (t, J = 7.4 Hz, 2H, CH-3 
and -6), 7.63 (d, J = 7.5 Hz, 2H, CH-1 and -8), 7.79 (d, J = 7.6 Hz, 2H, CH-4 and -5); 
13C NMR (125 MHz, MeOD): δ [ppm] = 13C NMR (125 MHz, MeOD): δ [ppm] =  
40.71 (CH2NHCO), 41.60 (HCl.NH2CH2), 67.75 (CO2CH2CH-9), 67.90 
(OCH2CH2O), 71.12 (OCH2CH2NH), 71.39 (HCl.NH2CH2CH2), 121.02 (CH-3 and -
6), 126.17 (CH-2 and -7), 128.19 (CH-4 and -5), 128.86 (CH-1 and -8), 142.68 (CH-
4a and -4b), 145.36 (CH-8a and -9a), 159.06 (NHCO2); LC-MS (ESI
+): m/z (%) = 
371.2 (100) [M+H]+; 393.2 (20) [M+Na]+; HR-MS (C21H26N2O4): calc: 370.1887; 















Yield: 0.56 g (51%); off-white solid 
 
M.p. 71 – 73oC; IR (neat): ν (cm-1) = 3312, 2942, 2830, 1567, 1449, 1115; 1H NMR 
(500 MHz, MeOD): δ [ppm] = 1.73 (quin., J = 6.4 Hz, 2H, CH2CH2CH2NHCO), 1.88 
(quin., J = 6.0 Hz, 2H, HCl.NH2CH2CH2CH2O), 3.05 (t, J = 6.4 Hz, 2H, 
HCl.NH2CH2), 3.16 – 3.20 (m, 2H, CH2NHCO), 3.48 [t, J = 6.0 Hz, 2H, 
HCl.NH2(CH2)2CH2O], 3.55 – 3.63 [m, 10H, HCl.NH2(CH2)3{O(CH2)2}2OCH2], 
4.20 (t, J = 6.7 Hz, 1H, CH-9), 4.36 (d, J = 6.8 Hz, 2H, CO2CH2CH-9), 7.30 (t, J = 
7.4 Hz, 2H, CH-2 and -7), 7.38 (t, J = 7.4 Hz, 2H, CH-3 and -6), 7.63 (d, J = 7.5 Hz, 
2H, CH-1 and -8), 7.79 (d, J = 7.5 Hz, 2H, CH-4 and -5); 13C NMR (125 MHz, 
CDCl3): δ [ppm] = 28.06 (CH2CH2NH), 30.93 (HCl.NH2CH2CH2), 35.42 
(HCl.NH2CH2), 39.02 (CH2CH2NH), 67.62 [HCl.NH2(CH2)2CH2O], 69.59 
[OCH2(CH2)2NH], 70.43 [HCl.NH2(CH2)3OCH2], 71.03 [HCl.NH2(CH2)3OCH2CH2], 
71.09 [HCl.NH2(CH2)3O(CH2)2OCH2], 71.41 [HCl.NH2(CH2)3O(CH2)2OCH2CH2], 
121.02 (CH-3 and -6), 126.17 (CH-2 and -7), 128.19 (CH-4 and -5), 128.85 (CH-1 
and -8), 142.69 (CH-4a and -4b), 145.38 (CH-8a and -9a), 159.02 (NHCO2); LC-MS 
(ESI+): m/z (%) = 443.3 (100) [M+H]+; 465.2 (11) [M+Na]+; HR-MS (C25H34N2O5): 
calc: 442.2462; found: 442.2461. Compound has not been reported in the literature. 
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5.3.3  Batch Synthesis of Ddiv Group Precursor  
 
Dimedone (5.02 g, 36 mmol), isovaleric acid (4.31 mL, 39 mmol), DMAP (4.77 g, 39 
mmol) and EDCI.HCl (7.48 g, 39 mmol) were dissolved in DMF (70 mL), and left to 
stir at room temperature overnight. The solution was then concentrated in vacuo, re-
dissolved in DCM and washed with HCl (1 M, 2 x 50 mL) and saturated NaHCO3 
solution (2 x 50 mL). The organic layer was dried over MgSO4, filtered and 
concentrated in vacuo. The crude mixture was purified via flash column 
chromatography (60:40 petroleum ether / EtOAc) to give a yellow oil (5.33 g, 66% 








IR (neat): ν (cm-1) = 2957, 2871, 1665, 1551, 1448, 1387, 1369, 1316, 1148, 1095, 
1040, 918; 1H NMR (500 MHz, CDCl3): δ [ppm] = 0.96 [d, J = 6.7 Hz, 6H, 
CH(CH3)2], 1.07 [s, 6H, DdivC(CH3)2], 2.13 [sep., J = 6.7 Hz, 1H, CH(CH3)3], 2.35 
and 2.52 (br s, 4H, 2 x COCH2), 2.91 (d, J = 6.6 Hz, 2H, (CH3)2CHCH2); 
13C NMR 
(125 MHz, CDCl3): δ [ppm] = 22.75 [CH(CH3)2], 28.18 and 28.95 [CH(CH3)2], 29.73 
and 29.97 [DdivC(CH3)2], 37.55 [DdivC(CH3)2], 40.96 [(CH3)2CHCH2], 53.42 (2 x 
COCH2), 107.23 (NHC=C), 176.60 (NHC=C), 192.95 (2 x CO); LC-MS (ESI
+): m/z 
(%) = 225.2 (92) [M+H]+; 247.2 ((11) [M+Na]+ 
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Figure 5.4 Mono-Ddiv enamination via continuous flow synthesis. 
 
Flow Screening Procedure:  
 
Diamine 1a (0.10 M, 2 mL) and DdivOH (0.10 M, 2 mL) in MeOH were fed 
continuously into a PTFE reactor (0.50 mm I.D., 2.00 mL total volume) immersed in 
an oil bath set to the desired working temperature (120 or 130oC) and pressurised to 5 
bar. The reactants were introduced via two separate pre-conditioning segments of 
PTFE tubing (0.5 mm I.D., 0.18 mL volume) immersed in a temperature adjusted 
bath. The reactants converged in the T-mixer and the stoichiometry as well as 
residence time of the reaction were determined by adjusting the individual flow rates 
of the HPLC pumps.  The reaction stream (4 mL) was collected at steady state after 
1.5 reactor volume, into a flask filled with cold MeOH (10 mL, –20oC). An aliquot of 
the solution (5 µL) was sampled and added to an internal standard solution (methyl 
benzoate, 2 mM, 200 µL) and analysed via HPLC. The individual components 
(product, side product and internal standard) in the solution were monitored with UV 
detection at 254 nm and the integrated areas of their respective peaks were obtained. 
The product yield and product to side product ratio were established based on 
Equation 3: 
PTFE Reactor 
0.5 mm I.D., 2.00 mL 
PTFE tubing, 1.0 / 1.5 mm I.D. 
0.58 mL  
PTFE tubing, 0.5 mm I.D. 
0.18 mL; Immersed in oil 
bath at 130oC 
τ = 1.0 min, T = 130oC  
Q = 2.00 mLmin-1 





DdivOH / MeOH, 5.0 mmol, 0.10 M 
Q = 1.00 mLmin-1 
 
Crude collection into cold MeOH. 
Diamine / MeOH, 10.0 mmol, 0.20 M 
Q = 1.00 mLmin-1 
 
T-Mixer 










×=      (3) 
 
where DRFProduct (Detector Response Factor of the N-Ddiv compound) = 10.66 
 DRFSide Product (Detector Response Factor of the N,N-Ddiv compound) = 27.82  
  
General Scale-Out Procedure:  
 
Diamines 1a – 1g (0.10 M, 50 mL) and DdivOH (0.20 M, 50 mL) in MeOH were fed 
continuously into a PTFE reactor (0.50 mm I.D., 2.00 mL total volume) immersed in 
an oil bath set at the desired working conditions (130oC, 5 bar). The reactants were 
introduced via two separate pre-conditioning segments (130oC) of PTFE tubing (0.5 
mm I.D., 0.18 mL volume). The reactants converged in the T-mixer and the total flow 
rate of reaction stream was fixed at 2.00 mLmin-1 to give a residence time of 1.0 min. 
The reaction stream (100 mL) was collected at steady state after 1.5 reactor volume, 
into a flask filled with cold methanol (200 mL, –20oC) under rigorous stirring. The 
solution was concentrated in vacuo and the crude mixture was purified via flash 











Yield: 1.21 g (91%); yellow oil 
 
IR (neat): ν (cm-1) = 3355, 2956, 1632, 1565, 1028; 1H NMR (500 MHz, CDCl3): δ 
[ppm] = 0.99 [d, J = 6.7 Hz, 6H, CH(CH3)2], 1.03 [s, 6H, Dimedone(CH3)2], 1.51 (br 
s, 2H, NH2), 1.98 [sep., J = 6.8 Hz, 1H, CH(CH3)2], 2.34 – 2.40 (m, 4H, 2 x COCH2), 
3.00 – 3.02 [m, 3H, (CH3)2CHCH2, NH2CH2], 3.44 – 3.52 [m, 3H, NH2(CH2)2NH]; 
13C NMR (125 MHz, CDCl3): δ [ppm] = 22.60 [C(CH3)2], 28.22 and 28.98 
[C(CH3)2], 29.69 and 29.93 [DdivC(CH3)2], 37.55 [DdivC(CH3)2], 41.06 
[(CH3)2CHCH2, NH2CH2], 46.53 (NH2CH2CH2NH), 53.41 (2 x COCH2), 107.23 
(NHC=C), 176.60 (NHC=C), 192.95 (2 x CO); LC-MS (ESI+): m/z (%) = 267.1 
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(100) [M+H]+; 289.0 (8) [M+Na]+; HR-MS (C15H27N2O2): calc: 267.2067; found: 
267.2060. Compound has been reported in the literature as an intermediate in a 











Yield: 1.12 g (80%); yellow oil 
 
IR (neat): ν (cm-1) = 2957, 1638, 1567, 1466, 1318; 1H NMR (500 MHz, CDCl3): δ 
[ppm] = 0.98 [d, J = 6.7 Hz, 6H, CH(CH3)2], 1.02 [s, 6H, Dimedone(CH3)2], 1.52 (br 
s, 2H, NH2), 1.82 (quin., J = 6.8 Hz, 2H, NH2CH2CH2CH2NH), 1.97 [sep.,  J = 6.8 
Hz, 1H, CH(CH3)2], 2.36 (s, 4H, 2 x COCH2), 3.01 [br s, 2H, (CH3)2CHCH2], 2.86 (t, 
J = 6.8 Hz, 2H, NH2CH2), 3.52 – 3.56 (m, 2H, CH2NHC=C); 
13C NMR (125 MHz, 
CDCl3): δ [ppm] = 22.58 [C(CH3)2], 28.20 [C(CH3)2], 28.95 and 29.92  
[DdivC(CH3)2], 32.62 (NH2CH2CH2CH2NH),  37.34 [DdivC(CH3)2], 39.15 
[(CH3)2CHCH2, NH2CH2], 40.41 [NH2(CH2)2CH2NH], 41.21 (2 x COCH2), 107.07 
(NHC=C), 176.56 (NHC=C), 201.72 (2 x CO); LC-MS (ESI+): m/z (%) = 281.1 
(100) [M+H]+; 303.0 (8) [M+Na]+; HR-MS (C15H27N2O2): calc: 281.2224; found: 











Yield: 1.06 g (72%); yellow oil 
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IR (neat): ν (cm-1) = 3328, 2955, 1635, 1563, 1465, 1322, 1029; 1H NMR (500 MHz, 
CDCl3): δ [ppm] = 0.98 [d, J = 6.7 Hz, 6H, CH(CH3)2], 1.02 [s, 6H, 
Dimedone(CH3)2], 1.60 (quin., J = 7.4 Hz, 2H, NH2CH2CH2), 1.74 (quin., J = 7.4 Hz, 
2H, NH2(CH2)2CH2), 1.88 (br s, 2H, NH2), 1.96 [sep.,  J = 6.8 Hz, 1H, CH(CH3)2], 
2.35 (s, 4H, 2 x COCH2), 2.77 (t, J = 6.9 Hz, 2H, NH2CH2), 2.98 [br s, 2H, 
(CH3)2CHCH2], 3.46 (q, J = 6.1 Hz, 2H, CH2NHC=C); 
13C NMR (125 MHz, CDCl3): 
δ [ppm] = 22.59 [C(CH3)2], 26.73 [C(CH3)2], 28.19 and 28.95 [DdivC(CH3)2], 29.92 
[NH2(CH2)2CH2], 30.48 [NH2CH2CH2], 37.39 [DdivC(CH3)2], 41.50 [(CH3)2CHCH2, 
NH2CH2], 43.53 (CH2NHC=C), 53.12 (2 x COCH2), 107.02 (NHC=C), 176.44 
(NHC=C), 201.72 (2 x CO); LC-MS (ESI+): m/z (%) = 295.0 (100) [M+H]+; 317.0 
(8) [M+Na]+; HR-MS (C17H31N2O2): calc: 295.2380; found: 295.2382. Compound has 











Yield: 1.11 g (72%); yellow oil 
 
IR (neat): ν (cm-1) = 3333, 2943, 2831, 1626, 1566, 1450, 1106; 1H NMR (500 MHz, 
CDCl3): δ [ppm] = 0.98 [d, J = 6.7 Hz, 6H, CH(CH3)2], 1.02 [s, 6H, 
Dimedone(CH3)2], 1.44 – 1.55 (m, 4H, NH2CH2CH2CH2CH2), 1.70 (quin, J = 7.2 Hz, 
2H, [NH2(CH2)2CH2], 1.88 (br s, 2H, NH2), 1.96 [sep.,  J = 6.8 Hz, 1H, CH(CH3)2], 
2.36 (s, 4H, 2 x COCH2), 2.74 (t, J = 6.8 Hz, 2H, NH2CH2), 2.98 [br s, 2H, 
(CH3)2CHCH2], 3.44 (q, J = 6.4 Hz, 2H, CH2NHC=C); 
13C NMR (125 MHz, CDCl3): 
δ [ppm] = 22.60 [C(CH3)2], 24.17 [NH2(CH2)2CH2], 28.20 [C(CH3)2], 28.95 and 
29.13 [DdivC(CH3)2], 29.92 (CH2CH2NH), 32.74 (NH2CH2CH2), 37.39 
[DdivC(CH3)2], 41.66 [(CH3)2CHCH2, NH2CH2], 43.62 (CH2NHC=C), 53.12 (2 x 
COCH2), 107.00 (NHC=C), 176.41 (NHC=C), 205.95 (2 x CO); LC-MS (ESI
+): m/z 
(%) = 309.1 (100) [M+H]+; 331.1 (10) [M+Na]+; HR-MS (C18H33N2O2): calc: 
309.2537; found: 309.2537. Compound has not been reported in the literature. 
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2-{1-[(6-Aminohexyl)amino]-3-methylbutylidene}-5,5-dimethylcyclohexane-1,3-








Yield: 0.94 g (58%); yellow oil 
 
IR (neat): ν (cm-1) = 2955, 2867, 1637, 1569, 1466, 1321; 1H NMR (500 MHz, 
CDCl3): δ [ppm] = 0.98 [d, J = 6.7 Hz, 6H, CH(CH3)2], 1.02 [s, 6H, 
Dimedone(CH3)2], 1.36 – 1.53 [m, 6H, NH2CH2(CH2)3CH2], 1.68 (quin., J = 7.0 Hz, 
2H, CH2CH2NH), 1.95 [sep, J = 6.8 Hz, 1H, CH(CH3)2], 2.35 (br s, 4H, 2 x COCH2), 
2.72 (t, J = 7.0 Hz, 2H, NH2CH2), 2.98 [br s, 2H, (CH3)2CHCH2], 3.42 (q, J = 6.4 Hz, 
2H, CH2NHC=C); 
13C NMR (125 MHz, CDCl3): δ [ppm] = 22.59 [C(CH3)2], 26.42 
and 26.68 [C(CH3)2], 26.76 [NH2(CH2)2CH2], 27.14 [NH2(CH2)3CH2], 28.19 
[DdivC(CH3)2], 28.94 [DdivC(CH3)2], 29.22 (CH2CH2NH), 29.28 (NH2CH2CH2), 
32.88 [(CH3)2CHCH2], 37.39 (NH2CH2), 41.79 (CH2NHC=C), 43.64 (COCH2), 
51.20 (COCH2), 106.98 (NHC=C), 176.39 (NHC=C), 206.96 (2 x CO); LC-MS 
(ESI+): m/z (%) = 323.1 (100) [M+H]+; 345.1 (7) [M+Na]+; HR-MS (C19H35N2O2): 













Yield: 1.12 g (63%); yellow oil 
 
IR (neat): ν (cm-1) = 3313, 2942, 2830, 1449, 1114; 1H NMR (500 MHz, CDCl3): δ 
[ppm] = 0.98 [d, J = 6.7 Hz, 6H, CH(CH3)2], 1.02 [s, 6H, Dimedone(CH3)2], 1.77 [br 
s, 2H, NH2], 1.96 [sep., J = 6.8 Hz, 1H, CH(CH3)2], 2.36 (br s, 4H, 2 x COCH2), 2.88 
(t, J = 5.2 Hz, 2H, NH2CH2), 3.01 [br s, 2H, (CH3)2CHCH2], 3.53 [t, J = 5.2 Hz, 2H, 
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OCH2CH2NH), 3.62 – 3.63 (m, 2H, OCH2CH2NH), 3.66 – 3.72 [m, 6H, 
NH2CH2CH2O(CH2)2O]; 
13C NMR (125 MHz, CDCl3): δ [ppm] = 22.59 [C(CH3)2], 
28.19 and 28.95 [C(CH3)2], 29.68 and 29.90 [DdivC(CH3)2], 30.91 [DdivC(CH3)2], 
37.43 (CH2NHC=C), 41.71 (NH2CH2), 43.64 (CH2CH2NH), 51.20 (2 x COCH2), 
69.00 (OCH2CH2O), 70.26 (OCH2CH2O), 70.90 (OCH2CH2NH), 73.23 (NH2CH2), 
107.19 (NHC=C), 176.50 (NHC=C), 206.96 (2 x CO); LC-MS (ESI+): m/z (%) = 
355.1 (100) [M+H]+; 377.1 (15) [M+Na]+; HR-MS (C19H35N2O4): calc: 355.25913; 













Yield: 1.51 g (71%); yellow oil 
 
IR (neat): ν (cm-1) = 3312, 2942, 2830, 1567, 1449, 1115; 1H NMR (500 MHz, 
CDCl3): δ [ppm] = 0.98 [d, J = 6.7 Hz, 6H, CH(CH3)2], 1.02 [s, 6H, 
Dimedone(CH3)2], 1.75 [br s, 2H, NH2], 1.91 – 1.98 [m, 3H, CH(CH3)2, 
NH2CH2CH2], 2.36 (br s, 4H, 2 x COCH2), 2.81 (t, J = 6.7 Hz, 2H, NH2CH2), 3.01 
[br s, 2H, (CH3)2CHCH2], 3.54 – 3.65 (m, 16H, ether bridge);  
13C NMR (125 MHz, 
CDCl3): δ [ppm] = 22.56 [C(CH3)2], 28.20 and 28.94 [C(CH3)2], 29.46 and 29.92 
[DdivC(CH3)2], 32.93 [CH2 CH2NH, DdivC(CH3)2], 37.14 [NH2CH2CH2, 
(CH3)2CHCH2], 39.60 (NH2CH2), 40.59 (CH2NHC=C), 58.42 (2 x COCH2), 67.59 
[NH2(CH2)2CH2], 69.53 [OCH2(CH2)2NH], 70.14, 70.39, 70.51 and 70.56 (ether 
bridge), 107.06 (NHC=C), 176.64 (NHC=C), 206.96 (2 x CO); LC-MS (ESI+): m/z 
(%) = 427.1 (100) [M+H]+; 449.1 (12) [M+Na]+; HR-MS (C23H43N2O5): calc: 
427.31665; found: 427.31672. Compound has not been reported in the literature. 
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5.3.5 Stability Study of Mono-Ddiv Protected Compounds 
 
The N-Ddiv compounds (21, 23 – 28) were dissolved in MeOH to give a series of 
solutions. In general, an aliquot of the N-Ddiv solution (100 µL) was added to an 
internal standard solution (methyl benzoate, 2 mM, 400 µL) and analysed via HPLC. 
The mono-protected compound and internal standard were monitored with UV 
detection at 254 nm and the integrated areas of their respective peaks were obtained. 













.Conc ×=       (3) 
 
where DRFNDdiv (Detector Response Factor of the N-Ddiv compound) = 10.66 
 
Subsequently, the sample was heated to 80oC for 16.5 h and re-analysed accordingly. 
Using Equation 3, the final concentration of the mono-protected compound was 
computed and in all cases, the calculated concentrations were adjusted for the dilution 
factor of sample preparation. A calibration curve of compound concentration against 
time was plotted and the half life of the N-Ddiv compound was then determined from 
the calibration curve.  
 








H2N NHDdiv2  
1.58 0.04 y = -0.0933x + 1.58 
b H2N NHDdiv3  
2.20 0.05 y = -0.1303x + 2.2 
c H2N NHDdiv4  
1.63 0.49 y = -0.0691x + 1.63 
d H2N NHDdiv5  
1.49 0.68 y = -0.0491x + 1.49 
e H2N NHDdiv6  





1.79 0.16 y = -0.0988x + 1.79 
g H2N O NHDdiv3  
1.10 0.35 y = -0.0455x + 1.1 










5.4 Experimental for Chapter 3 
 




Benzyl 2-bromoacetate (5.55 mL, 35 mmol) in MeCN (600 mL) was added dropwise 
into a stirred solution of 2 (7.53 g, 35 mmol) and DIPEA (12.0 mL, 87.5 mmol) in 
MeCN (600 mL) at room temperature. The reaction was left to stir for 21 h and 
concentrated in vacuo. The crude mixture was dissolved in EtOAc and washed with 
brine solution (3 x 50 mL). The organic layer was concentrated in vacuo and purified 
via flash column chromatography (silica gel, 60:40 hexane / EtOAc) to give 29a (7.51 
g, 59% yield; yellow oil). 
 
Flow Screening Procedure:  
 
Mono-Boc diamine 2 (40 mM) and base (3.0 equiv) in MeCN (0.5 mL), along with 
benzyl 2-bromoacetate (40 mM) in MeCN (0.5 mL) were fed continuously into a 
PTFE reactor (0.50 mm I.D., 2.00 mL total volume) immersed in an oil bath set to the 
desired working temperature (80 – 130oC) and pressurised to 2 bar. The reactants 
were introduced via two separate pre-conditioning segments of PTFE tubing (0.5 mm 
I.D., 0.18 mL volume) immersed in a temperature adjusted bath. The reactants 
converged in the T-mixer and the residence time of the reaction (3 or 5 min) was 
determined by adjusting the total flow rate of the HPLC pump-driven reaction stream.  
The reaction stream (1 mL) was collected at steady state after 1.5 reactor volume, into 
a vial filled with cold MeCN (4 mL, -20oC) containing an excess of trisamine 
scavenger (13 mg, 20 µmol) under stirring and subsequently, filtered off. An aliquot 
of the diluted solution (100 µL) was sampled and added to an internal standard 
solution (methyl benzoate, 1 mM, 100 µL) and analysed via HPLC. The individual 
components (product, side product and internal standard) in the solution were 
monitored with UV detection at 254 nm and the integrated areas of their respective 
peaks were obtained. The product yield and product to side product ratio were 











×=     (3) 
 
where DRFProduct (Detector Response Factor of 29a) = 0.173 
DRFSide Product (Detector Response Factor of 29b) = 0.540  
 



















Figure 5.5 Selective mono-alkylation via continuous flow synthesis. 
 
Mono-Boc diamine 2 or 10 (40 mM, 8 mmol) and DIPEA (4.2 mL, 24 mmol) in 
MeCN (200 mL), along with benzyl 2-bromoacetate (40 mM, 1.3 mL, 8 mmol) in 
MeCN (200 mL) were fed continuously into a PTFE reactor (0.50 mm I.D., 4.00 mL 
total volume) immersed in an oil bath set at 130oC and pressurised to 2 bar. The 
reactants were introduced via two separate pre-conditioning segments (temperature 
set at 130oC) of PTFE tubing (0.5 mm I.D., 0.18 mL volume). The reactants 
converged in the T-mixer and the total flow rate of reaction stream was fixed at 1.33 
mLmin-1 to give a residence time of 3.0 min. The reaction stream (400 mL) was 
collected at steady state after 1.5 reactor volume, into a flask filled with cold MeCN 
(400 mL, -20oC) containing an excess of trisamine scavenger (3.04 g, 4.8mol; 
assuming 70% alkylation efficiency) under rigorous stirring. The solution was filtered 
off and concentrated in vacuo. The crude mixture was purified via flash column 
chromatography (silica gel, 60:40 hexane / EtOAc) to give: 
T-Mixer 





N-Boc-1,6-diaminohexane 14 / MeCN 
8.0 mmol, 40 mM, Q = 0.67 mLmin-1 
 
Crude collection into cold MeCN with 
excess Trisamine scavenger. 
Benzyl 2-bromoacetate / MeCN 
8 mmol, 40 mM, Q = 0.67 mLmin-1 
 
PTFE Reactor 
0.5 mm I.D., 4.00 mL 
PTFE tubing, 1.0 / 1.5 mm I.D. 
0.58 mL  
PTFE tubing, 0.5 mm I.D. 
0.18 mL; Immersed in oil 
bath at 130oC 
τ = 3.0 min, T = 100oC 
Q = 1.33 mLmin-1 
BPR P = 2 bar 
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Yield: 1.95 g (67%); yellow oil  
 
IR (neat): ν (cm-1) = 3361, 2929, 2857, 1687, 1518, 1389, 1167; 1H NMR (500 MHz, 
CDCl3): δ [ppm] = 1.29 – 1.32 [m, 4H, BocNH(CH2)2(CH2)2], 1.43 [s, 9H, C(CH3)3], 
1.46 – 1.49 [m, 4H, BocNHCH2CH2(CH2)2CH2], 2.58 (t, J = 7.2 Hz, 2H, 
CH2NHCH2CO), 3.09 – 3.10 (m, 2H, CH2NHCO), 3.44 (s, 2H, NHCH2CO), 5.16 (s, 
2H, CO2CH2Ph), 7.30 – 7.38 (m, 5H, C6H5); 
13C NMR (125 MHz, CDCl3): δ [ppm] = 
26.58 [BocNH(CH2)2CH2], 26.81 [BocNH(CH2)3CH2], 28.40 [C(CH3)3], 29.88 
(BocNHCH2CH2), 29.94 (CH2CH2NHCH2), 40.47 (CH2NHCO), 49.43 
(CH2NHCH2CO), 50.92 (NHCH2CO), 66.52 (CO2CH2Ph), 79.02 [C(CH3)3], 128.34, 
128.37, 128.58 and 135.59 (C6H5), 155.97 [CO2C(CH3)3], 172.45 (CO2Bn); LC-MS 
(ESI+): m/z (%) = 365.3 (99) [M+H]+; 387.3 (5) [M+Na]+; HR-MS (C20H32N2O4): 

















Yield: 1.90 g (60%); yellow oil 
 
IR (neat): ν (cm-1) = 3335, 2867, 1705, 1517, 1365, 1249, 1172; 1H NMR (500 MHz, 
CDCl3): δ [ppm] = 1.43 [s, 9H, C(CH3)3], 2.82 (t, J = 5.2 Hz, 2H, CH2NHCH2CO), 
3.30 – 3.31 (m, 2H, CH2NHBoc), 3.50 (s, 2H, NHCH2CO), 3.52 (t, J = 5.1 Hz,  2H, 
CH2CH2NHCH2CO), 3.58 – 3.60 [m, 6H, CH2O(CH2)2O(CH2)2NHBoc], 5.16 (s, 2H, 
CO2CH2Ph), 7.31 – 7.38 (m, 5H, C6H5); 
13C NMR (125 MHz, CDCl3): δ [ppm] = 
28.40 [C(CH3)3], 40.35 (CH2NHBoc), 48.69 (CH2NHCH2CO), 50.89 (NHCH2CO), 
66.49 (CO2CH2Ph), 70.13, 70.23 and 70.69 (ether bridge), 79.09 [C(CH3)3], 128.34, 
128.57 and 135.61 (C6H5), 156.02 [CO2(CH3)3], 172.23 (CO2Bn); LC-MS (ESI
+): 
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m/z (%) = 397.2 (99) [M+H]+; 419.2 (26) [M+Na]+; HR-MS (C20H32N2O6): calc: 
396.2255; found: 396.2266. Compound has not been reported in the literature.  
 



























Figure 5.6 Selective mono-alkylation via continuous flow synthesis with in-line scavenging. 
 
Mono-Boc diamine 2 or 10 (40 mM, 4.9 mmol) and DIPEA (2.6 mL, 14.7 mmol) in 
MeCN (123 mL), along with benzyl 2-bromoacetate (40 mM, 0.8 mL, 4.9 mmol) in 
MeCN (123 mL) were fed continuously into a PTFE reactor (0.50 mm I.D., 4.00 mL 
total volume) immersed in an oil bath set at 130oC and pressurised to 2 bar. The 
reactants were introduced via two separate pre-conditioning segments (temperature 
set at 130oC) of PTFE tubing (0.5 mm I.D., 0.18 mL volume). The reactants 
converged in the T-mixer and the total flow rate of reaction stream was fixed at 1.33 
mLmin-1 to give a residence time of 3.0 min. Post back pressure regulator, the 
reaction stream was connected to a stainless steel scavenger column (0.5 x 6.0 cm, d x 
l) packed with trisamine scavenger (0.62 g, 0.98 mmol). The solution (246 mL) was 
collected at steady state after 1.5 reactor volume, into a flask filled with cold MeCN 





Pump 1 Pump 2 
N-Boc-1,6-diaminohexane / MeCN 
4.9 mmol, 40 mM, Q = 0.67 mLmin-1 
 
Crude collection into cold MeCN. 
Benzyl 2-bromoacetate / MeCN 
4.9 mmol, 40 mM, Q = 0.67 mLmin-1 
 
PTFE tubing, 1.0 / 1.5 mm I.D. 
0.58 mL  
PTFE tubing, 0.5 mm I.D. 
0.18 mL; Immersed in oil 
bath at 130oC 
SS column (0.5 x 6.0 cm, d x l) 




0.5 mm I.D., 4.00 mL 
τ = 3.0 min, T = 100oC 
Q = 1.33 mLmin-1 
P = 2 bar 
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via flash column chromatography (silica gel, 60:40 hexane / EtOAc) to give 29a (1.20 
g, 67% yield) or 32 (1.17 g, 60%).  
 








Fmoc-OSu (6.95 g, 21 mmol) was added into a stirred solution of 29a (7.51 g, 21 
mmol) in MeCN (200 mL). The reaction was left to stir overnight at room 
temperature. Subsequently, silica-based trisamine scavenger (6.00 g, 9.48 mmol) was 
added into the solution and the reaction was left to stir for 21 h. The scavenger resins 
were filtered off and the solution was concentrated in vacuo. The crude mixture was 
dissolved in EtOAc (50 mL) and washed with brine solution (3 x 50 mL). The organic 
layer was concentrated in vacuo to give 30 (12.09 g, 98% yield; yellow oil). 
 


















Figure 5.7 Fmoc carbamation via continuous flow synthesis. 
 
N
α-alkyl-Nω-Boc-diamines 29a or 32 (20 mM, 1.0 mmol) in MeCN (50 mL) and 
Fmoc-OSu (20 mM, 0.34 g, 1.0 mmol) in MeCN (50 mL) were fed continuously into 
a PTFE reactor (0.50 mm I.D., 2.00 mL total volume) immersed in water bath set at 
25oC. The reactants were introduced via two separate segments of PTFE tubing (0.5 
mm I.D., 0.18 mL volume). The reactants converged in the T-mixer and the total flow 
rate of reaction stream was fixed at 0.67 mLmin-1 to give a residence time of 3.0 min. 
Pump 1 Pump 2 
T-Mixer 
33 or 36 / MeCN, 1.0 mmol, 20 mM 
Q = 0.34 mLmin-1 
 
Crude collection into cold MeCN. 
Fmoc-OSu / MeCN, 1.0 mmol, 20 mM 
Q = 0.34 mLmin-1 
 
PTFE Reactor  
0.5 mm I.D., 2.00 mL 
PTFE tubing, 1.0 / 1.5 mm I.D. 
0.58 mL  
PTFE tubing, 0.5 mm I.D. 
0.18 mL 
τ = 3.0 min, T = 25oC 
Q = 0.67 mLmin-1 
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The reaction stream (100 mL) was collected at steady state after 1.5 reactor volume, 
into a flask filled with cold MeCN (100 mL, -20oC) under stirring and concentrated in 
vacuo. The crude mixture was dissolved in EtOAc (25 mL) and washed with brine 
solution (3 x 25 mL). The organic layer was concentrated in vacuo to give: 
 











Yield: 0.57 g (98%); yellow oil 
 
IR (neat): ν (cm-1) = 3371, 2932, 2854, 1739, 1705, 1682, 1524, 1446, 1195, 1168; 1H 
NMR (500 MHz, CDCl3) two rotamers: δ [ppm] = 1.24 – 1.27 [m, 4H, 
(CH2)2(CH2)2NHBoc], 1.44 – 1.45 [m, 9H, C(CH3)3], 1.60 [s, 4H, 
CH2(CH2)2CH2CH2NHBoc], 3.08 – 3.09 (m, 2H, CH2NHBoc), 3.14 and 3.32 (t, J = 
7.6 Hz, 2H, CH2NR’R”), 3.94 and 4.01 (s, 2H, NR’CH2CO2Bn), 4.25 (t, J = 6.1 Hz, 
1H, CH-9), 4.38 and 4.51 (d, J = 6.4 Hz, 2H, NCO2CH2CH-9), 5.11 and 5.16 (s, 2H, 
CO2CH2Ph), 7.27 – 7.41 (m, 9H, C6H5 and CH-2/7 and CH-3/6), 7.52 – 7.58 (d, J = 
7.5 Hz, 2H, CH-1/8), 7.73 – 7.79 (m, 2H, CH-4/5); 13C NMR (125 MHz, CDCl3): two 
rotamers δ [ppm] = 26.23 [CH2(CH2)2NHBoc], 26.38 and 26.49 [CH2(CH2)3NHBoc], 
27.79 (CH2CH2NR’R”), 28.22 and 28.42 [C(CH3)3], 29.88 and 29.98 
(CH2CH2NHBoc), 40.44 (CH2NHBoc), 47.24 and 47.25 (CH-9), 48.75 and 48.81 
(CH2NR’R”), 50.35 (NR’CH2CO2Bn), 66.91 (CO2CH2CH-9), 67.29 and 67.55 
(CO2CH2Ph), 126.97 (CH-3/6), 127.01 and 127.07; 127.58 and 127.63 (C6H5), 
128.30 (CH-2/7), 128.37 (CH-4/5), 128.45 (CH-1/8), 128.55 and 128.58 (C6H5), 
141.26 and 141.37 (CH-4a/4b), 141.51 (C6H5), 143.93 and 143.97 (CH-8a/9a), 
155.86 and 155.96 (NR’CO2CH2CH-9), 156.45 [NHCO2(CH3)3], 169.49 and 169.58 
(NHR’CH2CO2Bn); LC-MS (ESI
+): m/z (%) = 587.4 (51) [M+H]+; 609.4 (97) 
[M+Na]+; HR-MS (C35H42N2O6): calc: 586.3037; found: 586.3043. Spectral data are 


















Yield: 0.61 g (98%); yellow oil 
 
IR (neat): ν (cm-1) = 3352, 2867, 1747, 1702, 1501, 1451, 1364, 1244, 1173, 1139, 
1001; 1H NMR (500 MHz, CDCl3): two rotamers δ [ppm] = 1.43 [s, 9H, C(CH3)3], 
3.27 – 3.28 (m, 2H, CH2NHBoc), 3.34 – 3.41 and 3.46 – 3.50 (m, 8H, ether bridge), 
3.56 – 3.58 and 3.61 – 3.63 (m, 2H, CH2NR’R”), 3.94 and 4.01 (s, 2H, 
NR’CH2CO2Bn), 4.25 (t, J = 6.1 Hz, 1H, CH-9), 4.37 and 4.51 (d, J = 6.5 Hz, 2H, 
NCO2CH2CH-9), 5.11 and 5.15 (s, 2H, CO2CH2Ph), 7.25 – 7.34 (m, 9H, C6H5 and 
CH-2/7 and CH-3/6), 7.36 – 7.41 (m, 2H, CH-1/8), 7.51 and 7.57 (d, J = 7.4 Hz, 2H, 
CH-4/5); 13C NMR (125 MHz, CDCl3): two rotamers δ [ppm] = 28.40 [C(CH3)3], 
40.28 (CH2NHBoc), 47.17 and 47.22 (CH-9), 48.46 (CH2NR’R”), 50.13 and 50.26 
(NR’CH2CO2Bn), 66.82 (CO2CH2CH-9), 67.46 and 67.71 (CO2CH2Ph), 70.06 and 
70.11 (CH2CH2NR’R”), 70.21 [CH2CH2O(CH2)2NHBoc], 70.23 and 70.25 
[CH2O(CH2)2NHBoc], 70.33 and 70.35 (CH2CH2NHBoc), 124.82 and 124.91 (CH-
3/6), 127.02 and 127.09; 127.64 and 127.67 (C6H5), 128.27 (CH-2/7), 128.35 (CH-
4/5), 128.41 (CH-1/8), 128.58 (C6H5), 141.26 and 141.35 (CH-4a/4b), 143.88 and 
143.93 (CH-8a/9a), 155.95 (NR’CO2CH2CH-9), 156.17 [NHCO2(CH3)3], 169.64 and 
169.70 (NHR’CH2CO2Bn); LC-MS (ESI
+): m/z (%) = 619.3 (25) [M+H]+; 641.4 
(100) [M+Na]+; HR-MS (C35H42N2O8): calc: 618.2936; found: 618.2933. Compound 
has not been reported in the literature. 
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Figure 5.8 Tandem alkylation and Fmoc carbamation via continuous flow synthesis. 
 
Mono-Boc diamine 2 or 10 (40 mM, 4.9 mmol) and DIPEA (2.6 mL, 14.7 mmol) in 
MeCN (123 mL), along with benzyl 2-bromoacetate (40 mM, 0.8 mL, 4.9 mmol) in 
MeCN (123 mL) were fed continuously into a PTFE reactor (0.50 mm I.D., 4.00 mL 
total volume) immersed in an oil bath set at 130oC and pressurised to 2 bar. The 










N-Boc-1,6-diaminohexane / MeCN 
4.9 mmol, 40 mM, Q = 0.67 mLmin-1 
 
Benzyl 2-bromoacetate / MeCN, 
4.9 mmol, 40 mM, Q = 0.67 mLmin-1 
 
PTFE Reactor 
0.5 mm I.D., 4.00 mL 
PTFE tubing, 1.0 / 1.5 mm I.D. 
0.58 mL  
PTFE tubing, 0.5 mm I.D. 
0.18 mL; Immersed in oil 
bath at 130oC 
τ = 3.0 min, T = 100oC 
Q = 1.33 mLmin-1 
SS column (0.5 x 6.0 cm, d x l) 
packed with Trisamine scavenger. 
P = 2 bar 
Fmoc-Cl / MeCN, 3.8 mmol 
15 mM, Q = 1.33 mLmin-1 
 
Crude collection into cold MeCN. 
PTFE Reactor, 0.5 
mm I.D., 8.00 mL 
τ = 3.0 min, T = 25oC 
Q = 2.66 mLmin-1 
PTFE tubing, 0.5 mm I.D. 
0.18 mL ; Immersed in water 
bath at r.t. 
PTFE tubing, 1.0 / 1.5 mm I.D. 
0.58 mL  
PTFE tubing, 0.5 mm I.D. 
0.18 mL 
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reactants were introduced via two separate pre-conditioning segments (temperature 
set at 130oC) of PTFE tubing (0.5 mm I.D., 0.18 mL volume). The reactants 
converged in the T-mixer and the total flow rate of reaction stream was fixed at 1.33 
mLmin-1 to give a residence time of 3.0 min. Post back pressure regulator, the 
reaction stream was connected to a stainless steel scavenger column (0.5 x 6.0 cm, d x 
l) packed with trisamine scavenger (0.62 g, 0.98 mmol). The exiting reaction stream 
(cooled via a segment of PTFE tubing immersed in water bath) and Fmoc-Cl (0.97 g, 
3.8 mmol) in MeCN (15 mM, 250 mL) was immediately fed into another PTFE 
reactor (0.50 mm I.D., 8.00 mL total volume) immersed in water bath set at 25oC. The 
reactants converged in the second T-mixer and the total flow rate of reaction stream 
was fixed at 2.66 mLmin-1 to give a residence time of 3.0 min. The reaction stream 
(492 mL) was collected at steady state after 1.5 reactor volume, into a flask filled with 
cold MeCN (200 mL, -20oC) under stirring and concentrated in vacuo. The crude 
mixture was purified via flash column chromatography (silica gel, 60:40 hexane / 
EtOAc) to give 30 (1.39 g, 69% yield; yellow oil) or 33 (1.87 g, 62% yield; yellow 
oil).  
 




Ammonium formate (3.25 g, 51 mmol) was added into a stirred solution of benzyl 2-
[(6-{[(tert-butoxy)carbonyl]amino}hexyl)[(9H-fluoren-9-ylmethoxy)carbonyl]amino] 
acetate 30 (12.09 g, 21 mmol) and 10% Pd/C (1.79 g, 1.68 mmol) in EtOH (525 mL). 
The solution was stirred vigorously and the progress of reaction was monitored by 
HPLC. After 19 min, the reaction was immediately quenched by filtering the solution 
through celite and the filtrate was concentrated in vacuo. The crude mixture was 
dissolved in EtOAc (50 mL) and washed with brine solution (3 x 50 mL). The organic 
layer was concentrated in vacuo and and purified via flash column chromatography 
(silica gel, 90:10 DCM / MeOH with 0.1% AcOH) to give a viscous yellow oil. The 
compound was subsequently recrystallised using hexane / EtOAc to give 31a (5.59 g, 
54% yield; white solid).  
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Batch-Mode Microwave Procedure: 
 
Fmoc protected Nα-alkyl-Nω-Boc-diamine 30 (0.48 or 1.20 mmol) and 10% Pd/C (4.5 
mol%) in EtOH (0.25 M) were microwave irradiated in the presence of H2 gas in a 
microwave module fitted with a gas addition unit. The reaction conditions (time, 
temperature and gas pressure) were adjusted accordingly via the control panel of the 
microwave module. The reaction was quenched by filtering the solution through 
celite. An aliquot of the diluted solution (100 µL) was sampled and added to an 
internal standard solution (aniline, 1 mM, 100 µL) and analysed via HPLC. The 
individual components (starting material, product and internal standard) in the 
solution were monitored with UV detection at 254 nm and the integrated areas of their 
respective peaks were obtained. The product yield and product to side product ratio 










×=          (3) 
 
where DRFProduct (Detector Response Factor of 31a) = 48.417  
 
Flow Screening Procedure: 
 
Fmoc protected Nα-alkyl-Nω-Boc-diamine 30 (7.5 µmol) and 1,4-cyclohexadiene (2.5 
equiv) in EtOH were prepared at different concentrations (15, 30 or 50 mM) and fed 
continuously into a modified H-Cube (generation of H2 gas was deactivated). The 
catalyst compartment was fitted with the catalyst of choice (CatCart’s 10% Pd/C or 
20% Pd(OH)2/C) and the desired working temperature was adjusted accordingly (25 
or 40oC). The contact time between the substrate and the catalyst was approximately 
23 sec based on the reaction stream flow rate of 1.00 mLmin-1. The reaction stream 
(1 mL) was collected at steady state after 1.5 CatCart volume, into a vial filled with 
cold EtOH (4 mL, -20oC) under stirring. An aliquot of the diluted solution (100 µL) 
was sampled and added to an internal standard solution (aniline, 1 mM, 100 µL) and 
analysed via HPLC. The individual components (starting material, product and 
internal standard) in the solution were monitored with UV detection at 254 nm and the 
integrated areas of their respective peaks were obtained. The product yield and 










×=          (3) 
 
where DRFProduct (Detector Response Factor of 31a) = 48.417  
 











Figure 5.9 Catalytic transfer flow hydrogenolysis. 
 
Fmoc protected Nα-alkyl-Nω-Boc-diamine 30 or 33 (15 mM, 2.9 mmol) and 1,4-
cyclohexadiene (0.7 mL, 7.3 mmol) in EtOH (192 mL) were fed continuously into a 
modified H-Cube (generation of H2 gas was deactivated). The catalyst compartment 
was fitted with CatCart’s 20% Pd(OH)2/C and the desired working temperature was 
set at 40oC. The contact time between the substrate and the catalyst was 
approximately 23 sec based on the reaction stream flow rate of 1.00 mLmin-1. The 
reaction stream (192 mL) was collected at steady state after 1.5 CatCart volume, into 
a flask filled with cold EtOH (100 mL, -20oC) under stirring and concentrated in 
vacuo. The crude mixture was dissolved in EtOAc (50 mL) and washed with brine 
solution (3 x 50 mL). The organic layer was concentrated in vacuo and and purified 
via flash column chromatography (silica gel, 90:10 DCM / MeOH with 0.1% AcOH) 
to give a viscous yellow oil. The compound was subsequently recrystallised using 
hexane / EtOAc to give: 
34 or 37 / EtOH, 2.9 mmol, 
15 mM, Q = 1.00 mLmin-1 
 
Pump Crude collection into 
cold EtOH. 
τ = 23 sec, T = 40oC 
Q = 1.00 mLmin-1 

















Yield: 1.00 g (70%); white solid  
 
M.p. 80 – 82oC; IR (neat): ν (cm-1) = 3359, 2978, 2930, 2851, 1728, 1680, 1519, 
1416, 1367, 1168, 960, 918; 1H NMR (500 MHz, CDCl3): two rotamers δ [ppm] = 
1.21 – 1.34 [m, 8H, R’R”NCH2(CH2)4CH2NHBoc], 1.44 [s, 9H, C(CH3)3], 3.08 – 
3.09 (m, 2H, CH2NHBoc), 3.13 and 3.33 (t, J = 7.2 Hz, 2H, CH2NR’R”), 3.90 and 
3.98 (s, 2H, NR’CH2CO2H), 4.20 – 4.25 (m, 1H, CH-9), 4.43 and 4.54 (d, J = 5.3 Hz, 
2H, NCO2CH2CH-9), 7.27 – 7.32 (m, 2H, CH-2/7), 7.36 – 7.41 (m, 2H, CH-3/6), 
7.57 (t, J = 8.7 Hz, 2H, CH-1/8), 7.75 (t, J = 8.1 Hz, 2H, CH-4/5); 13C NMR (125 
MHz, CDCl3): two rotamers δ [ppm] = 25.96 and 26.15 [CH2(CH2)2NHBoc], 26.21 
and 26.31 [CH2(CH2)3NHBoc], 27.76 and 28.09 (CH2CH2NR’R”), 28.41 [C(CH3)3], 
29.69 (CH2CH2NHBoc), 40.40 (CH2NHBoc), 47.26(CH-9), 48.53 and 48.78 
(CH2NR’R”), 50.35 (NR’CH2CO2H), 67.39 and 67.70 (CO2CH2CH-9), 79.33 
[C(CH3)3], 124.77 and 124.93 (CH-3/6), 127.05 (CH-2/7), 127.61 (CH-4/5), 127.67 
(CH-1/8), 141.30 and 141.38 (CH-4a/4b), 143.87 and 143.93 (CH-8a/9a), 155.96 
(NR’CO2CH2CH-9), 156.78 [NHCO2(CH3)3], 172.63 (NHR’CH2CO2H); LC-MS 
(ESI+): m/z (%) = 519.3 (38) [M+Na]+; HR-MS (C28H36N2O6): calc: 496.2568; found: 
496.2560. Spectral data are consistent with the literature.X 
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2-(12-{[(tert-Butoxy)carbonyl]amino}-1-(9H-fluoren-9-yl)-3-oxo-2,7,10-trioxa-4-














Yield: 1.04 g (68%); yellow oil 
 
IR (neat): ν (cm-1) = 2870, 2248, 1692, 1511, 1476, 1451, 1409, 1365, 1244, 1139, 
998, 909; 1H NMR (500 MHz, CDCl3): two rotamers δ [ppm] = 1.44 [s, 9H, 
C(CH3)3], 3.30 – 3.67 (m, 12H, ether bridge), 4.1 (s, 2H, NR’CH2CO2H), 4.21 – 4.26 
(m, 1H, CH-9), 4.38 and 4.52 (br s, 2H, NCO2CH2CH-9), 7.29 – 7.32 (m, 2H, CH-
2/7), 7.36 – 7.41 (m, 2H, CH-3/6), 7.57 (d, J = 7.4 Hz,  CH-1/8), 7.75 (t, J = 6.8 Hz, 
2H, CH-4/5); 13C NMR (125 MHz, CDCl3): two rotamers δ [ppm] = 28.40 [C(CH3)3], 
40.26 (CH2NHBoc), 47.16 and 47.21 (CH-9), 48.40 (CH2NR’R”), 50.59 
(NR’CH2CO2H), 67.44 (CO2CH2CH-9), 67.99 (CH2CH2NR’R”), 69.98 
[CH2CH2O(CH2)2NHBoc], 70.07 [CH2O(CH2)2NHBoc], 70.25 (CH2CH2NHBoc), 
124.81 (CH-3/6), 125.07 (CH-2/7), 127.07 (CH-4/5), 127.62 (CH-1/8), 141.23 and 
141.34 (CH-4a/4b), 143.90 (CH-8a/9a), 156.02 (NR’CO2CH2CH-9), 156.19 
[NHCO2(CH3)3], 172.27 and 172.44 (NHR’CH2CO2H); LC-MS (ESI
+): m/z (%) = 
529.3 (32) [M+H]+; 551.3 (99) [M+Na]+; HR-MS (C28H36N2O8): calc: 528.2466; 











5.5 Experimental for Chapter 4 
 
5.5.1 Rink Amide Functionalisation of Aminomethyl Polystyrene Resins 
 
Fmoc-linker (0.60 g, 1.11 mmol, 3 equiv) and Oxyma (0.16 g, 1.11 mmol, 3 equiv) 
were dissolved in DMF (0.37 M, 3 mL) and left to mix via shaking for 5 – 10 min. 
DIC (0.17 mL, 1.11 mmol, 3 equiv) was subsequently added to the mixture and 
shaken for another 2 min. The final mixture was added to the aminomethyl PS resins 
(0.30 g, 0.37 mmol) and left to react on the rotary wheel for 1.5 h. The reaction 
solution was drained and the resins washed with DMF, DCM and MeOH (3x each). 
The progress of reaction was monitored with ninhydrin test and a yellow ninhydrin 
solution was indicative of a complete coupling reaction.  
 
5.5.2 Solid Phase Synthesis of Standard Peptoids 
 
20% piperidine in DMF (1.00 mL) was added to the Rink amide-functionalised 
aminomethyl PS resins (60 mg, 44.37 µmol) and left to react for 15 min. The Fmoc 
deprotection step was performed twice at room temperature. The resins were washed 
with DMF and DCM (3x each) after the cleavage cocktail was drained off. Monomer 
31a (44 mg, 88.74 µmol, 2 equiv) and Oxyma (13 mg, 88.74 µmol, 2 equiv) were 
dissolved in DMF (0.15 M, 0.60 mL) and left to mix via shaking for 5 – 10 min. DIC 
(0.17 mL, 1.11 mmol, 2 equiv) was subsequently added to the mixture and shaken for 
another 2 min. The final mixture was added to the Fmoc-deprotected resins (60 mg, 
44.37 µmol) and left to react on the rotary wheel for 30 min at room temperature. The 
reaction solution was drained and the resins washed with DMF, DCM and MeOH (3x 
each).  
For oligomers > 5 residues, the coupling reaction was heated to 60oC for 15 
min, followed by an extended 15 min of mechanical agitation at room temperature. 
The coupling and deprotection protocol was reiterated until the desired oligomer back 
bone length was achieved. N-Fmoc-6-aminohexanoic acid (31 mg, 88.74 µmol, 2 
equiv) was added to the final residue, followed by 5(6)-carboxyfluorescein (33 mg, 
88.74 µmol, 2 equiv). The coupling and Fmoc deprotection conditions were as 
previously stated. The progress of reaction was monitored with chloranil test and blue 
beads were indicative of a complete coupling reaction. The target compound was 
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cleaved from the solid support with the addition of 95% TFA : 2.5% TIS : 2.5% H2O 
(1.00 mL). The reaction was left on the rotary wheel for 3 h at room temperature.  
The reaction solution was drained from the solid phase cartridge and collected 
into an Eppendorf tube. The beads were rinsed twice with the cleavage cocktail and 
the TFA solution concentrated with N2 gas to a minimal volume. Cold diethyl ether 
was added into the Eppendorf tube to precipitate the oligomer. The precipitate was 
centrifuged at 4oC and 104 RPM for 10 min. The ether solution was decanted and the 
solid precipitate was sonicated upon the addition of fresh diethyl ether. The rinsing 
cycle was repeated thrice, and the precipitate was blown dry with N2 gas and left in 
the desiccator overnight. The oligomer was dissolved in H2O and analysed via HPLC 

















n = 5      S5  
   = 7      S7
   = 9      S9
 
 
Standard Pentamer S5 
 
Yield: 40 mg (71%); yellow solid  
 
UV/Vis HPLC (495 nm): tR = 2.46 and 2.64 min; MALDI (C67H104N12O12): calc: 
1269.6159; found: 1269.8614. Melting point was not measured.  
 
Standard Heptamer S7 
 
Yield: 42 mg (60%); yellow solid 
 
UV/Vis HPLC (495 nm): tR = 2.30 and 2.39 min; MALDI (C83H136N16O14): calc: 
1582.0667; found: 1582.7013. Melting point was not measured. 
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Standard Nonamer S9 
 
Yield: 46 mg (55%); yellow solid 
 
UV/Vis HPLC (495 nm): tR = 2.13 and 2.32 min; MALDI (C99H168N20O16): calc: 
1894.5176; found: 1895.3915. Melting point was not measured. 
 
 
5.5.3 Microwave-Assisted Solid Phase Synthesis of TEG Peptoids 
 
20% piperidine in DMF (1.00 mL) was added to the Rink amide-functionalised 
aminomethyl PS resins (60 mg, 44.37 µmol) and left to react for 15 min. The Fmoc 
deprotection step was performed twice at room temperature. The resins were washed 
with DMF and DCM (3x each) after the cleavage cocktail was drained off. Monomer 
34 (47 mg, 88.74 µmol, 2 equiv) and Oxyma (13 mg, 88.74 µmol, 2 equiv) were 
dissolved in 3 : 1 of DMF : DCM (0.14 M, 0.63 mL) and left to mix via shaking for 5 
– 10 min. DIC (0.17 mL, 1.11 mmol, 2 equiv) was subsequently added to the mixture 
and shaken for another 2 min. The final mixture was added to the Fmoc-deprotected 
resins (60 mg, 44.37 µmol) and microwave irradiated for 25 min at 70oC. The reaction 
solution was drained and the resins washed with DMF, DCM and MeOH (3x each).  
Once the first residue was successfully coupled, the subsequent Fmoc 
deprotection procedure was performed twice via microwave irradiation at 60oC for 10 
min. The coupling and deprotection protocol was reiterated until the desired oligomer 
back bone length was achieved. N-Fmoc-6-aminohexanoic acid (31 mg, 88.74 µmol, 
2 equiv) was added to the final residue, followed by 5(6)-carboxyfluorescein (33 mg, 
88.74 µmol, 2 equiv). The coupling and Fmoc deprotection conditions were as 
previously stated. The progress of reaction was monitored with chloranil test and blue 
beads were indicative of a complete coupling reaction. The target compound was 
cleaved from the solid support with the addition of 95% TFA : 2.5% TIS : 2.5% H2O 
(1.00 mL). The reaction was left on the rotary wheel for 3 h at room temperature. 
The reaction solution was drained from the solid phase cartridge and collected 
into an Eppendorf tube. The beads were rinsed twice with the cleavage cocktail and 
the TFA solution concentrated with N2 gas to a minimal volume. Cold petroleum 
ether was added into the Eppendorf tube and the mixture was centrifuged at 4oC and 
104 RPM for 10 min. The petroleum ether solution was decanted and the immiscible 
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oil was sonicated upon the addition of fresh petroleum ether. The rinsing cycle was 
repeated thrice, and the viscous oil was blown dry with N2 gas and left in the 
















(TEG = Triethylene glycol)
n = 5      T5  
   = 7      T7
   = 9      T9
 
 
TEG Pentamer T5 
 
Yield: 29 mg (45%); orange-red oil  
 
UV/Vis HPLC (495 nm): tR = 2.42 and 2.52 min; MALDI (C67H104N12O22): calc: 
1429.6099; found: 1429.7113 
 
TEG Heptamer T7 
 
Yield: 34 mg (42%); orange-red oil 
 
UV/Vis HPLC (495 nm): tR = 2.22 and 2.33 min; MALDI (C83H136N16O28): calc: 
1806.0583; found: 1806.2077 
 
TEG Nonamer T9 
 
Yield: 37 mg (38%); orange-red oil  
 
UV/Vis HPLC (495 nm): tR = 2.10 and 2.19 min; MALDI (C99H168N20O34): calc: 
2182.5068; found: 2183.4156 
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5.5.4 Microwave-Assisted Solid Phase Synthesis of Hybrid Peptoids 
 
20% piperidine in DMF (1.00 mL) was added to the Rink amide-functionalised 
aminomethyl PS resins (60 mg, 44.37 µmol) and left to react for 15 min. The Fmoc 
deprotection step was performed twice at room temperature. The resins were washed 
with DMF and DCM (3x each) after the cleavage cocktail was drained off. Monomer 
31a or 34 (88.74 µmol, 2 equiv) and Oxyma (13 mg, 88.74 µmol, 2 equiv) were 
dissolved in 3 : 1 of DMF : DCM (0.14 M, 0.63 mL) and left to mix via shaking for 5 
– 10 min. DIC (0.17 mL, 1.11 mmol, 2 equiv) was subsequently added to the mixture 
and shaken for another 2 min. The final mixture was added to the Fmoc-deprotected 
resins (60 mg, 44.37 µmol) and microwave irradiated for 25 min at 70oC. The reaction 
solution was drained and the resins washed with DMF, DCM and MeOH (3x each).  
Once the first residue was successfully coupled, the subsequent Fmoc 
deprotection procedure was performed twice via microwave irradiation at 60oC for 10 
min (up to 7 residues). The Fmoc deprotection cocktail was changed to 4% DBU : 4% 
piperidine in DMF for octamer and beyond. The coupling (performed using 31a and 
34 in successive manner) and deprotection protocol was reiterated until the desired 
oligomer back bone length was achieved. N-Fmoc-6-aminohexanoic acid (31 mg, 
88.74 µmol, 2 equiv) was added to the final residue, followed by 5(6)-
carboxyfluorescein (33 mg, 88.74 µmol, 2 equiv). The coupling and Fmoc 
deprotection conditions were as previously stated. The progress of reaction was 
monitored with chloranil test and blue beads were indicative of a complete coupling 
reaction.  
The target compound was cleaved from the solid support with the addition of 
95% TFA : 2.5% TIS : 2.5% H2O (1.00 mL). The reaction was left on the rotary 
wheel for 3 h at room temperature. The reaction solution was drained from the solid 
phase cartridge and collected into an Eppendorf tube. The beads were rinsed twice 
with the cleavage cocktail and the TFA solution concentrated with N2 gas to a 
minimal volume. Cold petroleum ether was added into the Eppendorf tube and the 
mixture was centrifuged at 4oC and 104 RPM for 10 min. The petroleum ether 
solution was decanted and the immiscible oil was sonicated upon the addition of fresh 
petroleum ether. The rinsing cycle was repeated thrice, and the viscous oil was blown 
dry with N2 gas and left in the desiccator overnight. The oligomer was dissolved in 



















n = 2      H5  
   = 3      H7
   = 4      H9
 
 
Hybrid Pentamer H5 
 
Yield: 7 mg (12%); orange-red oil  
 
UV/Vis HPLC (495 nm): tR = 2.49 and 2.60 min; MALDI (C67H104N12O16): calc: 
1333.6135; found: 1333.8332 
 
Hybrid Heptamer H7 
 
Yield: 6 mg (8%); orange-red oil 
 
UV/Vis HPLC (495 nm): tR = 2.31 and 2.42 min; MALDI (C83H136N12O20): calc: 
1678.0631; found: 1679.0334 
 
Hybrid Nonamer H9 
 
Yield: 4 mg (5%); orange-red oil  
 
UV/Vis HPLC (495 nm): tR = 2.19 min; MALDI (C99H168N20O24): calc: 2022.5128; 
found: 2023.5198 
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5.5.5 Biological Evaluation of Peptoids 
 
Cells were grown in DMEM or Ham’s F12 medium supplemented with glutamine (4 
mM), 10% FCS and 100 UmL-1 of penicillin / streptomycin in T75 cell culture flasks 
until 70% confluence. The cells were maintained in a humid chamber at 37°C in an 
atmosphere of 5% CO2. 
 
5.5.5.1 Cell Viability Assays 
 
For cell viability assays, 1 x 104 cells per well were seeded in 96-well plates and 
incubated overnight. Twenty four hours after the addition of the peptoids (10 µM), 
cell death was measured using an MTT cell proliferation assay. Absorbance was 
spectrophotometrically measured at 570 nm. For the propidium iodide (PI) cell death 
assay, 3 x 104 cells per well were seeded in 48-well plates and incubated overnight. 
The following day, the test compounds were mixed with the corresponding medium to 
give a final concentration of 10 µM. The old media were removed from the wells and 
the cells were washed twice with warm phosphate buffer saline (PBS) solution. The 
peptoid / media mixture was added (250 µL or 1.6 mL to each 48- or 6-well plate, 
respectively). Each experiment was performed in triplicate. After incubating the cells 
for a specific duration (at 37ºC and 5% CO2), they were washed twice with PBS and 
incubated with the fluorochrome solution (0.1% wt/v sodium citrate, 0.1% v/v Triton 
X-100 and 50 mgL-1 PI in distilled water) for 1 h at 4°C. The cells were washed again 
with PBS and detached with trypsin / EDTA. They were harvested with 2% fetal 
bovine serum (FBS) in PBS, centrifuged and resuspended with 2% FBS in PBS 
(supplemented with Trypan Blue [0.04%]), and analysed using a BD FACSAria® flow 
cytometer.  
 
5.5.5.2 Cellular Uptake Assays 
 
Cells were suspended using 0.25% trypsin / EDTA and counted. For the flow 
cytometry assay, 3 x 104 cells per well were seeded in 48-well plates and incubated 
overnight. For the confocal assays, 4 x 105 cells were seeded onto glass cover slip 
within a 6-well plate. The following day, the test compounds were mixed with the 
corresponding medium to give a range of concentrations (1.0, 2.5 or 10.0 µM).  The 
old media were removed from the wells and the cells were washed with warm 
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phosphate buffer saline (PBS) solution. The peptoid / media mixture was added (250 
µL or 1.6 mL to each 48- or 6-well plate, respectively). Each experiment was 
performed in triplicate. After incubating the cells for a specific duration (at 37ºC and 
5% CO2), they were washed twice with PBS and detached with trypsin / EDTA. They 
were harvested with 2% fetal bovine serum (FBS) in PBS, centrifuged and 
resuspended with 2% FBS in PBS (supplemented with Trypan Blue [0.04%]), and 
analysed using a BD FACSAria® flow cytometer.  
 
5.5.5.3 Confocal Microscopy Analysis 
 
The cells used for confocal microscopy imaging were fixed with paraformaldehyde 
(4% w/v in PBS) and the nuclei were stained with Hoechst-33342 (1% w/v in PBS). 
Cellular fluorescence of fixed cells was analyzed by confocal microscopy using a 
Leica SP5 Confocal Microscope under laser excitation at 488 nm and 407 nm, 
respectively.  
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